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Scope of Thesis 
In this thesis two very different types of ligand classes are brought together, namely                
N-heterocyclic carbenes (NHCs) and carboranes. Chapter one discusses the fundamental 
structure and bonding involved in these two types of compound. An account of the synthetic 
strategies employed in the literature for the synthesis of NHCs and carboranes, and the 
techniques employed to coordinate these ligands to various metal centres is discussed. 
Chapter two discusses the synthetic strategies explored towards a new hybrid ligand scaffold 
that fuses N-heterocyclic carbenes (NHCs) and o-carborane. A focal point of this work was to 
demonstrate the tailorability of this novel ligand system. A detailed account of the techniques 
employed for the characterisation of these novel ligands is given.  
Chapter three discusses the synthetic challenges associated with deprotonation of the 
zwitterionic ligand precursors reported in Chapter 2. A deprotonation study revealed that the 
ligand must possess an ethyl linker or longer between the imidazolium and the carborane for a 
free carbene to be isolated. Subsequent coordination to various metal centres, including 
titanium, iron and rhodium, is explored.  
The synthesis and full characterisation of RhI-NHC complexes that exhibit closo-carboranyl 
substituents is described in Chapter four. These complexes display unprecedented chemistry 
with a rare example of a RhI-metallacycle coordinating through both the NHC and the carbon 
vertex of the carborane. The catalytic activity of these complexes was probed in the 
hydrosilylation of acetophenone. 
Chapter five investigates the application of our NHC-carborane ligands to the higher oxidation 
states of RhIII and IrIII as well as RuII. We have discovered that the nature of the α-substituent of 
the NHC, as well as reaction conditions, can determine the vertex at which cyclometallation 
occurs. A series of IrIII complexes were successfully cyclometallated through the NHC and 
either a carbon atom or the B3/B6 vertex of the cage. Examination of the Ir complexes in the 
transfer hydrogenation of acetophenone revealed that cyclometallation through the carborane 
has a profound effect on the catalytic activity, indicating a bifunctional mechanism and 
involvement of the carborane moiety. 
Chapter six describes the diverse coordination modes of NHC-carborane ligands at AgI. The 
steric nature of the ligand precursor plays a crucial role in the overall stability and the type of 
silver complex formed, with the first structurally elucidated example of AgI directly bound 
through the carborane reported. In addition, a series of carboranyl complexes derived from the 
natural product theobromine were synthesised. The antiproliferative properties of these 
complexes against the HCT116 (colon) cancer cell line was evaluated. 
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DCM   Dichloromethane 
DFT   Density Functional Theory 
DMSO  Dimethyl sulfoxide 
DSD   Diamond-Square-Diamond 
δ   chemical shift 
e.d  electron density 
ee  enantiomeric excess 
eq  equivalent 
ESI   Electron Spray Ionisation 
Et2O  Diethyl ether 
g   grams 
HMQC  Heteronuclear Multiple-Quantum Correlation 
HRMS   High Resolution Mass Spectrometry 
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J  NMR coupling constant 
K  kelvin 
m-  meta- 
LDA  Lithium diisopropylamide 
LiHMDS Lithium bis(trimethylsilyl)amide 
M+   Parent ion 
M  Metal 
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  Chapter 1
Introduction 
 
In this thesis two very different types of ligand classes are brought together, namely                
N-heterocyclic carbenes (NHCs) and carboranes. This chapter discusses the fundamental 
structure and bonding involved in these two types of compound. An account of the synthetic 
strategies employed in the literature for the synthesis of NHCs and carboranes, and the 
techniques employed to coordinate these ligands to various metal centres is discussed. 
 
1.1 Structure and bonding of boranes and their derivatives 
The behaviour of boron atoms originates from their electron deficiency, i.e. from the presence 
of only three bonding electrons and four available atomic orbitals. As a consequence, in order 
for boron to satisfy the octet rule it can partake in a combination of 2c2e (two-centre,           
two-electron) and 3c2e (three-centre, two-electron) electron-pair bonds. This can be observed 
in the simplest of boron hydrides (B2H6) in which four of the valence electrons, two of which 




Figure 1.1 Structure of B2H6. 
The most unique property of boron is its ability to form polyhedral skeletons, comprised of 
combinations of 2c2e and 3c2e bonds, with the principle building block consisting of triangular 
boron facets (1) (Figure 1.2).  Every additional boron atom combines with one or more edges 
forming a new triangular face, and due to the approximate sp3-hybridisation of each boron, 
triangles joined at an edge possess an obtuse angle (2). Successive addition of boron atoms 












Figure 1.2 Successive building of boranes: the principle building blocking (1), obtuse angle 
formed upon addition of another boron (2), nest structure (3) and the closed icosahedron (4). 
A common misconception is that these polyhedral structures are electron deficient, when in 
truth they have precisely the right number of orbitals and electrons for maximum stability. To 
illustrate this the different types of localised bonds involved in the molecular structure of    
nido-2,3-C2B4H8 is presented (Figure 1.3). The structure possesses a total of ten 2c2e bonds (2 
C−H, 2 C−B, 4 B−H, 1 C−C and 1 B−B) and four 3c2e bonds (2 B−H−B and 2 C−B−B), 
requiring fourteen electron pairs, which are supplied by two carbons, four borons, and eight 
hydrogens. In addition, each carbon and boron has four neighbouring atoms, requiring four 






Figure 1.3 Molecular structure of nido-2,3-C2B4H8 and the different types of localised bonds.2 
The requirement for a precise number of orbitals and electrons led to Lipscomb and co-workers 
developing a topological model, which predicted a limited range of possible structures for any 
given borane, and could even predict those yet to be discovered.3 The theory worked well for 
smaller boranes but failed at predicting larger structures. In 1971, Wade’s rules were developed 
for predicting the structure of boranes, which not only worked but can also be easily applied to 
heteroboranes and other main group cluster compounds.4 The method simply involves counting 
the number of skeletal electrons to determine the geometry of the cage. For a detailed account 
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1.2 Nomenclature  
Dicarba-dodecaborane (C2B10H12) possesses three common isomeric forms; 1,2- (ortho), 1,7- 
(meta) and 1,12- (para), with the numbers describing the positioning of the CH vertices in the 
cage.  The numbering of the cage starts at the top vertex and successive belts are numbered in a 
clockwise fashion. Heteroatoms are numbered corresponding to their atomic number, with 
atoms of the highest atomic number usually holding the highest precedence (Figure 1.4). In 
this thesis, ortho- meta- and para- or o-, m- and p- are used interchangeably for brevity. The 
loss of a BH vertex gives the corresponding nido-dicarbaundecaborates, with the numbering of 
the cage now starting at the opposing vertex to the open face. In this thesis, the numbering 
system of the cage does not change upon loss of a BH vertex which simplifies matters when 
discussing the vertices of a cage between an ortho-carboranyl compound and its nido-derivative 
(Figure 1.5).  
 
Figure 1.4 Numbering system used in the literature for ortho- meta- and para-carborane and 





Figure 1.5 The numbering system adopted in this thesis. 
 
 
  CHAPTER 1 
 
 4 
1.3 Synthesis of carboranes 
1.3.1 Alkyne insertion  
The synthesis of o-carborane (3), involves the insertion of carbon into a polyborane framework, 
namely decaborane (1). Electron donors such as MeCN readily react with 1 to form the 
considerably more stable Lewis base adduct B10H12(MeCN)2 (2).5 Alkynes are the most 
commonly employed insertion reagents, and the reaction of 2 with acetylene gives 3 in high 
yields, with the carbon atoms of acetylene becoming the vicinal carbon atoms in the cage 
(Scheme 1.1).6 In practice, the Lewis base adducts are usually not isolated, and the reaction can 
be conducted in a one pot synthesis by treating 1 with an alkyne in the presence of an electron 
donor. It is noteworthy that acetylene is an extremely flammable gas and requires an elaborate 





Scheme 1.1 Carborane synthesis via alkyne insertion.4,5 
o-Carborane is the most widely utilised of its 3 isomers, and its derivatives are reported with 
numbers into the thousands with an extensive compilation gathered in Grimes’s book 
“Carboranes (Second edition)”.2 By simply changing the substituent on the alkyne one has 
access to a plethora of potential carborane derivatives. However, there is one major drawback 
to this synthetic method; attaching bulky substituents directly to the alkyne, or use of alkynes 
which possess high Lewis basicity, leads to unfavourable carborane formation and the products 
are obtained in very low yields. The mechanism for insertion of the alkyne into the polyborane 
framework is complex, though the widely accepted mechanism includes two reactive 
intermediates: 1) the dissociation of a molecule of the electron donor (MeCN) (4), which is 
postulated following kinetic studies,10,11 and 2) the coordination of the alkyne to 4 (4.adduct), 










Scheme 1.2 Plausible mechanism for carborane formation via alkyne insertion. 
This long standing issue of being restricted to alkynes that do not possess high Lewis basicity 
or bulky substituents directly attached to the vicinal carbons has led a number of researchers 
looking at why carborane formation is so unfavourable, and to optimise reaction conditions 
(Figure 1.6). The first milestone came through the work of Sneddon and co-workers in 2004, 
who reported the use of ionic liquids, which not only increased the yield but allowed products 
from internal alkynes to be isolated, which by conventional methods either fail or give much 
lower yields.12 Almost a decade later, Valliant’s preliminary work with AgNO3 as a 
heterogeneous catalyst was able to drastically improve the yields using a range of substituted 
alkynes with B10H12(MeCN)2.13 It was proposed that the alkyne coordinates to silver, lowering 
both its Lewis basicity and the activation energy to formation of the desired product. A year 
later, Valliant reported the synthesis of a tailored homogenous catalyst allowing some reactions 








Figure 1.6 Evolution of carborane synthesis via the alkyne insertion route.6,12-14 
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1.3.2 Metalation at the C-vertex 
An alternative synthetic route to substituted carboranes is to functionalise o-carborane directly 
through deprotonation of the most acidic carboranyl protons with a strong base such as nBuLi, 
to give C-lithiated carborane 6 (Scheme 1.3, A). It is noteworthy that 6 exists in equilibrium 
with the parent carborane (3) which often leads to a mixture of mono- (6) and di-C-substituted 
(7) products. This complication can be averted by either carrying out the lithiation in 
dimethoxyethane, which affords 6 exclusively, or by blocking the C2- position with a silyl 
moiety (8) that can later be removed to give the desired mono-substituted product (10) 
(Scheme 1.3, B). This synthetic method is considered much more versatile in comparison to the 
alkyne insertion method (see Grimes’s book and references therein for a detailed account of the 
chemical transformations in which lithiated carboranes such as 3, 7 and 9 have been utilised).2 
 

















Metallacarboranes fall into one of two classes, π- or σ-metallacarboranes, with the former 
describing the bonding of a metal through the open face of the carborane cluster. Conversely, a 
metal can bind through a linked periphery of the icosahedral cage, through a boron or carbon 
vertex. This chapter will focus on π-metallacarboranes, with exo-metallated derivatives 
discussed in later chapters.  
The field of metallacarborane chemistry was developed on the basis of two key chemical 
advances. The first was the degradation reaction of o-carborane to the dianion [C2B9H11]2-,15 
and the second was the reaction of this species with FeCl2 to give the first metallacarborane 
reported by Hawthorne and co-workers in 1965 (Scheme 1.4).16 The open face of the 
dicarbollide dianion [C2B9H11]2- is considered isolobal to that of the cyclopentadienide ion 
[C5H5]-, with an η5-coordination to the metal centre. The Fe metallacarborane showed improved 
stability over its Cp analogue achieved through ‘peanut-like’ bonding, which describes the 
more effective orbital overlap between the two icosahedral clusters and the metal centre 
(Scheme 1.4). Furthermore, due to the divalent charge of the dicarbollide ligands they are able 
to stabilise complexes of higher oxidation state with Fe metallacarboranes preferring the Fe3+ 









Scheme 1.4 Synthesis of the first metallacarborane and a representation of the orbitals in    
nido-carborane and Cp.2 
Preparative routes to metallacarboranes are both diverse and plentiful, but the most utilised due 
to its versatility and accessibility is through 7,8-RR’C2B9H92-, which yields 12-vertex 
icosahedral closo-MC2B9 clusters.2,17–19 Scheme 1.5 presents some of the synthetic methods 
employed for the synthesis of these clusters. 
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1.5 Isomerisation of the icosahedral cage  
As previously discussed, dicarba-dodecaborane (C2B10H12) can exist in three common isomeric 
forms 1,2- (ortho), 1,7- (meta) and 1,12- (para) (Figure 1.4). 1,7- and 1,12- isomers are 
accessible through thermal rearrangement with temperatures of 450 and 700 °C required to 
convert 1,2- to 1,7-,20 and 1,7- to 1,12 respectively.21 The precise mechanism of isomerisation 
has never been fully understood due to the high temperatures required preventing isolation of 
intermediates. Moreover, there is evidence for the scrambling of not only the carbon atoms but 
also the boron atoms indicating the reaction may proceed via more than one mechanism.22 
Nonetheless, this hasn’t stopped mechanisms from being proposed. The first was reported by 
Lipscomb and termed the ‘diamond-square-diamond’ mechanism (Scheme 1.6).23 This 
describes the breaking of an edge shared between two adjacent vertices, and formation of a new 
edge between two vertices perpendicular to the break. This theory applied well to the 
isomerisation of 1,2- to 1,7- with a proposed ‘cuboctahedral intermediate’, however, this 
mechanism was quickly rejected when the mechanism failed to conclude the formation of the 
para-isomer. The revised mechanism reported by Dvorak quite simply describes the rotation of 











Scheme 1.6 Proposed isomerisation mechanisms of o-carborane.20,22  
Although this mechanism arrives at the 1,12- isomer, computational studies rule it out due to 
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The first progresses towards understanding the polyhedral rearrangement mechanism was upon 
the realisation that replacement of a boron vertex with a metal lowered the rearrangement 
barrier, allowing experimental investigations to be carried out at lower temperatures. 
Hawthorne pioneered this field and published the first examples of metallacarboranes, which 
thermally isomerise at 200 °C (Figure 1.7).25 Over the course of the next 5 years, the 
isomerisation of cyclopentadienyl-π-dicarbollyl derivatives of cobalt became well established 
but required much higher temperatures to isomerise (400-700 °C).26,27 The isomerisation of 
other metallacarboranes was not so well-known and it was a decade later that Hawthorne 
published an iridium metallacarborane (3,3-(PPh3)2-3-H-3,1,2-IrC2B9H11) that was capable of 
isomerisation at reflux in toluene.28 
 
Figure 1.7 Examples of metallacarboranes that thermally isomerise.25,26,27,28 
This chemistry then became stagnant until the mid 1990s when Welch et al. revolutionised the 
field with reports on isomerisation of sterically crowded metallacarboranes at room 
temperature.29 Welch went on to identify a key intermediate in the isomerisation reaction of a 
molybdenum metallacarborane, which had previously only been identified theoretically 
(Scheme 1.7).30 Over the course of the next twenty years, more examples of complexes which 
exhibit low temperature polytopal rearrangement have been reported.31–34 These low 
temperature isomerisation complexes give chemists the opportunity to study the mechanism 
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1.6 Carbenes, singlet or triplet? 
A carbene is a divalent carbon centre that has six valence electrons and no formal charge. The 
carbene can adopt either a linear or bent geometry, which governs the hybridisation of the 
carbon centre as either sp or sp2-hybridised (Figure 1.8). The former consists of two degenerate 
non-bonding p-orbitals (px and py) each containing one unpaired electron. This gives linear 
carbenes triplet multiplicity. Carbenes which adopt a bent geometry break this degeneracy as a 
result of the stabilisation of the px orbital as it acquires some s-orbital character, thus is 
renamed the σ-orbital. The py orbital remains essentially unchanged and is referred to as the   
pπ-orbital. The vast majority of carbenes adopt a bent geometry, therefore their frontier orbitals 
are assigned σ and pπ-orbitals. Carbenes which possess a bent geometry have the possibility to 






Figure 1.8 Schematic representation of the geometry and hybridisation states of carbenes. 
The multiplicity of a bent carbene is dictated by the energy difference between the σ and        
pπ-orbitals. Hoffman and Gleiter illustrated computationally that the singlet ground state is 
bound to a large energy separation between the σ and pπ-orbitals, whilst the triplet ground state 
favours smaller energy separations.35 The energy separation is influenced significantly by the 
steric and electronic nature of the α-substituents neighbouring the carbene centre (Figure 
1.9).36 For example, bulky α-substituents can be used to obtain carbenes which adopt triplet 
multiplicity through increasing the carbene bond angle. The carbene bond angle approaches 
linearity to minimise steric repulsion between the two α-substituents, whilst also stabilising the 
triplet state as the σ and pπ-orbitals approach degeneracy. Carbenes, which possess triplet 
multiplicity, are known for their high reactivity and are commonly termed ‘di-radicals’. 
The electronic influence of the α-substituents consist of a combination of both inductive and 
mesomeric effects, though the later dominates. The mesomeric effect describes the movement 
of π-electrons within a conjugated system, and π-donating groups such as F, Cl, NR2, PR2 and 
OR can donate electron density into the pπ-orbital. This increases the pπ-orbital energy, which 
leads to a larger σ and pπ-orbital separation favouring a carbene with singlet multiplicity and a 
bent geometry.  
















Figure 1.9 Orbital energy diagrams illustrating how the electronic and steric nature of the       
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1.7 N-Heterocyclic Carbenes (NHCs) 
NHCs primarily consist of a constrained 5-membered ring with diamino α-substituents. They 
are often termed persistent carbenes, and their inherent stability arises from mesomeric 
interactions of both nitrogen lone pairs with the empty pπ-orbital of the carbene. Inductive 
stability is also provided through the electron withdrawing nature of the diamino α-substituents. 
These strong interactions lead to carbene centres being sp2-hybridised with singlet multiplicity, 
therefore acting as a highly nucleophilic species. As a result they are considered very strong 
Lewis base donors. 
Carbenes were first proposed theoretically in 1958 by Breslow, who was studying the role of a 
coenzyme thiamine, and suggested that the enzyme is activate upon deprotonation of the 
thiazolium (Scheme 1.8, A).37 In 1962, Wanzlick attempted to isolate a free carbene species 
(1,3-diphenylimidazolidin-2-ylidene) by thermal elimination of chloroform (Scheme 1.8, B).38 
However, due to the reactive nature of such species only the dimer was observed. The first 
example of isolating a crystalline NHC came through the independent research of Arduengo in 
1991 (Scheme 1.8, C).39 Arduengo utilised an imidazolium salt bearing bulky adamantane 
groups and deprotonated the salt with a strong base (NaH) to give the persistent carbene. 
Scheme 1.8 Deprotonation of coenzyme thiamine generating active species (A),37 attempted 
synthesis of 1,3-diphenylimidazolidin-2-ylidene (B),38 and preparation of the first crystalline 
NHC (C).39 
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1.8 Synthesis of imidazolium salts 
The isolation of the first stable NHC by Arduengo gave rise to a new class of ligand precursor, 
imidazolium salts. One of the most popular synthetic routes to symmetrical imidazolium salts 
involves the condensation of glyoxal with a substituted amine (2 eq) and paraformaldehyde in 
the presence of hydrochloric acid. This is a modification to the Debus-Radziszewski reaction 
and was patented by Arduengo in 1991 (Scheme 1.9, A).40 Although this reaction is relatively 
facile the workup can often be tedious due to the number of by-products, and for the sterically 
bulky IPr.HCl this reaction is ineffective. In this case, Arduengo and co-workers found that 
starting from a diimine and reacting with chloromethyl-ethyl ether gave IPr.HCl in respectable 
yields (Scheme 1.9, B).41 These synthetic routes remain the most commonly employed methods 
for forming symmetrical imidazolium salts to date. When asymmetrical salts are required a 
two-step synthesis can be employed involving reaction of a substituted imidazole with an 
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1.9 N-heterocyclic carbene (NHC) complex synthesis  
1.9.1 Transmetallation from silverI 
Without question, transmetallation from AgI is one of the most widely adopted methods for 
forming transition metal-NHC complexes. The low bond strength of the Ag-Ccarbene bond 
coupled with the precipitation of a silver halide, which possesses a high lattice enthalpy, gives 
rise to a strong driving force for the transmetallation reaction to occur. The first reported     
AgI-NHC complex was reported by Arduengo and co-workers in 1993.43 Yet the use of AgI-
NHCs as carbene transfer agents was not realised until 1998 when Lin and co-workers isolated 
AuI and PdII complexes by reacting the corresponding AgI-NHC complex with Au(SMe)2Cl and 








Scheme 1.10 Synthesis of AuI- and PdII-NHC complexes via AgI transmetallation.44 
It is noteworthy that transmetallation from other transition metals has been reported and these 
include CuI 45,46 and NiII 47 with the same general concept that the resulting complex forms a 
stronger metal-Ccarbene bond. 
 
1.9.2 Formation of a free NHC and subsequent metallation 
Generation of the free NHC generally requires the use of a strong base, with Arduengo’s 
synthesis being the principle synthetic strategy employed. The free carbene is subsequently 
reacted with a metal salt (Scheme 1.11, A), or used to replace a labile phosphine as reported by 
Nolan and co-workers (Scheme 1.11, B).48,49 The choice of base can lead to variations in the 



















Scheme 1.11 Synthesis of a AuI-NHC complex (A) and a Ru-NHC complex (Grubbs, 2nd 
generation catalyst) via the free carbene (B).48,49 
 
1.9.3 In situ deprotonation and metallation 
A related method to the formation of a free NHC is the in situ deprotonation of the imidazolium 
salt and metallation. This method does not require such a strong base with NaOAc,51–53 and 
K2CO354 amongst the most popular bases employed. As an example, Richeter et al. utilised an 
imidazolium based porphyrin with K2CO3 and [Rh(COD)Cl]2 in toluene at room temperature to 
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1.9.4 In situ metallation with a basic metal precursor 
This synthetic method was in fact the first utilised to synthesise a transition metal-NHC 
complexes with Öfele and Wanzlick both independently reporting the method in 1968.55,56 
Similarly to transmetallation via silver, this route takes advantage of the relatively acidic nature 
of the NCHN proton and the reagents utilised tend to be acetates,57 oxides,58 alkoxides59 or 










Scheme 1.13 Examples of transition metal complexes synthesised from basic metal 
precursors.57–60 
1.9.5 Electrochemical method 
The first example of an electrochemical synthesis to preparing metal-NHCs was reported by 
Chen and co-workers in 2011.61 During the electrochemical reaction, an imidazolium ion is 
reduced at the cathode, releasing H2 forming the free NHC. This is accompanied by the 
oxidation of the anode generating M+ ions in solution. These two species then combine to 
produce a metal-NHC complex (Scheme 1.14, A). The Willans group reported a valuable 
extension to this work by preparing both neutral and cationic CuI-NHC complexes selectively 
(Scheme 1.14, B).62 The major advantage of this synthetic route is basic conditions are not 
necessary, with base-sensitive substituents being compatible, thus significantly widening the 
range of metal-NHC complexes that may be developed. The diversity of this synthetic method 
was later demonstrated with the preparation of a range of metal-salen/salan complexes 
(Scheme 1.14, C).63 Willans and co-workers then translated this batch process into flow, with 
the development a highly efficient electrochemical flow-cell capable of generating CuI-NHC 
complexes under neutral and ambient conditions.64 
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Scheme 1.14 Electrochemical synthesis of metal-NHC complexes (A), an example of Cu-NHC 
complexes (B) and metal-salen/salan complexes (C) prepared by Willans and co-workers using 
the electrochemical method.62–64 
 
1.10 Fusion of NHCs and carboranes 
Although both NHCs and carboranes are two very well established fields, the idea of fusing the 
two to create a brand new ligand class has only very recently been developed. In parallel to our 
work, Lavallo and co-workers reported an anionic imidazolium salt bearing two                
carba-closo-dodecaborate N-substituents (12), which was prepared by reacting the 
corresponding diimine (11) with paraformaldehyde and HCl (Scheme 1.15).65 Deprotonation of 
2 with bases of varying sterics led to isolation of three very different carbene species; 
employing LDA led to isolation of an abnormal carbene (13), the sterically less demanding 
amide of LiHMDS selectively deprotonates the C2 position (14), whilst nBuLi deprotonates 
both sites when used in excess to give 15. In a follow up report Lavallo reported the synthesis 
of unsymmetrical N-carboranyl NHCs,66 and went on to publish anionic and zwitterionic AuI 
complexes (Figure 1.10).67 Future reports look to utilise these Au(I) complexes in catalysis and 
look into preparing polyhalogenated carboranyl NHCs which posses even larger steric profiles. 













Scheme 1.15 An anionic imidazolium salt bearing two carba-closo-dodecaborate N-substituents 





Figure 1.10 AuI complexes bearing N-carboranyl NHCs ligands.67 
 
1.11 Preliminary work and project aims 
Willans and co-workers reported the reaction of the free carbenes 1,3-dimethylimidazol-2-
ylidene (1) and 1-methyl,3-ethylimidazol-2-ylidene (2) with ortho-carborane in a 3:1 ratio to 
give stable 1:2 carborane-NHC adducts 19 and 20 (Scheme 1.16).68 The nature of the α-
substituent of the NHC is crucial to its formation; when the significantly more bulky NHC (18) 
is employed an unusual imidazolium salt with a two-cage anion (21) is formed. The unique 
steric profiles of the 1:2 NHC adducts make them attractive precursors to metallacarboranes. 
The initial work carried out in this thesis looked at coordinating 20 to an Fe centre. Typically 
metallacarboranes are prepared by deprotonation of nido-carboranes with NaH under 
anhydrous conditions, and subsequently a metal salt such as FeCl2 is added (Section 1.4).69 
Unfortunately, all attempts at forming a metallacarborane with 20 were unsuccessful, and 
through deprotonation studies of 20 with NaH it was concluded that the bridging proton of the 
carborane could not be selectively deprotonated.  











Scheme 1.16 Deprotonation and deboronation of o-carborane with NHCs.68 
This work inspired the design of a brand new ligand class, with the aim of exploring the 
possibility of fusing NHCs with carboranes through the α-substituent of the NHC and the 
carboranyl carbon atoms. This would allow the carbenic carbon to be available for metal 
binding, with the possibility of also coordinating through a carbon or boron atom of the ortho-
carborane, forming chelating complexes. Removal of a BH vertex should also allow for 
selective deprotonation of the bridging proton of a nido-carborane, allowing us to exploit the 
different properties of both moieties within one system and enabling the synthesis of mono- and 





Figure 1.11 Proposed new ligand class. 
The Willans group holds strong interests in the synthesis of novel organometallic complexes, 
and their potential as catalysts and as anticancer agents. These novel systems will be fully 
characterised by multinuclear NMR spectroscopy, HRMS, micro-analysis and X-ray diffraction 
analysis. The ultimate goal is to understand the properties of these unique complexes and 
evaluate their viability as catalysts in the hydrosilyation of ketones and transfer hydrogenation 
of acetophenone to 1-phenylethanol. In addition, selected complexes will be screened against 
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  Chapter 2
Dicarba-dodecaboranes bearing imidazolium tethers 
 
This chapter discusses the synthetic strategies explored towards a new hybrid ligand scaffold 
that fuses N-heterocyclic carbenes and dicarba-dodecaborane, also known as o-carborane. A 
focal point of this work was to demonstrate the tailorability of this novel ligand system. A 
detailed account of the techniques employed for the characterisation of these novel ligands is 
given.  
 
2.1 New hybrid ligand scaffold  
2.1.1 Ligand synthesis 
A variety of routes are known for the preparation of imidazolium salts, including nucleophilic 
substitution of an N-substituted imidazole with an alkyl halide. Haloalkyl-substituted               
o-carboranyl compounds can be synthesised via a two step procedure that is used to prepare   
C-substituted carboranes. Treatment of decaborane (1) with MeCN yields the considerably 
more stable Lewis base (2), which is subsequently reacted with the corresponding 
commercially available alkyne to give P1.1 in high yield (70 %) (Scheme 2.1). In practice, the 
Lewis base adducts are usually not isolated. However, decaborane slowly forms polymeric 
materials overtime, so it is therefore more cost effective to store decaborane as one of its Lewis 
base adducts if the compound is going to be stored for a prolonged period of time.  
Scheme 2.1 Preparation of C-substituted o-carborane precursor P1.1. 
 tBu-imidazole (I1), which is prepared from a modification to the Debus-Radziszewski1,2  
synthesis for imidazole, is reacted with P1.1 in a 1:1 ratio under hydrous conditions, and 
induces deboronation to give the zwitterionic ligand precursor L1.2 in excellent yield (82 %) 
(Scheme 2.2). Theoretical calculations3–5 and isolation of key intermediates experimentally 
(Adduct I6,7 and Adduct II8) have allowed a widely accepted mechanism for deboronation of               
o-carborane to be proposed (Scheme 2.3). Deboronation by alkoxides,9,10 amines11 and 
fluorides12–15 is well documented and typically a carborane/base ratio of 1:2 is required for 
complete deboronation.  
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The unusual course of reacting I1 with P1.1 is due to the introduction of a strongly electron 
withdrawing substituent (i.e. an imidazolium) into the cage. This increases the susceptibility of 
the most electropositive boron atoms to nucleophilic attack by I1, and based on the accepted 
mechanism for deboronation, affords Adduct I’ (Scheme 2.4). This then reacts with another 
molecule of I1 forming Adduct II’, which results in deboronation and then protonation to 
afford L1.2 and regenerate the nucleophile.  








Scheme 2.3 General mechanism for deboronation of o-carborane.8 
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Scheme 2.4 Proposed deboronation mechanism of L1.1 leading to formation of L1.2. 
From the mechanism proposed; if two molecules of I1 are required for deboronation of L1.1, it 
is surprising that L1.2 is obtained in such high yields when a 1:1 ratio of P1.1:I1 is used, as I1 
is consumed during the reaction on formation of L1.1. This suggests that the rate of 
deboronation is faster than nucleophilic substitution or that deboronation is facilitated by H2O, 
for which there is literature precedent when the α-substituent of the cage is strongly electron 
withdrawing.16–18 However, when repeating the reaction under strict anhydrous conditions the 
zwitterionic product is still isolated. There is literature precedent for deboronation of               
o-carborane promoted by a fluoride anion, but to the best of our knowledge there is no evidence 
of this occurring via the softer bromide nucleophile. To investigate the bromide anion as a 
possible promoter of deboronation an alternative synthetic strategy was employed. To eradicate 
the use of the basic imidazole in the formation of L1.1, the alkyne substituted imidazolium salt 
P1.2 was prepared from literature procedure,19 and subsequently reacted with B10H12(MeCN)2 
under anhydrous conditions (Scheme 2.5).  
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Scheme 2.5 Attempted synthesis of L1.1. 
Analysis of the crude product indicated L1.1 was not present and only the deboronated product 
L1.2 was observed suggesting that the bromide counterion partakes in deboronation, and 
illustrates the instability of the cage in the presence of a bromide anion. 
As a means to increase the stability of the cage in L1.1 towards deboronation, the length of the 
alkyl linker was increased. As mentioned previously, one of the longstanding problems in 
carborane synthesis is the dramatic drop in yield when reacting longer chain alkynes with 
B10H12(MeCN)2 (Chapter 1, Section 1.3.1). As a consequence, 1-bromoethyl-o-carborane (P2.2) 
was prepared in 35 % yield using this method. In order to form the desired product in higher 
yields via this synthetic route, the Lewis basicity of the alkyne needs to be low enough for 
hydroboration to be unfavourable. Valliant et al. reported that adding a catalytic amount of 
AgNO3 (0.02 mmol) to the reaction significantly increases the yield, and it was proposed that 
the silver coordinates to the alkyne lowering both its Lewis basicity and the activation energy 
to formation of the desired product.20 However, in this report these reactions were conducted on 
a very small scale (B10H12(MeCN)2 = 0.27 mmol), and it was found in our laboratory that these 
reactions are scale sensitive with no improvement on yield observed when 4.9 mmol of 
B10H12(MeCN)2 was employed.  
An alternative synthetic approach to P2.2, which was obtained in high yields, has recently been 
reported by Oldfield and co-workers (Scheme 2.6).21 The synthesis requires the use of           
nBuLi to deprotonate the acidic carboranyl proton in o-carborane, followed by the addition of 
ethylene oxide to form hydroxyethyl-o-carborane (P2.1). This can be converted to the alkyl 
bromide P2.2 by reacting with triphenyl phosphine and N-bromosuccinimide (NBS) in 
anhydrous DCM, at 0 °C for 3 hours. Reaction of P2.2 with tBu-imidazole in a 1:1 ratio gives 
the closo-carboranyl imidazolium bromide salt L2.1 in high yield (71 %), whereas an excess of 
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2.2 Characterisation of ligand precursors 
Successful formation of the closo-carboranyl imidazolium bromide salt L2.1 and zwitterionic 
ligand precursors L1.2 and L2.2 was confirmed using 1H, 11B, and 13C NMR spectroscopy, 
HRMS, micro-analysis and X-ray diffraction analysis. 
 
2.2.1 1H and 13C{1H} NMR spectroscopy 
Comparison of the multinuclear NMR spectroscopic analysis of L2.1 and L2.2 shows the 
diagnostic differences between closo- and nido-carboranyl compounds. The 1H NMR spectrum 
of L2.1 exhibits a broad resonance in the baseline between 3 and 0 ppm arising from the BH 
protons of the cage (Figure 2.1, B). This B-H region appears less resolved in comparison to the 
spectrum of o-carborane, which possess more defined peaks (Figure 2.1, A). The broadening 
of these peaks is a result of the protons being bound to a nucleus with a high quadrupole 
moment. 
Figure 2.1 1H NMR spectra (500 MHz, DMSO-d6) of o-carborane (A) ligand precursors L2.1 
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The most notable difference between the two carborane species L2.1 and L2.2 is the 
appearance of a broad singlet at -2.98 ppm in the 1H NMR spectrum of L2.2, which 
corresponds to the bridging proton of the open face of the carborane cage. The cage CH proton 
in closo-carboranyl compounds such as L2.1 appears as a broad singlet due to the electron 
acceptor effect of the cage and resonates at 5.39 ppm for L2.1, whereas this proton is  highly 
shielded in L2.2, resonating at 1.83 ppm masked by the tBu resonance H(9). A characteristic 
downfield resonance attributable to the imidazolium proton H(7) at 9.41 ppm for L2.1 and 8.98 
ppm for L2.2 confirms the formation of imidazolium salts. The imidazolium proton of L2.1 
appears more downfield due to its hydrogen bonding interaction with the bromide counterion. 
This H-bonding interaction causes the proton to experience a larger deshielding effect, thus 
resonating at a more downfield position. The 13C{1H} NMR spectra provide further 
clarification for whether the closo-species has been retained or deboronation has occurred. The 
former shows sharp resonances for each carbon vertex at 72.4 ppm for C1 and 63.1 ppm for C2, 
respectively (Figure 2.2, bottom). Removal of either the B3 or B6 vertex results in a high 
upfield shift of the carbon vertices and appear as very broad signals at 56.2 ppm and 44.7 ppm 
(Figure 2.2, top).  
Figure 2.2 13C{1H} NMR spectra (300 MHz, DMSO-d6) of ligand precursors L2.1 (bottom) 
and L2.2 (top). The C4 proton for L2.2 is masked by the DMSO-d6 signal and resonates at  
38.9 ppm, which was confirmed by the 13C{1H} 135 DEPT spectrum. 
 
 
  CHAPTER 2 
 
 31 
2.2.2 11B NMR spectroscopy 
Boron has two naturally occurring isotopes, 10B and 11B, with relative abundances of 19.6 % 
and 80.4 % respectively. Both are NMR active, though 11B dominates due to its higher 
abundance, lower quadrupole moment and higher resonance frequency, resulting in much better 
resolution compared to 10B. Despite this 10B has been found useful in thermal isomerisation 
mechanistic studies.22 An underlying problem with 11B NMR spectroscopy is the broadening of 
signals due to the large nuclear spin of the 11B nucleus, even at high magnetic field strengths. 
This usually results in signal overlap as well as loss of coupling information, primarily 11B-11B 
coupling. 1H coupling adds further complications, with each B-H nucleus possessing quartet 
multiplicity with relative intensities of 1:1:1:1. Therefore, 11B{1H} NMR experiments are most 
common in order to provide clearer spectra by reducing the degree of signal overlap. 
11B chemical shifts are dominated by paramagnetic shielding.23 Simple geometric rules have 
been found to correlate well with known 11B chemical shifts.24 These rules contain antipodal 
(AE), butterfly (BE) and neighbour (NE) effects, with the AE effect having greatest influence 
on the 11B chemical shift and NE having the smallest effect (Figure 2.3). The antipodal effect 
in substituted carboranes was found to be similar to the positive mesomeric effect in substituted 
benzenes; an increase in electron density (e.d) in the substituted atoms results in an increase in 
electron density in the para- position.25  
 
Figure 2.3 A illustrates which vertices of the cage are most effected by a substitution at the C2 
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The 11B{1H} NMR spectra of L2.1 and L2.2 were fully elucidated with the aid of similar 
compounds in the literature, with the 11B{1H} NMR spectrum of L2.1 being similar to that of 
o-carborane (Figure 2.4). The 11B{1H} NMR spectrum of o-carborane shows four resonances 
between 3 and -15 ppm, with integral values of 2:2:4:2. One may initially predict that the boron 
atoms ortho to the carbon atoms would appear most downfield if the same rules that govern 1H 
NMR spectroscopy in most other cases are applied here. As mentioned, different effects 
dominate in carborane derivatives, with AE>BE>NE. Therefore, the boron atoms antipodal to 
the carbon atoms B9 and B12 appear most downfield, followed by the boron atoms situated in 
the butterfly positions B8 and B10. Upon substitution at the carboranyl carbon the antipodal 
boron atoms are no longer magnetically equivalent, with B9 appearing more downfield. The 
11B{1H} NMR spectrum of L2.2 is drastically different to that of L2.1. A direct result of 
deboronation is a more electron rich carborane skeleton and an uneven distribution of electron 
density, with the bulk being situated on the opposing vertex B10. As a result, a large upfield 
shift of this boron atom is observed. Equally, this gives rise to electropositive boron atoms 
antipodal to this vertex in the open pentagonal face, namely B4 and B7.  
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In the early 1970s, Heřmánek reported a regularity in open cage structures: 1) the direct 
neighbouring boron atom to that of the boron atoms in the open pentagonal face bearing the 
bridging proton (i.e. B9) resonates at the lowest frequency. It was proposed that an electron 
cloud exists at B9, resulting in the shielding of this vertex. A direct consequence of this is that 
the B12 vertex resonates at the highest frequency.26 2) In carborane derivatives the bridging 
proton on the open face is able to tautomerise and as a result an average of the signals is 
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2.2.3 Mass spectrometry 
As previously mentioned, boron has two naturally occurring isotopes, 10B and 11B, with relative 
abundances of 19.6 % and 80.4 % respectively. This gives rise to a distinct isotope pattern for 
boron rich carboranes, with a polyisotopic mass spectrum of statistically distributed 10B and 
11B. o-Carborane should display an isotope distribution between m/z 136 and 146, with a base 
peak of m/z 144 corresponding to 12C21H1210B211B8. However, the spectrum produced from the 
electron spray (ESI) technique in the positive ion mode does not show a peak corresponding to 
the parent cage. When using a very concentrated sample a molecular ion peak can be observed 
in the negative ion mode for [M − H]−. The requirement of a concentrated sample is possibly 
due to the high degree of proton abstraction which destabilises the cage resulting in a low 
abundance of the molecular ion by the time it reaches the detector. When a charged 
imidazolium group is introduced into the cage the molecular ion is detectable in the positive ion 
mode, allowing the ligands to be characterised using mass spectrometry. Example spectra of a 
closo-imidazolium L2.1 and a nido-zwitterion L2.2 are exhibited in Figure 2.5. 
 
Figure 2.5 HRMS (ESI+) of L2.1 (bottom) and L2.2 (top). The insets of each spectrum 
compares the observed molecular ion peaks [M+H]+for L2.1 and [M]+ for L2.2 against their 
calculated molecular masses. 
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2.2.4 Infrared spectroscopy 
When comparing the infrared (I.R.) spectra of the three isomers of ortho, meta and             
para-carborane, one would expect the spectra to become more complex on going from the 
highest symmetry para isomer, belonging to the D5d point group, to the less symmetrical ortho 
and meta isomers possessing C2v symmetry. However, this is not the case, with all three spectra 
being incredibly similar as well as being much simpler than predicted. Approximately 15 bands 
are observed for o-carborane with group theory predicting 53 normal infrared vibrations.27 This 
does have its advantages, with strong bands observed for characteristic environments of the 
cage allowing the spectrum of o-carborane to be easily assigned (Figure 2.6).28,29  
Figure 2.6 Infrared spectra of o-carborane (bottom) and L2.1 (top). The FTIR spectra were 
recorded as solid-state samples.  
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The carboranyl CH stretching vibration in o-carborane is observed as a sharp band at 3069 cm-1 
(Figure 2.6, bottom). Its high frequency arises from the strong electron acceptor effect in 
carboranes.30 This band becomes difficult to assign for L2.1, with alkene and alkyl C-H 
stretches masking this region. The BH stretching vibrations in o-carborane appear as a strong 
broad band at 2564 cm-1 and the appearance of this band is dependent on the cage substituents, 
with bulky groups revealing its fine vibrational structure. This can be observed on introducing 
the imidazolium arm for L2.1 (Figure 2.6, top). Other characteristic peaks in the IR spectrum 
of o-carborane include the bending bands at 1213-1148 cm-1 and 1034-917 cm-1 for C-H and  
B-H respectively, and a strong sharp band at 713 cm-1 which can be assigned to an 
antisymmetric cage vibration (Figure 2.6, bottom).31  
One advantage of I.R. spectroscopy is that it can be used as a quick analytical technique for  
monitoring the progress of the degradation of closo-carboranes to their respective nido-species. 
Hawthorne and coworkers noted the ν(B-H) band shifts to a lower frequency by approximately 
50 cm-1.9,10 This can be observed when comparing the infrared spectrum of L2.1 to that of L2.2 
(Figure 2.7). On loss of the B vertex, all 11 protons are retained and one of the challenges is 
locating the band for the bridging proton of the open pentagonal face. One proposed theory is 
the dynamic behaviour of this proton leads to band broadening.32  
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2.2.5 X-ray Diffraction Analysis 
X-ray crystallography is an excellent technique for unambiguously determining the molecular 
structure of a compound in the solid state. With advances in technology, high throughput 
diffractometers have revolutionised experimental methods, with processing time comparable to 
that of NMR spectroscopy in some instances. Crystals of L2.1 and L2.2 suitable for X-ray 
diffraction  analysis were grown by vapour diffusion of Et2O into concentrated MeCN solutions 
of each compound. The molecular structures are shown in Figure 2.8, and selected bond 
distances and angles given in Table 2.1.  The parameters of the imidazolium group such as the 









Figure 2.8 Molecular structure of L2.1 (left) and L2.2 (right). Thermal ellipsoids shown at    







Table 2.1 Selected bond distances (Å) and angles (deg) for  L2.1 and L2.2. 
Bond L2.1 (Å) L2.2 (Å) Angle  L2.1 (deg) L2.2 (deg) 
N(1)-C(7) 1.331(3) 1.346(13) N(1)-C(7)-N(2) 108.9(2) 108.8(9) 
N(2)-C(7) 1.328(3) 1.341(14)    
C(5)-C(6) 1.351(3) 1.358(17)    
  CHAPTER 2 
 
 38 
One of the long standing problems in single crystal X-ray diffraction analysis of carboranyl 
compounds is the unambiguous determination of the carbon atoms in the icosahedral cage, in 
particular where one or both carbon atoms are not substituted. This is due to C and B having 
very similar X-ray scattering powers as a simple consequence of their periodic adjacency. A 
common method employed for distinguishing between C and B vertices is to assign each vertex 
as a boron and inspect the thermal parameter (Ueq) values; those for C should be smaller.  
However, these values can be influenced significantly by their environment, which leads to 
ambiguity. Often these values are coupled with the bond lengths of the cage. This can be quite 
effective for icosahedral cages where the carbon atoms are adjacent, as this bond length should 
have the shortest connectivity. Recently, Welch et al. reported a simple yet highly effective 
method for distinguishing between C and B vertices termed the Vertex-to-Centroid Distance 
(VCD) method.34 This method involves measuring the distances from the topologically 
equivalent vertex atoms to the polyhedral centroid, where the shortest connectivity can be 
identified as a C vertex. In this comprehensive study a range of icosahedral and sub-icosahedral 
closo-carboranes, icosahedral metallacarboranes and supra-icosahedral metallacarboranes were 
employed, illustrating the generality of this method. Utilising this method allowed the 
unsubstituted carbon vertex of each carboranyl precursor and ligand to be unambiguously 
assigned in this thesis. Nonetheless, the method does have its limitations; an example of a 
cyclometallated complex reported in this thesis (Chapter 4, Section 4.3) where the carborane is 
bound through a vertex of the cage results in distortion of the icosahedral cage. As a result the 
VCD method fails and other analytical techniques were used in conjunction with the X-ray 
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2.3 Expansion of the ligand library 
The length of the alkyl linker between the carborane and the NHC plays a crucial role in the 
overall stability of the cage, and consequently directs the type of ligand precursor synthesised, 
with an ethyl linker allowing both a closo-carboranyl imidazolium bromide salt L2.1 and its 
nido- counterpart L2.2 to be isolated in high yields (Section 2.1). Structural diversity could 
easily be introduced into these scaffolds through varying the N-substituent of the imidazole 
precursor. A range of alkyl and aryl groups with other neutral (pyridyl, amine) or anionic 
(alkoxide) donor functionalities were employed (Scheme 2.8).  
Scheme 2.8 Library of ligand precursors prepared in this work. 
In the syntheses of the closo-carboranyl ligands (L2.1, L2.3, L2.4, L2.5) highest yields were 
obtained when strict anhydrous conditions were employed. All reagents were dried and stored 
in the glove box, and the imidazoles that exist as oils were also stored over 4 Å molecular 
sieves. Even under these strictly anhydrous reaction conditions the zwitterion can still form, 
and in some cases accounts for 10 % of the materials isolated. The majority of the             
closo-species can be selectively crystallised by the slow diffusion of Et2O into concentrated 
MeOH solutions. However, as crystal formation can often require weeks this method becomes 
impractical as a method of isolation. Optimisation of reaction conditions found that reducing 
the amount of solvent in the reaction (1 mL per 200 mg of carboranyl precursor) completely 
eradicated the formation of the zwitterion, as it promotes the desired product to precipitate from 
the reaction before deboronation can occur.  
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o-Carborane can typically be deboronated by amines11 and alkoxides.9,10 Imidazoles I4-I6 were 
employed to gage their tolerability when tethered to the base sensitive cage. When 
hydroxymethyl imidazole (I5) was reacted with P2.2, analysis of the crude material by 11B{1H} 
NMR spectroscopy indicated that the majority of the product was the zwitterionic species L2.7, 
with the characteristic resonances for a nido cage.  The HRMS data supports the NMR data, 
with a major peak at m/z 228.2343 corresponding to [L2.8 − CHOH]+. Isolation of the L2.6 
was unsuccessful due to the highly hygroscopic nature of this compound leading to                
co-crystallisation with L2.7. Pleasingly, when pyridyl imidazole I4 is employed, the 
corresponding closo-carboranyl ligand L2.5 can be isolated in high yield. However, when the 
primary amine imidazole I6 is employed, a mixture of the closo- (L2.8) and nido- (L2.9) 
species is obtained.  
One of the problems encountered in this work was the synthesis of halide-mixed complexes due 
to utilising bromide imidazolium salts with metal chloride precursors (Chapter 5, Section 5.3). 
To prevent the formation of halide mixed complexes the synthesis of a chloride congener L3.1 
was attempted (Scheme 2.9). However, the reaction of P3.2 with I2 was incredibly slow and 
L3.1 could only be isolated in very poor yields. The slow rate of reaction is most probably due 
to the chloride being a poorer leaving group when compared to bromide.  
Scheme 2.9 Synthesis of closo-carboranyl imidazolium chloride salt L3.1. 
A similar result was obtained when the length of the linker was extended to a propyl chain; the 
reaction of chloro-propyl-o-carborane P4.1 with I1 was incredibly slow and the expected   
closo-carboranyl ligand could not be isolated. If a closo-carboranyl ligand with a propyl linker 
is required, it would be advantageous to prepare the brominated precursor from                        
5-bromo-1-pentyne, which can be prepared from the corresponding alcohol, CBr4 and PPh3.35  
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When the zwitterionic ligand is desired, anhydrous conditions are not necessary and addition of 
H2O actually facilitates the reaction. An excess of imidazole is used in the reaction to achieve 
full deboronation to form the zwitterionic species (Scheme 2.10). However, this can often 
make the work up of the reactions tedious; the zwitterionic ligands are recrystallised from 
MeOH with Et2O, but in the majority of cases the excess imidazole employed in the reaction 
can ‘oil-out’ with the product. In these cases slow diffusion of Et2O into concentrated MeOH 
solutions over the course of several days can selectively crystallise the zwitterionic ligand, but 
the yields vary considerably. 


















  CHAPTER 2 
 
 42 
2.4 Di-C-substituted carborane derivatives  
Whilst o-carborane possesses many intriguing properties, it displays chemical reactivity that in 
some cases is problematic when it comes to coordinating these ligands to metal centres. More 
specifically, the acidic cage CH proton can either react with the metal leading to decomposition 
of the complex, or a mixture of C and B vertex coordination at the metal centre is observed, 
both of which have been encountered throughout this thesis. To improve the stability of the 
complex, or to allow selective cyclometallation through a boron vertex, the acidic proton can be 
blocked through utilising a methylated carborane derivative (P5.1) (Scheme 2.11). 
Scheme 2.11 Synthesis of ligand precursor L5.1. 
The synthesis of Grignard reagents by activation of magnesium metal and reaction with an 
alkyl halide has been known since 1899.36 Methyl-o-carborane (P5.1) can be prepared by 
reacting P1.1 with magnesium turnings under anhydrous conditions, with P5.1 being formed 
upon acid workup.37 Lithiation of P5.1 and its subsequent reaction with ethylene oxide gives 
P5.2 without the requirement of further purification. P5.2 is then brominated using NBS and 
PPh3 to give P5.3, and subsequently reacted with I2 to give the di-C-substituted carboranyl 
ligand precursor L5.1 in good yield (Scheme 2.11). L5.1 displays key differences when 
analysed by multinuclear NMR spectroscopy in comparison to mono-C-substituted ligands. In 
the 1H NMR spectrum of L5.1, the disappearance of the characteristic broad singlet for the cage 
CH proton (Figure 2.9), and the presence of two quaternary carbon resonances in the 13C{1H} 
NMR spectrum at 77.5 and 75.6 ppm, is indicative of a di-C-substituted cage. There is little 
difference, however, in the 11B{1H} NMR spectra which is to be expected, with peaks in the 
range of a typical closo-carborane (Figure 2.9, inset). The HRMS provided the expected 
molecular ion peak at m/z 267.2877 corresponding to [L5.1 − Br]+, and the X-ray diffraction 
analysis further clarifies the formation of L5.1 (Figure 2.10).   
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Figure 2.9 1H NMR spectrum (500 MHz, CD3OD)  and 11B{1H} NMR spectrum (161 MHz, 
CD3OD) (inset) of L5.1. 
Figure 2.10 Molecular structure determined by single crystal X-ray diffraction analysis and 
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2.5 Towards the development of CBC-type ligands 
2.5.1 Background  
Pincer ligands, formally known as tridentate ligands, were pioneered by Shaw, with his work 
on transition metals bearing a 1,3-bis(dialkylphosphinomethyl)benzene motif.38 Pincer ligands 
offer great tailorability with respect to: 1) The central anchoring site, the majority of which are 
either carbon-based, including aliphatic and aromatic motifs, or heteroatom analogues of N, Si 
and P (see Reek’s review and references therein),39 2) The metal-binding atom of the arms, with 
examples of P, C, N, O, S and Se donor atoms,40,41 and 3) The auxiliary sites on the arms, 
which can be tuned to control the steric properties and the chirality of the ligand (Figure 
2.11).42  
Figure 2.11 Examples of reported pincer ligands.43 
Remarkably, boron was not considered in the design of pincer ligands until 2009, when 
Yamashita and Nozaki reported the first PBP ligand.44,45 That same year Mirkin and co-workers 
established a new chapter in carborane chemistry, with the first example of a tridentate ligand 
which incorporates a carborane as the central anchoring site.46 Surprisingly, since the 
establishment of this new carboranyl chemistry, only one other publication by Nakamura and 
co-workers on a series of NBN m-carborane based chiral pincer complexes has been reported.47 
This could be due to challenging synthetic methodology required to introduce functionality into 
the carborane. One of the most common methods used for functionalisation of o-carborane is 
deprotonation with a strong base (nBuLi) and reaction with a suitable electrophile. However, 
due to the steric bulk of the resulting anion upon deprotonation, only reactive electrophiles are 
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2.5.2 Synthesis of pincer ligand precursors 
In the literature, one of the most popular synthetic methods to preparing imidazolium-based 
pincer ligand precursors involves reacting two equivalents of substituted imidazole with 
dibromoethylbenzene. The aim of this work was to replace the aryl ring with a carborane, 
which would pave the way to new carboranyl pincer ligands that possess good tailorability.  
1,2-Dibromoethyl-closo-dodecaborane (P6.1) and its m-carborane counterpart P7.1 were 
prepared via a modified procedure to precursor P2.2. Reaction of o- or m-carborane with nBuLi 
(2 eq) followed by addition of an excess of ethylene oxide (3 eq) gives the disubstituted 
hydroxyethyl carboranyl compounds (P6.1 and P7.1), which are then brominated using NBS 
and PPh3 to give P6.2 and P7.2 in excellent yields (Scheme 2.12).  
Scheme 2.12 Synthesis of 1,2- and 1,7-dibromoethyl-closo-dodecaborane precursors. 
Our previous synthetic method for synthesising closo-carboranyl imidazolium salts involved 
using an apolar solvent to promote precipitation of the imidazolium salt and prevent further 
reaction to form the zwitterionic ligand (Scheme 2.13). In the case of P6.2, upon formation of 
the mono-substituted imidazolium salt L6.1, it is required to remain in solution to allow the 
second substitution to take place. However, upon formation of L6.1 the cage will be highly 
susceptible to deboronation due to the strongly electron withdrawing imidazolium group. As a 
result, when P6.2 is reacted with methyl imidazole I2 in refluxing MeCN, a large proportion of 
L6.1 and L6.3 are deboronated to the suspected nido species (L6.2 and L6.4), which was 
observed by 1H and 11B{1H} NMR spectroscopy.  
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Scheme 2.13 Attempted synthesis of L6.3. 
To overcome this problem P7.2 was employed, as m-carborane derivatives are generally more 
stable towards basic conditions. Pleasingly, when P7.2 is subjected to the same reaction 
conditions the closo-carborane bis-imidazolium salt L7.2 can be isolated in high yields 
(Scheme 2.14).  It is noteworthy that when toluene is used as the solvent and the imidazole is 
reduced to 0.9 equivalents, the mono-substituted product (L7.1) was the major product 
observed by 1H NMR spectroscopy and HRMS. These reactions were screening reactions 
carried out on an NMR scale, and L7.1 was not isolated. Nonetheless, this synthetic route is 
particularly interesting as future work should allow asymmetrical pincer ligands to be isolated, 
and to the best of our knowledge there are no examples of asymmetrical NHC-pincer ligands 
reported to date.  
Scheme 2.14 Synthesis of the closo-carborane bis-imidazolium salt L7.2. 
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2.6 Conclusions  
The fusion of two very different ligand families, namely NHC precursors and carboranes, has 
led to the synthesis of a novel ligand architecture. Various synthetic challenges to combining 
N-substituted basic imidazoles with the base sensitive carboranes have been overcome. The 
strongly electron withdrawing nature of the imidazolium group increases the susceptibility of 
the cage to nucleophilic attack, resulting in deboronation under very mild conditions by the 
action of a bromide counterion. We found that the length of the alkyl tether between the 
imidazolium salt and the carborane plays a crucial role in the stability of the cage, with a longer 
tether reducing the electron withdrawing capabilities of the imidazolium group, hence 
stabilising the cage and allowing stable closo-carboranyl imidazolium salts to be isolated.  
Due to the base sensitive nature of the cage, a range of different imidazole N-substituents were 
employed to gauge their tolerability when tethered to o-carborane. Pleasingly, a range of alkyl 
and aryl groups, including other donor functionalities such as pyridyl, were isolated in high 
yields. However, functional groups such as primary amines or a hydroxyl group led to 
deboronation. Nonetheless, the library of closo-carboranyl imidazolium salts and zwitterionic 
ligand precursors that have been prepared illustrates the tailorability of the system. This is 
further demonstrated with functionalisation of both carboranyl carbon atoms leading to a Me 
protected and CBC type ligand precursors. The ligand precursors were fully characterised using 
1H, 11B{1H} and 13C{1H} NMR spectroscopy, high resolution MS and, for those which are 
publicised, by elemental analysis and X-ray diffraction analysis. The use of these analytical 
techniques to differentiate between closo-carborane and its nido counterpart was reviewed.   
Scheme 2.15 Summary of work presented in this chapter: synthesis of mono-substituted (A) 









All chemicals used in this work were bought from either Sigma Aldrich or Alfa Aesar 
including imidazoles I2, I6 and I8, and used without further purification. Anhydrous solvents 
were prepared by passing over activated alumina to remove water, copper catalyst to remove 
oxygen and molecular sieves to remove any remaining water, via the Dow–Grubbs solvent 
system, and then freeze–pump–thaw degassed prior to use. NMR spectra were recorded on a 
Bruker AV500, Bruker AV400 or a Bruker DPX300 spectrometer. 1H NMR and 13C{1H} NMR 
chemical shifts were referenced against residual solvent peaks. Mass spectra were collected on 
a Bruker Daltonics (micro TOF) instrument operating in the electrospray mode. Elemental 
analyses were performed by Mr Stephen Boyer at London Metropolitan University. For 
compounds which have been previously reported in the literature the 1H and 13C{1H} NMR 
spectroscopy and HRMS data are listed. For novel compounds all NMR spectroscopic data are 
fully assigned with the aid of 2D 1H1H COSY, 1H13C HMQC, 1H13C HMBC and 13C{1H} 
DEPT 135 experiments. 
 
2.7.1 N-substituted imidazoles 
Preparation of I1.48  
Tert-butylamine (10.50 mL, 100 mmol) was dissolved in MeOH (70 mL) at  
0 °C and formaldehyde (7.45 mL, 100 mmol, 37 % in H2O) was added 
followed by aqueous glyoxal (11.50 mL, 100 mmol, 40 % in H2O) and 
ammonium carbonate (4.80 g, 50 mmol). The mixture was allowed to reach 
room temperature and stirred for 18 hours. All volatiles were removed in vacuo. The product 
was extracted from H2O (20 mL) into DCM (4 × 20 mL). The DCM layer was washed with 
H2O (20 mL), dried over MgSO4, filtered and the solvent removed in vacuo to give an orange 
oil. Yield: 6.20 g, 50 mmol (50 %). 1H NMR (300 MHz, CDCl3): δ (ppm) 7.26 (s, 1H), δ 7.00 
(d, 2H), δ 1.50 (s, 9H). 13C{1H} NMR (75 MHz, CDCl3): δ (ppm) 157.8, 134.3,  128.9,  116.3,  
30.6. HRMS (ESI+): m/z [C7H13N2]+ 125.1069, calcd for [M + H]+ 125.1079. Consistent with 
data previously reported.48 
 
Preparation of I3.49  
Acetic acid (10 mL), formaldehyde (3.00 mL, 40 mmol) and aqueous 
glyoxal (4.60 mL, 40 mmol, 40 % in H2O) were heated at 70 °C. A 
solution of acetic acid (10 mL), ammonium acetate in water (3.10 g in 
2 mL, 40 mmol) and 2,4,6-trimethylaniline (9.40 mL, 66.9 mmol) was 
added drop wise over 30 minutes. The solution was continuously stirred and heated at 70 °C for 
18 hours. The reaction was then cooled to room temperature and a NaOH solution (20 g in   
300 mL H2O) was added to precipitate the product. The precipitate was filtered to obtain a 
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black solid. The crude product was recrystallised from acetone (30 mL) with H2O (30 mL), 
filtered and repeated a further 7 times until a beige solid is obtained. Yield: 2.1 g, 11.30 mmol 
(28 %). 1H NMR (500 MHz, CDCl3): δ (ppm) 7.42 (m, 1H), 7.22 (t, J = 1 Hz, 1H), 6.96 (m, 
2H), 6.88 (t, J = 1 Hz, 1H), 2.33 (s, 3H), 1.98 (s, 6H). 13C{1H} NMR (126 MHz, CDCl3): δ 
(ppm) 138.9, 137.6, 135.5, 133.5, 129.7, 129.1, 120.2, 21.1, 17.4. HRMS (ESI+): m/z 
[C12H14N2]+ 187.1249, calcd for [M + H]+ 187.1291. Consistent with data previously reported.49  
 
Preparation of I4.50  
Imidazole (500 mg, 7.34 mmol), 2-bromo-pyridine (0.23 mL, 2.41 
mmol) and K2CO3 (680 mg, 4.92 mmol) were added to an ampoule and 
degassed. This was heated at 190 °C under argon for 18 hours. The 
reaction mixture was allowed to cool then chloroform (10 mL) 
followed by H2O (20 mL) was added. The product was extracted into the chloroform and was 
washed with a saturated solution of Na2CO3 (20 mL), dried over MgSO4, filtered and dried in 
vacuo to give a white solid. Yield: 285 mg, 1.96 mmol (81 %). 1H NMR (300 MHz, CDCl3): δ 
(ppm) 8.49 (ddd, J = 4.9, 1.8, 0.8 Hz, 1H), 8.35 (s, 1H), 7.82 (ddd, J = 8.2, 7.5, 1.9 Hz, 1H), 
7.65 (t, J = 1.3 Hz, 1H), 7.36 (dt, J = 8.2, 0.9 Hz, 1H), 7.25-7.22 (m, 1H), 7.20 (s, 1H). 13C{1H} 
NMR (75 MHz, CDCl3): δ (ppm) 112.3, 116.1, 121.5, 122.0, 130.6, 135.0, 139.0, 149.1. 
HRMS (ESI+): m/z [C8H8N3]+ 146.0730, calcd for [M + H]+ 146.0718. Consistent with data 
previously reported.50 
 
Preparation of I5.51  
Imidazole (500 mg, 7.34 mmol) and paraformaldehyde (200 mg,          
9.31 mmol) were heated in a dry melt at 110	°C for 1 hour and the liquid 
solidified upon cooling. The solid residue was triturated in ethyl acetate, 
filtered and dried in vacuo to give a white solid. Yield 502 mg, 5.12 mmol (70 %).1H NMR 
(400 MHz, CDCl3): δ (ppm) 7.35 (s, 1H), 7.03 (s, 1H), 6.88 (s, 1H), 5.36 (s, 2H). 13C{1H} 
NMR (101 MHz, CDCl3): δ (ppm) 136.2, 128.3, 118.8, 70.2. HRMS (ESI+): m/z 
[C4H6N2ONaK]+ 158.9636, calcd for [M+Na+K-H]+ 158.9931. Consistent with data previously 
reported.51 
 
Preparation of I7.  
A mixture of 2-(Bromomethyl)pyridine hydrobromide (1.00 g,  3.95 mmol), imidazole (0.27 g, 
3.95 mmol), and K2CO3 (1.64 g, 11.85 mmol) in 20 mL of MeCN was heated at 80 °C for 24 
hours. The solvent was removed in vacuo and DCM (20 mL) and H2O (20 mL) were added. 
The organic layer was separated and further washed with H2O (2 × 20 mL). After separation, 
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the organic layer was dried with anhydrous MgSO4. The solution was 
filtered, and the solvent removed in vacuo to give a brown oil. Yield: 364 
mg, 2.29 mmol (58 %). 1H NMR (400 MHz, CDCl3) δ (ppm) 8.49 (d, J = 
4.8 Hz, 1H), 7.57 (td, J = 7.7, 1.8 Hz, 1H), 7.53 (s, 1H), 7.17-7.12 (m, 1H), 
7.01 (s, 1H), 6.91 (s, 1H), 6.88 (d, J = 7.9 Hz, 1H), 5.16 (s, 1H). 13C NMR 
(101 MHz, CDCl3) δ (ppm) 156.0, 149.6, 137.5, 137.3, 129.7, 123.0, 121.2, 119.5, 52.4. HRMS 
(ESI+): m/z [C9H10N3]+ 160.0884, calcd for [M + H]+ 160.0875. Consistent with data previously 
reported.52  
 
2.7.2 Carborane precursors 
Preparation of 2.53  
A stirred solution of decaborane (5.44 g, 44.50 mmol) in 
acetonitrile (18 mL) was slowly heated to 80 °C. After five 
hours the reaction mixture was cooled to room temperature. 
The white precipitate was filtered off and washed with 
acetonitrile to give the product as a white solid. Yield: 6.48 g, 32.04 mmol (72 %). 1H NMR 
(400 MHz, CDCl3): δ (ppm) 2.70 (s, 6H). 13C{1H} NMR (101 MHz, DMSO-d6): δ (ppm) 109.4, 
2.8. 11B{1H} NMR (CD3CN, 96 MHz): δ −4.9 (2B), −19.2 (4B), −30.5 (2B), −41.4 (2B). 
 
Preparation of P1.1.54  
B10H12(MeCN)2 (1.00 g, 4.94 mmol) was added to a Schlenk flask and 
degassed. Anhydrous toluene (8 mL) and propargyl bromide (0.52 mL, 
4.94 mmol, 80 % wt. toluene) was added and slowly heated to 100 °C 
and kept at this temperature for 4 hours. After cooling the solvent was 
removed in vacuo and the residue was extracted with hexane (3 ×      
20 mL). The combined extracts were washed with a 1M NaOH solution (20 mL) then H2O (2 × 
20 mL) and dried over MgSO4. This was then filtered and solvent removed in vacuo to give the 
product as a yellow oil. Yield: 811 mg, 3.42 mmol (69 %). 1H NMR (400 MHz, CDCl3): δ 
(ppm) 4.00 (br. s, 1H), 3.96 (s, 2H). 13C{1H} NMR (101 MHz, CDCl3): δ (ppm) 71.3, 61.1, 
32.3. 11B{1H} NMR (161 MHz, CDCl3): δ (ppm)  −2.4 (1B), −5.0 (1B), −8.7 (2B), −10.6 (2B), 
−12.4 (2B), −12.9 (2B). Anal. Calcd for C3H13B10Br: C, 15.19; H, 5.53. Found: C, 14.95; H, 
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Preparation of P2.2.  
Route 1. Prepared as described for P1.1 from 4-bromo-1-butyne 
(0.66 mL, 7.03 mmol), B10H12(MeCN)2 (1.40 g, 7.03 mmol) in 
anhydrous toluene (10 mL). After purification the product was 
obtained as a white crystalline solid. Yield: 618 mg, 2.46 mmol      
(35 %). 
Route 2.21 o-Carborane (300 mg, 2.08 mmol) was added to a Schlenk flask and degassed. 
Anhydrous THF (10 mL) was added and cooled to -78° C. A 1.6 M solution of nBuLi in           
n-hexane (1.32 mL, 2.08 mmol) was added drop wise. This was stirred for 30 minutes at −78 
°C. The temperature was then raised to 0 °C and a 2.5 M solution of ethylene oxide (1.03 mL,     
2.50 mmol) was added drop wise and stirred at 0 °C for 1 hour. The reaction was quenched by 
adding a saturated solution of NH4Cl (5 mL) and the aqueous phase extracted with ethyl acetate 
(3 × 10 mL). The organic fractions were combined and dried over MgSO4, filtered and solvent 
removed in vacuo to give as a oily residue. Without further purification this was transferred to a 
Schlenk flask, degassed and anhydrous DCM (5 mL) was added. This was cooled to 0 °C and 
PPh3 (539 mg, 2.06 mmol) and NBS (366 mg, 2.06 mmol) was added and stirred at 0 °C for 3 
hours. The solvent was removed in vacuo and the residue was purified by chromatography 
(silica gel, hexane/ethyl acetate = 15/1) to give the bromide product (367 mg, 1.46 mmol,       
70 %). 1H NMR (DMSO-d6, 300 MHz): δ (ppm) 5.21 (br. s, 1H), δ 3.53 (t, J = 7.8, 2H), δ 2.82 
(t, J = 8.1, 2H,). 13C{1H} (DMSO-d6, 75 MHz): δ (ppm) 74.2, 62.8, 38.7, 28.8. 11B{1H} NMR 
(DMSO-d6, 96 MHz): δ (ppm) −3.2 (1B), δ −5.9 (1B), δ −9.8 (2B) δ −11.7 (4B), δ −13.1 (2B).  
 
Preparation of P3.1.55  
3-Butynol (3.02 mL, 40.00 mmol) and pyridine (256 µL, 4.00 mmol) were 
placed in a 10 mL two-necked round bottom flask and cooled to 0°C. 
Thionyl chloride (2.90 mL, 40.0 mmol) was added drop wise over a 10 
minute period. The mixture was then heated at 100 °C for 30 minutes. The reaction was cooled 
to 90 °C and the product was distilled as a colourless oil. Yield: 3.20 mL, 36.36 mmol (91 %). 
1H NMR (300 MHz, CDCl3): δ (ppm) 3.59 (t, J = 6.0 Hz, 2H), 2.64 (td, J = 6.0 Hz, 3 Hz, 2H), 
2.07 (t, J = 3.0 Hz, 1H). 13C{1H} NMR (75 MHz, CDCl3): δ (ppm) 80.3, 70.5, 42.0, 22.9. 
HRMS Consistent with data previously reported.55 
 
Preparation of P3.2.56  
Prepared as described for P1.1 from 4-chloro-1-butyne (0.66 mL, 7.45 mmol) and 
B10H12(MeCN)2 (1.00 g, 4.94 mmol) in anhydrous toluene (8 mL). After purification the 
product was obtained as an off white crystals. Yield: 624 mg, 3.02 mmol (61 %). 1H NMR (300 
MHz, DMSO-d6): δ (ppm) 5.20 (br. s, 1H, carborane cage CH), 3.69 (t, J = 7.5 Hz, 2H, CH2Cl), 
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2.75 (t, J = 7.5 Hz, 2H, CH2). 13C{1H} NMR (75 MHz, DMSO-d6):    
δ (ppm) 73.5 (carborane cage quaternary C), 62.9 (carborane cage 
CH), 41.6 (CH2Cl), 38.6 (CH2). 11B{1H} NMR (96 MHz, CDCl3):      
δ (ppm) −3.1 (1B), −5.6 (1B), −9.7 (2B), −11.7 (4B), −13.1 (2B). 
Anal. Calcd for C4H15B10Cl: C, 23.24; H, 7.31. Found: C, 23.16; H, 7.42. 
 
Preparation P4.1.57  
Prepared as described for P1.1 from 5-chloro-1-pentyne (380 mg, 
3.71 mmol), B10H12(MeCN)2 (500 mg, 2.47 mmol) in anhydrous 
toluene (4 mL). After purification the product was obtained as a 
white waxy solid. Yield: 390 mg, 1.77 mmol (72 %). 1H NMR 
(CD3CN, 500 MHz): δ (ppm) 4.21 (s, 1H), 3.56-3.50 (m, 2H), 
2.44-2.36 (m, 2H), 2.15-2.13 (m, 2H). 11B{1H} NMR (DMSO-d6, 96 MHz): δ (ppm) −3.0 (1B), 
−6.2 (1B), −9.7 (2B), −11.8 (4B), −13.1 (2B). Consistent with data previously reported.57 
 
Preparation of P5.1.58  
To a RBF was added magnesium turnings (0.41 g, 0.02 mmol) and 
anhydrous Et2O (20 mL). This was heated to 30 °C and a solution of P1.1 
(3.34 g, 14.00 mmol) in anhydrous Et2O (20 mL) was added drop wise via 
a dropping funnel. After three hours refluxing the solution was cooled and 
poured over 100 mL ice-cold water. The mixture was acidified with 1:1 
hydrochloric acid : water and the aqueous phase was extracted with Et2O (3 × 20 mL). The 
organic fractions were combined and dried over MgSO4, filtered and the solvent removed in 
vacuo. The resulting residue was recrystallised from cold hexane (5 mL) to give the product as 
a white crystalline solid. Yield: 1.89 g, 11.80 mmol (84 %).. 1H NMR (300 MHz, CDCl3): δ 
(ppm) 3.57 (br. s, 1H), 2.03 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): δ (ppm) 70.5, 61.7, 26.0. 
11B{1H} NMR (96 MHz, CDCl3): δ (ppm) −1.8 (1B), −6.7 (1B), −9.2 (2B), −10.6 (2B), −11.3 
(2B), −12.7 (2B). Anal. Calcd for C3H14B10: C, 22.77; H, 8.92. Found: C, 22.72; H, 9.05.  
 
Preparation of P5.2.  
P5.1 (300 mg, 1.90 mmol) was added to a Schlenk flask and 
degassed. Anhydrous THF (10 mL) was added and cooled to -78°C. 
A 1. 6M solution of nBuLi in n-hexane (1.19 mL, 1.90 mmol) was 
added drop wise. This was stirred for 30 minutes at −78 °C. The 
temperature was then raised to 0 °C and a 2.5 M solution of 
ethylene oxide in anhydrous THF (1.13 mL, 2.81 mmol) was added 
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drop wise and stirred at 0 °C for 1 hour. The reaction was quenched by adding a saturated 
solution of NH4Cl (5 mL) and the aqueous phase extracted with ethyl acetate (3 × 10 mL). The 
organic fractions were combined and dried over MgSO4, filtered and solvent removed in vacuo. 
Hexane (3 mL) was added and cooled to −15 °C for 3 hours. The white crystals were filtered, 
washed with ice-cold hexane (5 mL) and dried in vacuo. Yield: 326 mg, 1.61 mmol (85 %).  1H 
NMR (500 MHz, DMSO-d6): δ (ppm) 4.87 (s, 1H, OH), 3.56 (t, J = 5 Hz, 2H, H4), 2.44 (t, J = 
5 Hz, 2H, H3), 2.09 (s, 3H, H1). 13C NMR (126 MHz, DMSO-d6): δ (ppm) 77.2 (C2/3), 76.0 
(C2/3), 59.5 (C5), 36.9 (C4), 22.6 (C1). 11B{1H} NMR (161 MHz, DMSO-d6): δ (ppm) −4.9 (1B), 
−6.4 (1B), −8.9 (2B), −10.0 (2B), −10.9 (4B). Anal. Calcd for C5H18B10O: C, 29.69; H, 8.97. 
Found: C, 29.77; H, 9.02.  
 
Preparation of P5.3.  
To a Schlenk flask was added P5.1 (360 mg, 1.78 mmol) and 
anhydrous DCM (5 mL). This was cooled to 0 °C and PPh3 (543 mg, 
2.07 mmol) and NBS (368 mg, 2.07 mmol) was added and stirred at 
0 °C for 3 hours. The organic phase was then washed with H2O (4 × 
10 mL), dried over MgSO4, filtered and solvent removed in vacuo. 
Et2O (10 mL) was added and filtered through a 5 cm silica plug and 
flushed with Et2O (2 × 10 mL). The solvent was removed in vacuo to give the product as a 
white crystalline solid. Yield: 366 mg, 1.38 mmol (78 %). 1H NMR (500 MHz, DMSO-d6): δ 
(ppm) 3.60 (t, J = 10 Hz, 2H, H4), 2.86 (t, J = 10 Hz, 2H, H3), 2.12 (s, 3H, H1). 13C NMR (126 
MHz, DMSO-d6): δ (ppm) 76.9 (C2/3), 76.2 (C2/3), 36.5 (C5), 28.9 (C4), 22.4 (C1). 11B{1H} NMR 
(161 MHz, DMSO-d6): δ (ppm) −4.4 (1B), −6.3 (1B), −9.0 (2B), −9.9 (2B), −10.9 (4B). Anal. 
Calcd for C5H17B10Br: C, 22.65; H, 6.46. Found: C, 22.77; H, 6.48.  
 
Preparation of P6.1.59  
A 1.60 M solution of nBuLi in n-hexane (2.60 mL, 4.10 mmol) was 
added dropwise to a solution of o-carborane (300 mg, 2.08 mmol) in a 
dry toluene/Et2O mixture (2:1, 30 mL) with stirring at 0 °C. The 
mixture was allowed to warm to room temperature and stirred for 30 
minutes. The solution was then cooled to 0 °C, and a 2.5 M solution of 
ethylene oxide in anhydrous THF (2.46 mL, 6.00 mmol) was added. 
The reaction mixture was stirred at room temperature overnight and 
then quenched with 50 mL of water. The organic layer was separated, and the aqueous layer 
was extracted with Et2O (2 × 30 mL). The combined organic portions were dried over 
anhydrous Na2SO4. Removal of the solvents gave a white solid that was washed with n-hexane 
(2 × 10 mL) and dried under vacuum to afford the product as a white powder. Yield: 445 mg,          
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1.91 mmol (92 %). Recrystallisation from dichloromethane yielded colourless crystals. 1H 
NMR (500 MHz, DMSO-d6): δ (ppm) 4.87 (br. s, 2H, OH), 3.54 (m, 4H, H3), 2.45 (t, J = 7.5 
Hz, 4H, H2). 13C{1H} NMR (126 MHz, DMSO-d6): δ (ppm) 78.5 (C1), 59.6 (C3), 36.7 (C2). 
11B{1H} NMR (161 MHz, DMSO-d6): δ (ppm) −5.3 (2B), −10.8 (8B). Consistent with data 
previously reported.59 
 
Preparation of P6.2.  
Prepared as described for P5.3 from P6.1 (200 mg, 0.86 mmol), 
PPh3 (262 mg, 1.00 mmol) and NBS (178 mg, 1.00 mmol) in 
anhydrous DCM (5 mL). After purification the product was obtained 
as a white crystalline solid. Yield: 276 mg, 0.77 mmol (90 %). 1H 
NMR (300 MHz, DMSO-d6): δ (ppm) 3.59 (m, 4H, H3), 2.90 (m, 
4H, H2). 13C{1H} NMR (75 MHz, DMSO-d6): δ (ppm) 78.8 (C1), 
36.1 (C3), 29.0 (C2). 11B{1H} NMR (96 MHz, DMSO-d6): δ (ppm)    
−4.8 (2B), −10.5 (8B). 
 
Preparation of P7.1.  
A 1.60 M solution of nBuLi in n-hexane (2.64 mL,         
4.3 mmol) was added dropwise to a solution of               
m-carborane (300 mg, 2.08 mmol) in anhydrous THF      
(5 mL) with stirring at 0 °C. The mixture was allowed to 
warm to room temperature and stirred for 30 minutes. The solution was then cooled to 0 °C, 
and an anhydrous THF solution of ethylene oxide (1.72 mL, 4.3 mmol). The reaction mixture 
was stirred at room temperature overnight and then quenched with water (50 mL). The organic 
layer was separated, and the aqueous layer was extracted with Et2O (2 × 30 mL). The combined 
organic portions were dried over anhydrous Na2SO4. Removal of the solvents gave a white 
solid that was washed with n-hexane (2 × 10 mL) and dried under vacuum to afford the product 
as a white powder (207 mg, 0.89 mmol (43 %). 1H NMR (300 MHz, DMSO-d6) δ (ppm) 4.68 
(t, J = 5.2 Hz, 2H, OH), 3.36 (m, 4H, H3), 2.07 (t, J = 7.1 Hz, 4H, H2). 13C{1H} NMR (75 MHz, 
DMSO-d6): δ (ppm) 73.6 (C1), 59.8 (C3), 38.7 (C2). 11B{1H} NMR (96 MHz, DMSO-d6): δ 
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Preparation of P7.2.  
Prepared as described for P5.3 from P7.1 (200 mg,      0.86 
mmol), PPh3 (269 mg, 1.03 mmol) and NBS (182 mg, 1.03 
mmol) in anhydrous DCM (5 mL). After purification the 
product was obtained as a white crystalline solid. Yield: 
262 mg, 0.73 mmol (85 %). 1H NMR (300 MHz, DMSO-d6) δ (ppm) 3.42 (m, 4H, H3), 2.52 
(m, 4H, H2). 13C{1H} NMR (75 MHz, DMSO-d6): δ (ppm) 38.4 (C3), 29.7 (C2). 11B{1H} NMR 
(96 MHz, DMSO-d6): δ (ppm) −7.1 (2B), −11.2 (6B), −13.4 (2B). Note: quaternary carboranyl 
carbon resonance not observed. 
 
2.7.3 Imidazolium salts 
Preparation of P1.2.19  
To a RBF was added MeCN (10 mL), tBu-imidazole (4.10 g, 
33.0 mmol) and propargyl bromide (7.30 mL, 66 mmol, 80 % 
wt. toluene). The resulting solution was stirred for 24 hours at 80 
ºC and cooled to room temperature. The solvent was removed in 
vacuo and the residue washed with Et2O (5 × 20 mL) then dried 
in vacuo to give a brown viscous oil. Yield: 6.50 g, 26.70 mmol (81 %). 1H NMR (400 MHz, 
CDCl3): δ (ppm) 10.65 (s, 1H), 7.62 (t, J = 1.8 Hz, 1H), 7.49 (t, J = 1.9 Hz, 1H), 5.52 (d, J = 
2.6 Hz, 2H), 2.69 (t, J = 2.6 Hz, 1H), 1.73 (s, 9H). 13C NMR (100 MHz, CDCl3): δ (ppm) 136.0, 
121.9, 119.4, 77.6, 74.6, 61.0, 40.0, 30.2. HRMS (ESI+): m/z [C9H13N3]+ 163.1232, calcd for 
[M + MeCN + H]+ 163.1109.  
 
Preparation of L2.1.  
P2.1 (500 mg, 1.99 mmol), tBu imidazole (246 mg,          
1.98 mmol) and anhydrous toluene (3 mL) were added to an 
ampoule and heated at 100 °C for 18 hours. The reaction was 
cooled to room temperature, filtered, and the solid washed 
with toluene (3 × 10 mL) to give an off white crystalline 
solid. This was recrystallised from MeOH (3 mL) / Et2O (30 
mL), filtered and dried in vacuo to give the product as a white crystalline solid. Yield: 529 mg, 
1.41 mmol (71 %). 1H NMR (500 MHz, DMSO-d6): δ (ppm) 9.41 (s, 1H, H7), 8.03 (t, J = 1.9 
Hz, 1H, H5), 7.90 (t, J = 1.9 Hz, 1H, H6), 5.38 (br. s, 1H, H1), 4.33 (m, 2H, H4), 2.99 (m, 2H, 
H3), 1.57 (s, 9H, H9). 13C{1H} NMR (126 MHz, DMSO-d6): δ (ppm) 135.0 (C7), 122.7 (C6), 
120.1 (C5), 72.5 (C2), 63.2 (C1), 59.6 (C8), 47.0 (C4), 35.2 (C3), 28.9 (C9). 11B{1H} NMR (161 
MHz, DMSO-d6): δ (ppm) −2.8 (1B), −5.5 (1B), −9.6 (2B), −11.8 (6B). HRMS (ESI+): m/z 
[C11H27B10N2]+ 295.3188, calcd for [M − Br]+ 295.3177. Anal. Calcd for C11H27B10N2Br: C, 
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35.20; H, 7.25; N, 7.46. Found: C, 34.90; H, 7.30; N, 7.10. Crystals suitable for X-ray 
diffraction analysis were grown by the slow diffusion of Et2O into a concentrated solution of 
the product in MeCN. 
 
Preparation of L2.3.  
Prepared as described from L2.1 from P2.1 (500 mg,             
1.99 mmol) and methyl imidazole (162 mg, 1.97 mmol) in 
anhydrous toluene (3 mL). Following purification the product 
was isolated as a fluffy crystalline white solid. Yield: 490 mg, 
1.47 mmol (75 %). 1H NMR (500 MHz, DMSO-d6): δ (ppm) 
9.21 (s, 1H, H7), 7.84 (t, J = 1.7 Hz, 1H, H5), 7.71 (t, J = 1.7 Hz, 
1H, H6), 5.37 (br. s, 1H, H1), 4.35 (m, 2H, H4), 3.86 (s, 3H, H8), 2.94 (m, 2H, H3). 13C{1H} 
NMR (126 MHz, DMSO-d6): δ (ppm) 137.0 (C7), 123.6 (C6), 122.3 (C5), 72.5 (C2), 63.1 (C1), 
46.9 (C4), 35.8 (C8), 35.3 (C3). 11B{1H} NMR (161 MHz, DMSO-d6): δ (ppm) −3.0 (1B), −5.6 
(1B), −9.7 (2B), −11.8 (4B), −12.9 (2B). HRMS (ESI+): m/z [C8H21B10N2]+ 253.2714, calcd for 
[M − Br]+ 253.2706. Anal. Calcd for C8H21B10N2Br: C, 28.83; H, 6.35; N, 8.41. Found: C, 
28.72; H, 6.41; N, 8.27.  
 
Preparation of L2.4.  
Prepared as described for L2.1 from mesityl imidazole 
(445 mg, 2.39 mmol) and P2.1 (600 mg, 2.39 mmol) 
in anhydrous toluene (3 mL). After purification the 
product is obtained as a white crystalline solid.    
Yield: 774 mg, 1.77 mmol (74 %).. 1H NMR (500 
MHz, DMSO-d6): δ (ppm) 9.53 (t, J = 1.4 Hz, 1H, H7), 
8.18 (t, J = 1.7 Hz, 1H, H5), 7.95 (t, J = 1.8 Hz, 1H, 
H6), 7.15 (s, 2H, H10), 5.38 (s, 1H, H1), 4.46 (t, J = 7.6 Hz, 2H, H4), 3.12 (t, J = 7.6 Hz, 2H, H3), 
2.33 (s, 3H, H13), 2.02 (s, 6H, H12). 13C NMR (126 MHz, DMSO-d6): δ (ppm) 140.3 (C11), 
137.9 (C7), 134.2 (C9), 131.0 (C8), 129.3 (C10), 123.9 (C6), 123.1 (C5), 72.7 (C2), 63.4 (C1), 47.7 
(C4), 34.8 (C3), 20.6 (C13), 16.9 (C12). 11B{1H} NMR (161 MHz, DMSO-d6): δ (ppm)           
−3.0 (1B), −5.5 (1B), −9.7 (2B), −12.1 (6B). HRMS (ESI+): m/z [C16H29B10N2]+ 357.3343, 
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Preparation of L2.5 
Prepared as described for L2.1 from pyridyl imidazole 
(371 mg, 2.56 mmol) and P2.1 (500 mg, 2.56 mmol) in 
anhydrous toluene (3 mL). After purification the 
product is obtained as a white crystalline solid. Yield: 
699 mg, 1.82 mmol, (71 %). 1H NMR (500 MHz, 
DMSO-d6): δ (ppm) 10.21 (s, 1H, H7), 8.67 (m, 1H, 
HAryl), 8.54 (t, J = 1.7 Hz, 1H, H6), 8.23 (td, J = 8.1, 1.7 
Hz, 1H, HAryl), 8.11 (s, 1H, H5), 8.04 (m, 1H, HAryl), 7.66 (m, 1H, HAryl), 5.38 (br. s, 1H, H1), 
4.48 (m, 2H, H4), 3.07 (m, 2H, H3).13C NMR (126 MHz, DMSO-d6): δ (ppm) 149.3 (CAryl), 
146.2 (C8), 140.7 (CAryl), 135.6 (C7), 125.3 (CAryl), 123.6 (C5), 119.1 (C6), 114.1 (CAryl), 72.5 
(C2), 63.1 (C1), 47.6 (C4), 35.1 (C3). 11B{1H} NMR (161 MHz, DMSO-d6): δ (ppm) −2.9 (1B),   
−5.6 (1B), −9.7 (2B), −11.8 (6B). HRMS (ESI+): m/z [C11H22B10N3]+ 317.2784, calcd for [M − 
Br]+ 317.2781. 
 
Preparation of L3.1.  
P3.2 (200 mg, 0.96 mmol), 1-methylimidazole (79 mg, 0.96 
mmol) and anhydrous toluene (2 mL) was added to an 
ampoule and heated at 100 °C for 72 hours. The reaction was 
then cooled to rt and solvent removed in vacuo. Methanol (3 
mL) was added and insoluble white precipitate filtered and 
dried in vacuo. The product was obtained as colourless 
crystals by slow diffusion of Et2O into the concentrated methanol filtrate. Yield: 20 mg, 0.07 
mmol, (7 %). 1H NMR (300 MHz, DMSO-d6): δ 9.34 (s, 1H, imidazolium H7), 7.90 (s, 1H, 
imidazolium H6), 7.72 (s, 1H, imidazolium H5), 5.62 (br. s, 1H, H1), 4.37 (t, J = 9 Hz, 2H, H4), 
3.86 (s, 3H, H8), 2.97 (m, 2H, H3). 13C NMR (75 MHz, DMSO-d6): δ 137.0 (C7), 123.5 (C6), 
122.3 (C5), 72.6 (C2), 63.2 (C1), 47.0 (C4), 35.8 (C8), 35.4 (C3). 11B{1H} NMR (96 MHz, 
DMSO-d6): δ −3.2 (1B), −5.6 (1B), −9.8 (2B), −12.1 (6B). HRMS (ESI+): m/z [C8H21B10N2]+ 
253.2714, Calcd for [M − Cl]+ 253.2706. 
 
Preparation of L5.1.  
Prepared as described for L2.1 from P5.3 (100 mg, 0.38 mmol) 
and 1-methylimidazole (31 mg, 0.38 mmol) in anhydrous 
toluene (1 mL), with a reaction time of 6 hours. After 
purification the product was obtained as a fluffy crystalline 
white solid. Yield: 79 mg, 0.23 mmol (60 %). 1H NMR (300 
MHz, CD3OD): δ (ppm) 9.07 (s, 1H, H8), 7.75 (m, 1H, H7), 7.59 
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(m, 1H, H6), 4.46 (m, 2H, H5), 3.93 (s, 3H, H9), 2.95 (m, 2H, H4), 2.15 (s, 3H, H1). 13C{1H} 
NMR (75 MHz, CD3OD): δ (ppm) 138.5 (C8), 125.1 (C7), 123.8 (C6), 77.5 (C3), 75.6 (C2), 48.9 
(C5), 36.6 (C4), 35.2 (C9), 23.6 (C1). 11B{1H} NMR (96 MHz, CD3OD): δ (ppm) −3.9 (1B), 
−5.9 (1B), −9.6 (4B), −10.5 (4B). HRMS (ESI+): m/z [C9H23B10N2]+ 267.2875, calcd for        
[M − Br]+ 267.2863. Anal. Calcd for C9H23B10N2Br: C, 31.13; H, 6.68; N, 8.07. Found: C, 
31.02; H, 6.79; N, 8.12.  
 
Preparation of L7.1. 
P7.2 (50 mg, 0.14 mmol), mesityl 
imidazole (52 mg, 0.28 mmol) and 
anhydrous CD3CN (0.70 mL) were 
added to a Young’s Tap NMR tube in 
the glove box. The reaction mixture was 
heated at 80 °C for 86 hours. The 
reaction was cooled to room temperature and the product precipitated as a white solid. This was 
filtered and washed with MeCN (5 mL) then Et2O (30 mL) and dried in vacuo to yield a 
crystalline white solid. Yield: 55 mg, 0.08 mmol (54 %). 1H NMR (300 MHz, CD3OD): δ 9.31 
(s, 1H, H6), 8.01 (t, J = 1.8 Hz, 1H, H5), 7.75 (t, J = 1.8 Hz, 1H, H4), 7.14 (s, 2H, H9), 4.46 (m, 
2H, H3), 2.84 (m, 2H, H2), 2.37 (s, 3H, H12), 2.08 (s, 6H, H11). 11B{1H} NMR (96 MHz, 
CD3OD): δ −10.8. Note: 11B{1H} NMR spectrum very broad with only one resonance.  
 
2.7.4 Zwitterionic ligands 
 Preparation of L1.2  
To a solution of I1 (3.68 g, 29.60 mmol) in toluene (10 mL) was 
added P1.1 (2.35 g, 9.91 mmol), and the reaction mixture was 
stirred at 110 ºC for 24 hours. The solvent was removed in vacuo 
to afford a brown oil. The product was obtained as a white solid by 
recrystallisation from MeCN (10 mL) with Et2O (30 mL). Yield: 
2.51 g, 9.27 mmol (93 %). 1H NMR (CD3CN, 500 MHz): δ (ppm) 8.52 (s, 1H, H6), 7.58 (s, 1H, 
H5), 7.53 (s, 1H, H4), 4.31 (d, J = 14.0 Hz, 1H, H3), 4.12 (d, J = 14.0 Hz, 1H, H3), 1.64 (s, 9H, 
H8). 13C{1H} NMR (75 MHz, DMSO-d6): δ (ppm) 134.1 (C6), 122.2 (C5), 120.2 (C4), 59.4 (C7), 
57.0 (C2), 56.3 (C3), 43.8 (C1), 29.1 (C8). 11B{1H} NMR (CD3CN, 96 MHz): δ (ppm)         
−10.6 (2B), −14.7 (2B), −19.4 (2B), −21.1 (1B), −32.6 (1B), −36.68 (1B). HRMS (ESI+): m/z 
[C10H26B9N2] 273.2735, calcd for [M + H]+ 273.2933.  
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Preparation of L1.3 
To a stirred solution of P1.1 (320 mg, 1.35 mmol) in toluene (5 mL) 
was added 1-methylimidazole (550 mg, 6.70 mmol). The reaction 
mixture was stirred at room temperature for seven days then 
concentrated in vacuo. The solid was sonicated, filtered and washed 
with iPrOH to give the product as a white solid. Yield: 94 mg, 0.41 mmol (30 %) as a white 
powder. 1H NMR (CD3CN, 300 MHz): δ (ppm) 8.41 (s, 1H, H6), 7.44 (s, 1H, H5), 7.34 (s, 1H, 
H4), 4.31 (d, J = 14.4 Hz, 1H, H3), 4.11 (d, J = 14.6 Hz, 1H, H3), 3.86 (s, 3H, H7). 13C{1H} 
NMR (75 MHz, DMSO-d6): δ (ppm) 136.0 (C6), 123.4 (C5), 122.4 (C4), 57.0 (C2), 56.3 (C3), 
43.7 (C1), 35.8 (C7). 11B{1H} NMR (CD3CN, 96 MHz): δ (ppm) −10.5 (2B), −14.6 (2B),    
−19.1 (2B), −21.0 (1B), −32.6 (1B), −36.7 (1B). HRMS (ESI+): m/z [C7H19B9N2Na] 253.2289, 
calcd for [M + Na]+ 253.2283.  
 
Preparation of L2.2.  
To a solution of I1 (4.00 g, 32.20 mmol) in toluene (10 mL) 
was added P2.1 (1.60 g, 6.37 mmol), and the reaction mixture 
was stirred at 110 ºC for 24 hours. The solvent was removed in 
vacuo to afford a brown oil to which MeOH (10 mL) was 
added to precipitate the product. This was filtered, washed 
with MeOH (3 × 10 mL) and dried in vacuo to afford the 
product as a white solid. Yield: 1.18 g, 4.14 mmol (65 %). 1H NMR (501 MHz, DMSO-d6): δ 
(ppm) 9.27 (t, J = 1.6 Hz, 1H, H7), 8.03 (t, J = 1.9 Hz, 1H, H5), 7.83 (t, J = 1.8 Hz, 1H, H6), 
4.17 (td, J = 6.8, 1.1 Hz, 2H, H4), 2.11 (m, 1H, H3), 1.94 (m, 1H, H3), 1.62 (s, 9H, H9), 1.55 (br. 
s, 1H, H1). 13C{1H} NMR (126 MHz, DMSO-d6): δ (ppm) 134.5 (C7), 122.8 (C6), 120.2 (C5), 
59.3 (C8), 56.1 (C2), 50.1 (C4), 44.7 (C1), 38.9 (C3), 29.0 (C9). 11B{1H} NMR (161 MHz, 
DMSO-d6): δ (ppm) −11.1 (2B), −14.2 (1B), −15.9 (1B), −19.4 (2B), −21.6 (1B), −33.2 (1B),        
−37.3 (1B). HRMS (ESI+): m/z [C11H28B9N2]+ 286.3131, calcd for [M + H]+ 286.3126. Anal. 
Calcd for C11H27B9N2: C, 46.42; H, 9.56; N, 9.84. Found: C, 46.60; H, 9.65; N, 9.80. Crystals 
suitable for X-ray diffraction analysis were grown by the slow diffusion of Et2O into a 
concentrated solution of the product in MeCN. 
 
Preparation of L2.10. 
Prepared as described for L2.2, from P2.1 (462 mg, 1.84 mmol) 
and 1-methylimidazole (205 mg, 2.5 mmol). Following 
purification the product was isolated as a fluffy crystalline 
white solid. Yield: 334 mg, 1.38 mmol (75 %). 1H NMR (500 
MHz, DMSO-d6): δ (ppm) 9.12 (s, 1H, H7), 7.73 (t, J = 1.7 Hz, 
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1H, H5), 7.67 (t, J = 1.7 Hz, 1H, H6), 4.15 (m, 2H, H4), 3.84 (s, 3H, H8), 2.05 (m, 1H, H3), 1.89 
(m, 1H, H3), 1.57 (br. s, 1H, H1). 13C NMR (126 MHz, DMSO-d6): δ (ppm) 136.6 (C7), 123.4 
(C6), 122.5 (C5), 56.2 (C2), 50.1 (C4), 44.8 (C1), 39.0 (C3) 35.6 (C8). 11B{1H} NMR (161 MHz, 
DMSO-d6): δ (ppm) −11.0 (1B), −11.4 (1B), −14.3 (1B), −15.8 (1B), −19.5 (2B), −21.6 (1B), 
−33.2 (1B), −37.3 (1B). HRMS (ESI+): m/z [C8H21B9N2Na]+ 266.2478, calcd for [M + Na]+ 
266.2476.  
 
Preparation of L4.1  
To a stirred solution of P4.1 (150 mg, 0.68 mmol) in 
toluene (5mL) was added tBu-imidazole (422 mg, 3.40 
mmol). The reaction mixture was heated at reflux for 
seven days then concentrated in vacuo. The residue was 
recrystallised from MeCN (5 mL) with Et2O (20 mL) to give the product as a beige powder. 
Yield: 147 mg, 0.49 mmol (72 %). 1H NMR (DMSO-d6, 300 MHz): δ (ppm) 9.23 (s, 1H, H8), 
7.98 (s, 1H, H7/6), 7.83 (s, 1H, H7/6), 4.04 (m, 2H, H5), 1.91 (s, 9H, H4), 1.58 (s, 9H, H10), 1.44 
(m, 2H, H3). 13C{1H} NMR (DMSO-d6, 75 MHz): δ (ppm) 134.8 (C8), 124.0 (C7/6), 120.7 
(C7/6), 59.8 (C9), 49.5 (C5), 35.9 (C4), 31.7 (C3), 29.5 (C9). 11B{1H} NMR (CD3CN, 96 MHz): δ 
(ppm) −11.19 (2B), −14.03 (1B), −16.63 (1B), −19.02 (2B), −21.97 (1B), −33.43 (1B), −37.29 
(1B). HRMS (ESI+): m/z [C12H30B9N2Na]+ 323.3073, calcd for [M + Na]+ 323.3066. Note: in 
the 1H NMR spectrum H1 is masked by the H10 and H3 signals, and in the 13C{1H} NMR 
spectrum the C2 and C1 resonances are too broad to assign. 
 
Preparation of L4.2  
To a stirred solution of P4.1 (150 mg, 0.68 mmol) in 
toluene (5 mL) was added picolylimidazole (541 mg, 
3.40 mmol). The reaction mixture was heated at reflux 
for seven days then concentrated in vacuo. The 
residue was recrystallised from MeOH (5 mL) with 
H2O (10 mL) to give the product as colourless 
crystals. Yield: 70 mg, 0.21 mmol (31 %). 1H NMR (300 MHz, DMSO-d6): δ (ppm) 9.28 (s, 
1H, H8), 8.54 (ddd, J = 4.8, 1.6, 0.9 Hz, 1H, HAryl), 7.88 (td, J = 7.7, 1.8, 1H, HAryl), 7.79 (t, J = 
1.7 Hz, 1H, H7/6), 7.76 (t, J = 1.7 Hz, 1H, H7/6), 7.47 (m, J = 7.8 Hz, 1H, HAryl), 7.40 (ddd, J = 
7.5, 4.9, 0.9 Hz, 1H, HAryl), 5.55 (s, 2H, H9), 4.13 (t, J = 7.1 Hz, 2H, H5), 1.88 (m, 2H, H4), 1.64 
(br. s, 1H, H1), 1.46 (m, 2H, H3), -2.85 (B-H-B). 13C NMR (75 MHz, DMSO-d6): δ (ppm) 153.6 
(C10), 149.5 (C8), 137.5 (CAryl), 136.8 (CAryl), 123.6 (CAryl), 123.3 (CAryl), 122.4 (C7/6), 122.3 
(C7/6), 58.5 (C2), 53.0 (C9), 49.0 (C5), 45.6 (C1), 35.2 (C4), 31.2 (C3). 11B{1H} NMR (161 MHz, 
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DMSO-d6): δ (ppm) −11.2 (2B), −14.2 (1B), −17.0 (1B), −18.9 (2B), −22.2 (1B), −33.4 (1B), 
−37.2 (1B). HRMS (ESI+): m/z [C14H26B9N3Na]+ 357.2904, calcd. for [M + Na]+ 357.2898.  
 
Preparation of L4.3   
To a stirred solution of P4.1 (150 mg, 0.68 mmol) in 
toluene (5 mL) was added allylimidazole (368 mg, 3.40 
mmol). The reaction mixture was heated at reflux for 
seven days then concentrated in vacuo. The residue was 
recrystallised from MeCN (5 mL) with Et2O (20 mL) to 
give the product as a white powder. Yield: 46 mg, 0.16 mmol (24 %). 1H NMR (300 MHz, 
CD3CN): δ (ppm) 8.44 (s, 1H, H8), 7.96 (t, J = 1.7 Hz, 1H, H7/6), 7.89 (t, J = 7.1 Hz, 1H, H7/6), 
6.03 (m, 1H, H10), 5.40 (m, 2H, H9), 4.73 (m, 2H, H11), 4.09 (t, J = 7.3Hz, 2H, H5), 2.01 (m, 
2H, H4), 1.69 (br. s, 1H, H1), 1.59 (m, 2H, H3), -2.77 (br. s, 1H, B-H-B). 13C NMR (75 MHz, 
DMSO-d6): δ (ppm) 149.1 (C8), 140.5, 135.0, 125.1, 123.5, 119.2, 114.2, 58.5 (C2), 49.7 (C5), 
45.7 (C1), 35.3 (C4), 31.0 (C3). 11B{1H} NMR (96 MHz, CD3CN): δ (ppm) −11.2 (2B),      
−14.1 (1B), −16.6 (1B), −19.0 (2B), −22.0 (1B), −33.4 (1B), −37.3 (1B). HRMS (ESI+): m/z 
[C11H25B9N2Na]+ 306.2794, calcd. for [M + Na]+ 306.2789.  
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  Chapter 3
Unique ligands that exhibit unprecedented and versatile coordination at early to 
mid transition metals 
This chapter discusses the synthetic challenges associated with deprotonation of the 
zwitterionic ligand precursors reported in Chapter 2. A deprotonation study revealed that the 
ligand must possess an ethyl linker or longer between the imidazolium and the carborane for a 
free carbene to be isolated. Subsequent coordination to various metal centres, including 
titanium, iron and rhodium, is explored.  
 
3.1 Introduction 
3.1.1 Applications of rhodocarboranes 
Hawthorne and co-workers were the first to report the utility of metallacarboranes in 
homogenous catalysis, by use of a rhodocarborane.1 The complex was prepared by reacting the 
tris(triphenyl-phosphine)rhodiumI cation with [7,8-C2B9H12]- in methanol at 60 °C, with 
formation of the product being considered to arise by oxidative addition of the bridging proton 
of the cage to the unsaturated RhI centre to give a η5-coordinating RhIII complex (i) (Scheme 
3.1). The rhodocarborane was shown to be catalytically active in the isomerisation and 
hydrogenation of alkenes,1 hydrosilyation of ketones1 and the exchange of terminal BH bonds 
with deuterium gas.2 These type of systems have been extensively studied, and in many the 







Scheme 3.1 Synthesis of rhodocarborane i and its respective catalytically active species.1 
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It has been reported that a second tautomer exists in which the metal centre migrates to the 
‘lower belt’ forming a less active species (iii).5 In 1996, Teixidor and co-workers reported a far 
superior catalyst for the hydrogenation of 1-hexene by preventing formation of the second 
tautomer (Scheme 3.2).6 This complex houses an exo-monothiocarborane ligand (iv) with the 
concept that the thioether provides the necessary B-H-M interaction favouring the catalytically 
active species (v) and preventing tautomerism to the catalytically inactive closo-tautomer as 





Scheme 3.2. Synthesis of Teixidor’s catalysts for the hydrogenation of 1-hexene.6 
 
3.1.2 Applications of rhodium-NHCs 
Over the course of the last thirty years, Rh-NHCs have been utilised across a vast range of 
catalytic transformation, including hydrosilyation,7,8 arylation,9 cyclisation reactions,10–13 and 
hydroformylation.14 However, in comparison to the highly catalytically active rhodocarboranes 
for direct hydrogenation of alkenes, Rh-NHCs are lacklustre in this area. One of the main 
downfalls was that the NHC complexes decompose under hydrogenation conditions.15 Greater 
success has been found in an alternative method employed for hydrogenating compounds, 
known as transfer hydrogenation (TH).16–20 The TH method avoids the use of pressured H2 gas 
by using a sacrificial alcohol as a hydrogen source. A more detailed account of the literature 
and mechanistic insights into TH is discussed in Chapter 5, Section 5.1. 
Hydrosilyation is arguably the most widely studied application for Rh-NHCs.7,8 In 1996, 
Herrmann reported the first NHC complex for asymmetric hydrosilylation (Figure 3.1).21 
Despite low enantiomeric excess (32 %), the results were promising enough to demonstrate that 
NHCs can be employed in asymmetric synthesis. Shortly after this report, Enders published 
details of (triazolinylidene)rhodium(COD) complexes, which attained yields of 60 % and ee 
values of up to 40 % in the hydrosilylation of various ketones (Figure 3.1).22 The first break-
through report was in 2003 by Shi and co-workers, with a chiral bis-carbene ligand which 
achieved 98 % yield with an ee of 87 % in the hydrosilylation of methyl ketones (Figure 3.1).23 
Shortly after, Gade et al. reported a bidentate oxazoline NHC ligand, which achieved 90 % ee 
with excellent yields employing similar substrates (Figure 3.1).24 To date, this system is still 
one of the most active for the asymmetric hydrosilyation of ketones.25  












Figure 3.1 Important advances in rhodium catalysts developed for the hydrosilylation of 
ketones.21–24 
 
3.1.3 Iron dicarbollides  
Iron dicarbollides changed the course of organometallic chemistry with the synthesis of the 
carboranyl analogue of ferrocene in 1965.26 However, the majority of these complexes are 
synthesised purely out of curiosity and to examine their structural properties. Extraction of 
radioactive species from nuclear waste is one of the largest fields to which metallacarboranes 
have been applied.27  
3.1.4 Iron-NHC complexes 
One of the most effective methods for the synthesis of Fe-NHCs was reported by Danopoulos 
and utilises the highly reactive FeII precursor [Fe{N(SiMe3)2}2],28, previously reported by 
Lappert and co-workers.28,29 Conveniently, the sole by-product of this reaction is two 
equivalents of HN(SiMe3)2, allowing the FeII-NHC complex to be isolated cleanly by simply 
removing the volatile by-product in vacuo. A comprehensive review on Fe-NHC synthesis and 
their catalytic applications was recently reported by Kühn and co-workers,30 and highlights a 
plethora of ligand scaffolds. By mass, Fe is the most common element on earth making it also 
the cheapest metal element, around 10,000 times cheaper than Pd.31 It is also much less toxic so 
‘allowed’ levels of trace metal in final products can be much higher for Fe than for Pd.32 As a 
result, Fe-NHCs have seen a surge of interest in catalysis.30 More specifically, Cp*Fe-NHCs 
have been found to be highly efficient in the hydrosilyation of ketones, and the reduction of 
ketones via hydrosilylation and transfer hydrogenation reactions, respectively (Figure 3.2).33,34 
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Figure 3.2 Catalytic hydrosilyation (A), transfer hydrogenation (B) and reduction of ketones 
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3.1.5 Titanium complexes in the polymerisation of alkenes 
The chemistry of NHCs bound to early transition metals, especially higher oxidation state 
metals, is relatively under-developed when compared to the late transition metals. There is a 
tendency of the NHC to dissociate from early transition metals due to the weak MIV-NHC bond. 
To enhance the binding of the NHC one can utilise tridentate ligands, such as the 
bis(carbene)pyridyl ligand scaffold as reported by Gibson et al., which was found to have 
moderate activity in the polymerisation of ethylene.35 Alternatively, incorporation of chelating 
anionic groups, which act as anchor points, is a popular synthetic strategy for stabilising        
Ti-NHC complexes. One of the earliest examples of an anionic-tethered NHC was reported by 
Kawaguchi in 2003 (Figure 3.3).36 There are numerous examples of CpTi-NHC type 
complexes but the catalytic activity of these complexes in the polymerisation of ethylene have 
not been reported.37 The use of the dicarbollide ligand (C2B9H11) as an anchoring point in half 
sandwiched Ti complexes is largely unexplored, even though the first reports of such 
complexes were reported over a decade ago by Kang and co-workers (Figure 3.3).38,39  
 Figure 3.3 Examples of Ti-NHCs and Ti-dicarbollides used in ethylene polymerisation.35,36,39 
 
3.2 Aims 
A plethora of NHC and carborane complexes have been discussed, with an emphasis on the 
catalytic applications of these complexes. NHC ligands with anionic tethers have been 
described, and have carborane ligands linked to other neutral donors such as amines. The aim 
of this work was to prepare complexes of fused NHC-carborane ligands i.e. in which the NHC 
is the neutral donor and the carborane acts as the anionic tether. The zwitterionic compounds 





  CHAPTER 3 
 
 69 
3.3 Initial attempts at deprotonation and metallation of the zwitterionic ligand 
precursors 
The zwitterionic ligand precursors L1.2 and L2.2 prepared in Chapter 2 possess two acidic 
protons, which require deprotonation in order to coordinate to a metal centre. These are the 
imidazolium NCHN proton and the bridging proton of the C2B3 face of the carborane (Scheme 
3.3). Initial attempts at deprotonation and metallation involved using three of the most effective 
synthetic methods for synthesising NHC complexes; i) reaction with an inorganic base (CsCO3 
or KOtBu) in the presence of a metal halide salt, ii) reaction with a basic metal precursor, with 
Pd(OAc)2 and Ag2O being employed, and iii) deprotonation and transmetallation using Ag2O in 
combination with metal halide salts. 
Scheme 3.3 Synthetic methods employed for the attempted synthesis of NHC-carborane 
complexes. i) (CsCO3 or KOtBu) with a metal halide salt, ii) Pd(OAc)2 or Ag2O, and iii) Ag2O 
with metal halide salts. 
With L1.2 and L2.2 possessing diagnostic resonances in the 1H NMR spectra for the acidic 
protons, the loss of these signals would strongly indicate coordination to a metal, making 1H 
NMR spectroscopy a powerful tool for monitoring the progress of reactions. HRMS is another 
useful technique, which goes in hand with NMR spectroscopy. An extensive number of 
reactions were conducted, and with respect to the reactions involving an inorganic base and 
metal salt, no reaction occurred. The crude 1H NMR spectra still possessed the diagnostic 
signals for the acidic protons and the major peaks in the HRMS at m/z 271.2892 and m/z 
286.3131 correspond to the zwitterionic ligand precursors L1.2 and L2.2, respectively. 
Likewise, for the other two synthetic methods, the metal salts employed formed a black 
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3.4 Deprotonation studies 
In an attempt to understand the unsuccessful deprotonation and metallation reactions (Section 
3.3), the transition metals were removed from the reactions. The aim was to deprotonate the 
zwitterion and isolate the doubly deprotonated species i.e. the free carbene and the dianion. The 
most common base employed for deprotonation of nido-carboranes is NaH in anhydrous 
THF.40 Since NHCs can also be deprotonated by NaH,41 deprotonation studies with zwitterionic 
ligands bearing a tBu N-substituent with varying tether lengths (L1.2, L2.2 and L4.1) were 
conducted (Scheme 3.4).  
 
Scheme 3.4 Deprotonation reactions of the zwitterionic ligands with NaH. 
After reacting L1.2 with NaH (2 eq., 40 °C, 120 hours, d8-THF), the resonance attributable to 
the bridging proton of the carborane cage at -3.01 ppm was absent from the 1H NMR spectrum 
(Figure 3.4, top). However, the NCHN proton (H6) is still present, which has shifted upfield 
from 8.89 to 7.82 ppm, a direct consequence of forming a more charge dense cage. 
Surprisingly, even at elevated temperatures (up to 60 °C) or employing a stronger base (nBuLi), 
the H6 proton still resists deprotonation. This is a very unusual observation for imidazolium 
protons, which are usually deprotonated under these conditions. On increasing the tether length 
to an ethyl (L2.2) or propyl (L4.1), both the bridging proton of the carborane cage and the 
imidazolium NCHN protons were successfully deprotonated to give C2.1 and C4.1 under the 
same reaction conditions (2 eq., 40 °C, 120 hours, d8-THF). Increasing the temperature to 60 °C 
reduced the reaction times considerably, with full deprotonation achieved after 18 hours, with 
both diagnostic resonances (H7 and BHB) being absent in the 1H NMR spectrum of C2.1 
(Figure 3.5, top).  
 















Figure 3.4 1H NMR spectra (300 MHz, d8-THF) of L1.2 (bottom) and after reacting with NaH 
at 60 °C for 14 hours (top). The broadness of the spectrum of L1.1 is a result of its poor 
solubility. 
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Comparing the 11B{1H} NMR spectra of L2.2 and C2.1; that of L2.2 contains peaks in the 
region −10 to −40 ppm, whilst that of C2.1 are in the region −15 to −50 ppm  (Figure 3.6). The 
spectrum of C2.1 is more symmetrical than that of L2.2 and is shifted more upfield due to an 
increase in electron density of the cage upon formation of C2.1. A large upfield shift of the B10 
resonance is due to the majority of the electron density delocalising about this vertex. A 










Figure 3.6 11B{1H} NMR spectra (98 MHz, d8-THF) of L2.2 (bottom) and free carbene C2.1 
(top). 
During the reaction between L2.2 and NaH a crystalline solid precipitates from the reaction 
after 4-8 hours of heating at 40 °C. X-ray diffraction analysis of these crystals identified it as a 
possible intermediate of the reaction, where the bridging proton of the carborane has been 
deprotonated but the NCHN proton is still present (C2.1’) (Figure 3.7). The structure was 
solved in the monoclinic P21/n space group with the selected metric parameters given in Table 
3.1. The asymmetric unit possesses one carborane ligand with a THF-solvated Na atom       
exo-polyhedrally attached to the B(8)-B(7) edge of the carborane, which is achieved through 
Na-H-B bridges. It became apparent that the structure exists as a dimer possessing a 
centrosymmetric centre on growing out the structure from the asymmetric unit.  
This interesting motif is common amongst carborane dianions, and the first reported crystal 
structures were reported by Meshcheryakov and co-workers in 2003.42 The report highlighted 
that carboranyl dianions such as [Na2(THF)3(7,8-C2B9H11)]n exist as polymeric structures 
(Figure 3.8). For charge compensated cages such as [Na2(THF)3(9-L-7,8-C2B9H11)]2, where L 
= SMe2 or NMe3, the structures exist as dimers with both Na atoms being exo-polyhedral with 
interactions to both of the carborane ligands. 
 
















Figure 3.7 The asymmetric unit (A), molecular structure (B) and space-filling model (C) of 
C2.1’. Ellipsoids are shown at 40 % probability and the hydrogen atoms, excluding those 
involved in Na-H-B bridges, are omitted for clarity. The THF molecules of the Na(2) atom are 











Table 3.1 Selected bond distances (Å) for C2.1’. 
Bond Distance (Å) Bond Distance (Å) 
Na(1)-O(1) 2.355(18) C(2)-B(7) 1.631(3) 
Na(1)-O(2) 2.363(18) B(7)-B(8) 1.749(3) 
Na(1)-H(7) 2.415(7) B(4)-B(8) 1.737(3) 
Na(1)-H(8) 2.329(7)   
C(1)-C(2) 1.551(3)   
C(1)-B(4) 1.621(3)   
A B 
C 









Figure 3.8 Structures of the first dianion and charge compensated anion.43 
In the case of C2.1’, the positively charged imidazolium group occupies the open face of the 
carborane, which prevents coordination of the Na atom to the C2B3 face, leading to formation 
of the dimeric structure similar to the findings of Meshcheryakov and co-workers. The space-
fill model of C2.1’ may show why the imidazolium NHCN proton of L1.2 does not 
deprotonate (Section 3.3). The shorter linker of L1.2 will allow for a stronger interaction 
between the positively charged imidazolium and the C2B3 face making the proton inaccessible. 
However, obtaining 1H and 11B{1H} NMR data on C2.1’ was not possible, as analysis of the 
crystalline material by NMR spectroscopy revealed the bulk was in fact the free carbene 
(C2.1). In an attempt to observe C2.1’ in solution; the amount of NaH used in the reaction was 
reduced from two to one equivalent. However, the 1H NMR spectrum revealed just a mixture of 
the zwitterion L2.2 and the free carbene C2.1. This suggests C2.1’ is a crystallisation effect 
and in solution is to likely exist as a 1:1 ratio of L2.2 and C2.1.  
A comprehensive kinetic study by Hawthorne and co-workers illustrated how the substituents 
of C-substituted carboranes exert primarily stereochemical rather than electronic influence on 
the rate of deprotonation of the bridging proton of the carborane.44 This study shows that 
substituents that posses a CH2 spacer deprotonate more readily than those bound directly to the 
cage such as a phenyl group. This is due to their ability to ‘swing out of the way’ allowing the 
metal hydride to approach the cage surface. Temperature also has a strong influence, with 
elevated temperatures reducing deprotonation times considerably. Our NMR experiments are in 
accordance with Hawthorne’s findings; the rate of deprotonation increases with the tether 
length from ethyl to propyl, and increasing the temperature from 40 °C to 60 °C dramatically 
decreases the reaction time. Most importantly, these reactions provide possible explanations for 
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3.5 Formation of a RhI bimetallic NHC-carborane complex: An example of low 
temperature polytopal rearrangement  
All reactions discussed herein were conducted on an NMR scale, with one of the challenging 
aspects of this chemistry being the handling of the dianion C2.1 (Scheme 3.5). Before addition 
of a metal salt, C2.1 must first be isolated from the excess NaH used in its formation, which 
can be achieved by removing the solution from the particulate via syringe in the glove box. 
Initial attempts at removing the NaH involved filtering over glass wool or Celite, which had 
been pre-treated with anhydrous THF, dried in vacuo and stored over argon, but even under 
these strict anhydrous conditions each filtration led to reprotonation of ca. 10-20 % of the 
material.  
Following removal from NaH via syringe, the treatment of C2.1 with [RhI(COD)Cl]2 in MeCN 
at room temperature produced an isomeric mixture of bimetallic complexes C2.2 and C2.3 
(Scheme 3.5). The formation of C2.3 is a consequence of isomerisation of the cage known as 
the 3,1,2 (ortho-) to 2,1,8 (meta-) rearrangement, with the numbers simply indicating the 
position of the carbons atoms in the cage. Thermal isomerisation of o-carborane to its 
respective isomers meta- and para- at high temperatures (ca. 470 °C and 700 °C) has been well 
established for over 50 years.45,46 In the case of C2.2 isomerisation occurs at room temperature, 
a phenomenon known to occur in metallacarboranes decorated with bulky substituents, with 
isomerisation relieving steric stress at the metal centre.47–50 
 
Scheme 3.5 Synthesis of a bimetallic RhI NHC-carborane COD complex C2.3 and attempted 
synthesis of an ethylene derivative. 
Work by Stone and co-workers demonstrated that low temperature isomerisation at Pd can be 
influenced by electronic effects of the exo-polyhedral ligands (Figure 3.9).51 Compounds of 
type 1,2-Me2-L2-PdC2B9 undergo low temperature isomerisation when L2 = COD (A), but not 
when L2 = tmeda (B).  
This behaviour can be rationalised by the magnitude of slipping distortion (Δ) induced by the 
different exo-polyhedral ligands. Ligands that possess the ability to accept π-electron density 
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from the metal result in stronger metal-to-cage bonding, with little to no ring slippage, retaining 
an η5-bonding mode. As a result, these complexes are sterically crowded and susceptible to 
isomerisation. As the electron accepting ability of the exo-polyhedral ligands decreases, the 
metal-to-cage bonding becomes weaker allowing for ring slippage. This reduces the steric 
stress at the metal centre and as a consequence isomerisation is not observed. This provides a 
good rationale for why we observe low temperature isomerisation in C2.2, which was 
examined by attempting to exchange the COD ligand for a weaker π-acceptor by using the 
[Rh(C2H4)2Cl]2 precursor. Unfortunately this resulted in formation of a black precipitate when 
added to C2.1, presumably Rh0, with the 1H NMR spectrum indicating reformation of an 





Figure 3.9 Complexes reported by Stone and co-workers that isomerise at room temperature.51 
Complexes C2.2 and C2.3 were determined as structural isomers by X-ray diffraction analysis. 
The slow evaporation of a concentrated MeCN solution produced single crystals of C2.2 and 
C2.3 within the same sample, with each producing crystals of different morphology. 
Examination of the molecular structures unambiguously determined that the two complexes are 
structural isomers (Figure 3.10). In C2.2, the Rh(2) centre is almost equidistant from the three 
boron and two carbon atoms [2.217-2.306 Å] indicating symmetrical bonding and an              
η5-bonding mode.  
Likewise for C2.3, almost equidistant bonding is observed for four of the atoms in the CB4 
face, with the exception of B11, which is considerably shorter at 2.250(3) Å. This is due to the 
CB4 face being puckered into an ‘envelope’ conformation, which arises from the carbon atoms 
being held closer to the centre of the cluster than the boron atoms, and is typical of rearranged 
2,1,8-complexes in the literature (Figure 3.10).50–52 In the rearranged product (C2.3), the Rh(2) 
and CB4 face bond lengths are on average shorter than in C2.2, indicating stronger bonding 
between the carborane and metal centre. This is married with the reduction in π-backbonding to 
the COD ligand, with the Rh(2)-COD alkenyl bond length in C6 averaging 2.157 Å, which is 
longer than in the parent complex C2.2 at 2.127 Å. 
The Rh(1) centres of both complexes display a distorted square planar geometry, with Rh-
Ccarbene bond lengths of  2.061(4) and 2.048(3) for C2.2 and C2.3 respectively, which is in the 
expected range for RhI-NHC(COD) type complexes.53–56  
 













Figure 3.10 Molecular structures of C2.2 (left) and C2.3 (right). Ellipsoids are shown at 40 % 
probability and the hydrogen atoms are omitted for clarity. 
 
 
Table 3.2 Selected bond distances (Å) for C2.2 and C2.3. 
Distance (Å) C2.2 C2.3  Distance (Å) C2.2 C2.3 
C(1)-C(2) 1.608(5) -  Rh(2)-C(23) 2.144(4) 2.158(3) 
C(1)-B(11) - 1.711(4)  Rh(2)-C(26) 2.110(3) 2.144(3) 
Rh(2)-C(1) 2.231(4) 2.290(3)  Rh(2)-C(27) 2.130(4) 2.153(3) 
Rh(2)-B(11) - 2.153(3)  Rh(1)-C(12) 2.198(4) 2.118(3) 
Rh(2)-C(2) 2.306(4) -  Rh(1)-(C13) 2.189(4) 2.123(3) 
Rh(2)-B(4) 2.245(4) 2.217(3)  Rh(1)-C(16) 2.126(4) 2.192(3) 
Rh(2)-B(6) 2.209(4) 2.237(3)  Rh(1)-C(17) 2.118(4) 2.199(3) 
Rh(2)-B(5) 2.276(4) 2.250(3)  Rh(1)-(C7) 2.061(4) 2.048(3) 
Rh(2)-C(22) 2.124(4) 2.173(3)  Rh(1)-N(3) 2.056(3) 2.073(2) 
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The formation of C2.2 and C2.3 in solution was determined using NMR spectroscopic analysis.  
Reaction of C2.1 with [RhI(COD)Cl]2 for 3 hours at room temperature produced a spectrum 
containing several species, and even after leaving the sample for 3 days at room temperature, 
these species persist with no change to the spectrum (Figure 3.11, A). The presence of multiple 
species is indicated by the number of NHC backbone resonances around 7.00 to 7.50 ppm. The 
identity of all the species present is not known but it can be rationalised that one set of 
resonances belong to the 3,1,2 isomer (C2.2) and another belonging to the 2,1,8 isomer (C2.3), 
as both were identified crystallographically. Upon heating the sample to 60 °C for 18-24 hours 
the majority of the peaks subside to the baseline, whilst one set of resonances intensify 
belonging to C2.3 (Figure 3.11, B). Slow evaporation of the MeCN solution allowed C2.3 to 
be isolated as a pure crystalline solid in 77 % yield.  
The 1H NMR spectroscopic data of C2.3 was fully assigned in acetone-d6 (Figure 3.11, C); the 
absence of the downfield imidazolium NCHN resonance, and presence of only one set of NHC 
backbone resonances at 7.45 and 7.30 ppm strongly suggests the formation of one NHC 
species. The COD ligands appear as broad resonances at 3.56-4.98 ppm for the alkynyl and 
2.91-2.03 ppm for the alkyl moieties, which are typical of similar carboranyl51,52 and NHC 
complexes in the literature.53–56 The CH2 protons of the ethyl linker become diasterotopic due to 
the steric bulk exerted by the two metal centres. One of the resonances can be assigned at 5.36 
ppm, whilst the others are masked under the COD alkynyl resonance at 4.22 ppm or under the 
alkyl COD resonances at 2.91-2.03 ppm. Similarly, the diagnostic cage CH resonance is 
masked by the COD alkyl resonances, all of which were determined by 1H13C 2D NMR 
experiments. Evidence for a coordinated MeCN is ambiguous for which we relied on the 13C 
NMR data and X-ray diffraction analysis. 
The 13C{1H} NMR spectrum of C2.3 contains a resonance at 3.30 ppm characteristic of the 
quaternary carbon of a coordinated MeCN,57 with its identity confirmed by its 2J coupling to the 
Me protons of the MeCN, which are masked by the COD alkyl protons in the 1H13C HMBC 
spectrum (Figure 3.12). The doublet at 174.2 ppm (1JRh-C = 50.4 Hz) is attributable to the     
RhI-NHC carbenic carbon, and those at 75.4 (1JRh-C = 10.1 Hz) and 75.0 ppm (1JRh-C = 11.3 Hz) 
correspond to the Rh-COD alkenyl carbons, with the coupling being typical for similar 
complexes in the literature.53–56 
 















Figure 3.11 1H NMR spectra (300 MHz, CD3CN) following reaction of free carbene C2 with 
[Rh(COD)Cl2]2 for 3 days at rt (A) and heating of the reaction mixture at 60 °C for 24 hours 
(B) and 1H NMR spectrum (500 MHz, acetone-d6) of isolated C2.3 (C). 
Figure 3.12 13C{1H} DEPT135 (bottom), 13C{1H} NMR (top) and 1H13C HMBC (inset) (126 
MHz, acetone-d6) spectra of C2.3. 
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Comparing the 11B{1H} NMR spectra of the free carbene C2.1 to that of the isomeric mixture 
of C2.2 and C2.3; the diagnostic B(10) downfield resonance at −49.1 ppm is lost upon 
coordination to Rh (Figure 3.13). This is a result of reforming a closo cage with the Rh centre 
occupying what was once the B3/B6 vertex, with the electron density no longer being localised 
at the B(10) vertex, but is once again evenly delocalised across the cage.  The 11B{1H} NMR 
data correlates well with the solid-state structures. The absence of a downfield resonance in the 
10-30 ppm region is indicative of symmetrical bonding between the metal and the cage, hence 
no ring slippage. If slippage does occur it can induce strong electron deshielding at the β-boron 












Figure 3.13 11B{1H} NMR spectra (161 MHz, CD3CN) of the free carbene C2.1 (A), reaction 
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Intriguingly, recrystallisation of C2.3 with a mixed solvent system (MeCN/Et2O/hexane) 
resulted in the formation of a dimeric solid-state structure C2.3’, in which the coordinated 
MeCN has dissociated and the resulting cationic [RhI(NHC)(COD)]+ fragment is stabilised by 
an anionic [RhI(carborane)(COD)]- moiety of a second molecule linked by Rh-H-B bridges 
(Figure 3.14). The formation of this dimer appears to be a crystallisation effect and does not 
persist in solution. If C2.3’ did exist in solution diagnostic resonances in the region of −4 to   
−9 ppm in the 1H NMR spectrum, and resonances in the region of 5-20 ppm in the 11B{1H} 
NMR spectrum would be present. 58 Nonetheless, demonstrating the lability of this MeCN 
ligand and the contrasting RhI environments renders C2.3’ interesting for development in 
catalysis.   
Figure 3.14 Molecular structure of C2.3’ (right). Ellipsoids are shown at 40 % probability and 
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3.6 Synthesis of an FeIII- bis(dicarbollide) complex containing imidazolium 
tethers 
As previously discussed (Section 3.1), chelating FeII(Cp-NHC) complexes have been reported 
to be highly active in hydrosilyation and transfer hydrogenation of ketones. The formation of 
related complexes in which the Cp is exchanged for a carborane group was investigated using 
ligand precursor L2.2. Employing a similar strategy used for the synthesis of C2.3 (Section 
3.5), L2.2 was reacted with NaH and the reaction was monitored by 1H NMR spectroscopy 
until both the NCHN and the bridging proton of the carborane had fully deprotonated to 
generate C2.1. This was isolated by transferring the solution from the particulate via syringe 
into a Young’s Tap NMR tube containing a d8-THF solution of FeCl2 in the glove box. Within 
a few minutes of addition, a bright violet precipitate crashed out of solution, indicative of 
formation of a FeII-bis(dicarbollide) (C2.4) (Scheme 3.6).40,59 A 1H NMR spectrum of the 
reaction mixture after 3 hours showed only residual C2.1 in solution. The violet precipitate was 
found to be insoluble in all organic solvents when kept under anhydrous conditions, but upon 
exposure to O2 the violet precipitate instantaneously solubilises in MeCN forming a deep red 
solution as the complex is presumably oxidised from FeII to FeIII. A salt metathesis reaction 
followed by recrystallisation from acetone with water gave a new charge compensated        














Scheme 3.6 Synthesis of a novel charge compensated FeIII-bis(dicarbollide)(PF6)2 complex 
C2.5. 
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Due to the paramagnetic nature of C2.5, characterisation was limited to HRMS, X-ray 
diffraction analysis and micro-analysis. Crystals suitable for X-ray diffraction analysis were 
grown from the slow evaporation of a mixed solvent system (acetone/water 3:1). The structure 
was solved in the P21/c space group with the molecular structure is shown in Figure 3.15 with 
selected bond distances given in Table 3.3. The Fe atom is sandwiched centrally between the 
two cages, with the bonding faces staggered so that the pair of carbon atoms in each cage are at 
maximum distance apart. The Fe-C and Fe-B bond lengths range from 2.108-2.190 Å, which 
are typical distances for Fe-bis(dicarbollide) reported in the literature.59,60 The Fe-C2B3 centroid 
distance of 1.55 Å is quite long in comparison to the unsubstituted Fe dicarbollide (Fe-
(C2H11B9)2) which possesses a Fe-C2B3 centroid distance of 1.48 Å.59 This can be rationalised 
by the fact that the unsubstituted dicarbollide is a dianion, hence will have a stronger        
metal-ligand interaction compared to C2.5, which is overall monoanionic. The substituents on 
the cage can also influence the geometry of the molecule, with the bonding faces of C2.5 being 
non-parallel with a dihedral angle of 3.8°. In more sterically encumbered complexes, such as 







Figure 3.15 Molecular structure of C2.5. Ellipsoids are shown at 40 % probability and the 









Table 3.3 Selected bond distances (Å) for C2.5. 
Bond Distance (Å) Bond Distance (Å) 
C(1)-C(2) 1.679(8) Fe(1)-B(4) 2.118(6) 
C(12)-C(13) 1.633(7) Fe(1)-B(7) 2.149(6) 
C(1)-Fe(1) 2.115(5) Fe(1)-B(8) 2.145(7) 
C(2)-Fe(1) 2.181(5) Fe(1)-B(13) 2.131(6) 
C(12)-Fe(1) 2.143(6) Fe(1)-B(16) 2.108(6) 
C(13)-Fe(1) 2.190(5) Fe(1)-B(17) 2.118(7) 
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Analysis of C2.5 by HRMS gave the expected molecular ion peak of m/z 623.5380 
corresponding to the cationic fragment [C22H32B18Fe]+, with the calculated isotope pattern 
matching that of the observed (Figure 3.16). This, along with micro-analysis of the bulk 
material, confirms the presence of only one species, i.e. the Fe-bis(dicarbollide) complex C2.5. 
Due to the violet precipitate formed following reaction of C2.1 with FeCl2 being completely 
insoluble, it prevented characterisation of this material. It is presumed that this is an FeII 
complex C2.4, with the complex bearing two carbenic tethers, which will be reprotonated upon 
exposure to hydrous solvents (Scheme 3.6).  
Figure 3.16 HRMS of C2.5. Inset shows the molecular ion peak of [M]+ against the calculated 
mass. 
Although the desired chelating complex did not form, C2.5 has the potential to be developed 
into a bimetallic system (Scheme 3.7). Two synthetic strategies were employed in an attempt to 
add a M-NHC to the FeII-bis(dicarbollide): 1) C2.5 was reacted with CsCO3 in the presence of 
[Rh(COD)Cl]2, and, 2) C2.5 was reacted with Ag2O in the presence of [Rh(COD)Cl]2. 
Unfortunately both of these attempts were unsuccessful, which was confirmed using HRMS 
showing only the molecular ion peak for C2.5. It is suspected that the two-imidazolium protons 
are not particularly acidic due to the partially zwitterionic nature of C2.5. Further work using 
C2.5 should employ stronger bases or electrochemical methods to deprotonate the imidazolium 
arms.  
Scheme 3.7 Attempted deprotonation reactions with C2.5. 
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3.7 Synthesis of an unusual NHC-carborane adduct 
Titanium tetrachloride (TiCl4) is a strong Lewis acid and is an important metal precursor for the 
synthesis of many titanocene and titanacarborane complexes.61–68 Similar to previously, L2.2 
was deprotonated using NaH to give C2.1, which was added to TiCl4 at room temperature in 
toluene. The target complex C2.6 was not isolated, instead an unusual NHC-carborane adduct 
(C2.6.adduct) was characterised by X-ray diffraction analysis (Scheme 3.8).  
Scheme 3.8 Synthesis of an NHC-carborane adduct (C2.6.adduct). 
Crystals of C2.6.adduct suitable for X-ray diffraction analysis were grown from the slow 
evaporation of a toluene solution. The molecular structure houses a puckered 6-membered ring 
with the NCN centre bound to the electrophilic B(7) vertex (Figure 3.17). The bridging proton 
of the carborane was located across the B(4)-B(8) edge, suggesting that the C2.6.adduct is 
zwitterionic with the imidazolium balancing the charge. However, upon inspection of the 
metric parameters of the imidazolium group it resembles the properties of a carbene. One of the 
striking differences in NHCs is the N1-C7-N2 bond angles which are significantly smaller in 
comparison to the parent imidazolium salts.69 In addition, the N1/2-C7 bond distances lengthen, 
indicative of a reduction in π-delocalisation in NHCs.69 This is highlighted in Table 3.4 with a 
comparison of the metric parameters of the C2.6.adduct to its parent imidazolium. Further 
clarification of its carbenic properties is provided by comparison to the 2:1 NHC-carborane 
adduct (i) previously reported by the Willans group, which possess an electropositive boron to 























Figure 3.17 Molecular structures of C2.6.adduct, the 2:1 NHC-carborane adduct (i) reported 
by Willans et al. and our ligand L2.2.70 Ellipsoids are shown at 40% probability and the 
hydrogen atoms with the exception of the bridging proton are omitted for clarity. The 
numbering of the carbon, boron and nitrogen atoms for L2.2 and i are labelled to match those 













Table 3.4 Selected bond distances and angles for L2.2, C2.6.adduct and the 2:1 
NHC-adduct (i). 
Parameter L2.2 C2.6.adduct i 
C(7)-B(7) - 1.583(3) 1.634(19) 
C(7)-N(1) 1.344(13) 1.361(3) 1.356(17) 
C(7)-N(2) 1.339(13) 1.355(3) 1.362(17) 
C(5)-C(6) 1.362(16) 1.336(4) 1.340(2) 
C(6)-N(1)-C(7) 107.93(9) 110.74(2) 110.88(12) 
N(1)-C(7)-N(2) 109.14(9) 105.50(2) 104.34(11) 
C(7)-N(2)-C(5) 108.57(9) 108.84(2) 110.83(12) 
N(2)-C(5)-C(6) 107.08(9) 106.65(2) 107.14(13) 
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The reaction of C2.1 with TiCl4 was monitored by multinuclear NMR spectroscopy from which 
a route to the formation of the C2.6.adduct was tentatively proposed (Scheme 3.10). The 1H 
NMR spectrum of C2.1 clearly indicates that the bridging proton of the carborane is absent, 
which reappears in the 1H NMR spectrum 3 hours after addition of TiCl4 at room temperature. 
Upon insertion of the NHC into the electrophilic B(7) vertex, a 1,2-migration of the B(7) 
proton (highlighted in red) occurs and bridges the B(4)-B(8) edge. It can be suggested that upon 
demetallation the ligand is oxidised with the titanium centre being reduced to TiCl2 as a black 
precipitate is produced in the reaction.  
As the reaction proceeds, in the 11B{1H} NMR spectrum multiple peaks are observed in the   
10-20 ppm region, which is characteristic of sterically encumbered complexes and is indicative 
of slippage distortion. Slippage distortion is a result of the metal centre deviating from a  
symmetrical η5-cooridnation mode and migration towards the β-boron atom, which in turn 
becomes highly shielded and experiences a large downfield shift (Scheme 3.9).51 The presence 
of multiple downfield resonances suggests the formation of multiple species that contain a 
sterically encumbered titanium centre. Likewise, the 1H NMR spectrum possesses multiple 
resonances attributable to the NHC backbone, suggesting that initially C2.6 may form but is 
unstable in solution.  
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Similar observations to those described above have been reported in the literature.39,71 Kang et 
al. reported sterically protected titanium (aminoethyl)dicarbollides, which undergo 
demetallation and nitrogen insertion into an electrophilic boron centre of the open face yielding 
the zwitterion 3.adduct (Scheme 3.10); however this only occurs when the complexes possess 
high levels of steric encumbrance.39 3.adduct can be isolated in higher yields when 3 is 
exposed to O2. Reducing the sterics of the amino group (4) allowed a stable complex to be 
isolated, which resisted demetallation. It is noteworthy that Kang reported a yield of 23 % for 3 
when synthesised via deprotonation of the ligand with KH and subsequent reaction with TiCl4. 
It was proposed that a complex redox reaction exists between the deprotonated ligand and TiCl4 
leading to a low yield. A respectable yield of 73 % was obtained when the basic metal 
precursor Ti(NMe2)4 is employed. 
 
Scheme 3.10 Sterically protected titanium (aminoethyl)dicarbollides.39 
Kang proposed that the formation of 3.adduct is metal-mediated and that steric crowding 
around the metal centre, exerted by the two bulky diphenyl units, causes the facile 
demetallation. Since Kang found greater success when using Ti(NMe2)4, this synthetic 
methodology was employed with L2.2 to investigate whether a stable Ti complex could be 
isolated. The reaction of L2.2 with Ti(NMe2)4 in CD3CN was monitored by 1H and 11B{1H} 
NMR spectroscopy. No reaction takes place until the reaction is heated to 50 ºC, with the 
downfield imidazolium NCHN almost completely disappearing in the 1H NMR spectrum after 
6 hours of heating, suggesting formation of a Ti-Ccarbene bond (Figure 3.18). This can also be 
observed visually with the initial yellow solution turning deep red, which is indicative of 
formation of a TiIV-metallacarborane complex.62,72 In contrast, the 11B{1H} NMR spectrum 
remains unchanged during reaction of L2.2 with Ti(NMe2)4, suggesting the metal is not 
coordinating to the open face of the carborane. Coordination of the Ti centre to the cage would 
result in diagnostic shifts in the 11B{1H} NMR spectrum.62,72  
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Bright red single crystals suitable for X-ray diffraction analysis were grown by slow diffusion 
of diethyl ether into the NMR sample. However, these crystals were found to be of the starting 
material (L2.2). This reaction was repeated numerous times, each producing the same outcome. 
In the reaction, two equivalents of dimethylamine (HNMe2) are produced as a side product. It 
can be proposed that a TiIV complex exists in equilibrium with the starting material; the highly 
basic carbene deprotonates the weakly basic HNMe2 (pKa 10.7) reforming the imidazolium 
(Scheme 3.11). The coordination of Ti to the carborane remains speculative but has been 
included in the proposed reaction, with the dianonic cage accepting the proton from the second 
equivalent of HNMe2 formed. Efforts were made to remove HNMe2 from the reaction by 
employing high temperatures and regular intervals of removing volatiles in vacuo from the 
reaction mixture, but C2.7 could not be isolated.  
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3.8 Conclusions and future work 
A series of studies have been conducted to examine the deprotonation of imidazolium        
nido-carborane zwitterions L1.2, L2.2 and L4.1. Successful deprotonation occurred at both the 
imidazolium NCHN proton and the bridging proton of the C2B3 face when the tether between 
the imidazolium and the carborane substituent is either an ethyl (L2.2) or propyl (L4.1) chain. 
When the shorter methyl (L1.2) tether is explored, deprotonation of the bridging proton of the 
C2B3 face was observed, though the imidazolium NCHN proton remains present. 
The fully deprotonated NHC-carborane, i.e. the free carbene C2.1 (with the ethyl tether), was 
subsequently screened with a range of metal precursors. Reaction with [Rh(COD)Cl]2 led to the 
isolation of an unusual bimetallic complex C2.3, which possesses two contrasting RhI 
environments (Scheme 3.12). While derivatives of the [RhI(carborane)(COD)]- anion have 
been known for decades,73,74 this is the first solid-state structural elucidation of its kind. In 
Chapter 4 the catalytic viability of C2.3 is evaluated in the hydrosilylation of acetophenone.     
An FeIII metallacarborane C8 was isolated through reaction of C2.1 with FeCl2. The presumed 
FeII complex that initially forms is completely insoluble, with the FeIII charge compensated 
complex being obtained on exposure to air (Scheme 3.12). Attempts to form bimetallic 
complexes through deprotonation of the imidazolium NCHN protons using a range of basic 
metal precursors were unsuccessful, and it is suspected that the acidity of these protons is too 
low. Future efforts should look towards screening different bases in conjunction with metal 
halide salts to determine whether under certain reaction conditions a bimetallic 
metallacarborane can be isolated.  
Reaction of C2.1 with TiCl4 led to formation of an unusual NHC-carborane adduct 
(C2.6.adduct) (Scheme 3.12). Similar observations have been reported in the literature, and it 
can be proposed that the steric stress that the NHC exerts at the metal centre leads reductive 
elimination of the metal. The question that arises from this chemistry is whether reducing the 
sterics of the NHC would allow a stable complex to be isolated.  
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3.9.1 General Considerations 
All manipulations were carried out under an inert atmosphere by means of standard Schlenk 
line or glovebox techniques, unless otherwise stated. Anhydrous solvents were prepared by 
passing over activated alumina to remove water, copper catalyst to remove oxygen and 
molecular sieves to remove any remaining water, via the DowGrubbs solvent system, and then 
freeze-pump-thaw degassed prior to use. All chemicals used in this work were bought from 
either Sigma Aldrich or Alfa Aesar and used without further purification. NMR spectra were 
recorded on a Bruker AV500 or a Bruker DPX300 spectrometer. 1H NMR and 13C{1H} NMR 
chemical shifts were referenced against residual solvent peaks. Assignment of 1H and 13C{1H} 
NMR spectra for all complexes was aided by the use of 2D 1H1H COSY, 1H13C HMQC, 1H13C 
HMBC and 13C{1H} DEPT 135 experiments. Mass spectra were collected on a Bruker 
Daltonics (micro TOF) instrument operating in the electrospray mode. Elemental analyses were 
performed by Mrs Tanya Marinko-Covell at The University of Leeds. The synthesis of the 
ligand precursors used in this chapter can be found in Chapter 2.  
 
3.9.2 Metal precursors 
Preparation of [Rh(COD)Cl]2.75  
To a RBF was added RhCl3.3H2O (2.00 g, 7.60 mmol). The system was flushed with N2 gas and 
degassed H2O (10 mL), anhydrous ethanol (50 mL) and 1,5-cyclooctadiene (2.33 mL, 19.00 
mmol) was added. The solution was then refluxed at reflux under N2 for 24 hours. The solvent 
was decreased to 30 mL in vacuo and the yellow solid was collected by filtration and washed 
with water (3 × 10 mL) and dried in vacuo. Yield: 1.44 g, 2.93 mmol (77 %). 1H NMR (300 
MHz, CDCl3): δ 4.21 (s, 4H), 2.55-2.39 (m, 4H), 1.81-1.63 (m, 4H). 13C{1H} NMR (75 MHz, 
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3.9.3 NHC-carborane complexes and adducts 
Preparation of C2.2, C2.3 and C2.3’.  
 
L2.2 (10 mg, 0.04 mmol), NaH (1.80 mg, 0.08 mmol) and anhydrous THF (0.5 mL) were 
added to a Young’s Tap NMR tube. The suspension was heated at 60 ºC for 14 hours. The clear 
yellow solution was removed via syringe from the excess NaH. The solvent was removed in 
vacuo and [Rh(COD)Cl]2 (19.10 mg, 0.04 mmol) and anhydrous MeCN (1 mL) were added. 
The reaction mixture was stirred at room temperature for 3 hours. Filtration of the mixture 
through Celite and slow diffusion of Et2O into the MeCN solution resulted in crystals of C2.2 
and C2.3 suitable for X-ray diffraction analysis. To obtain complex C2.3 only, the reaction 
mixture was heated at 60 ºC for 18 hours instead of room temperature for 3 hours. This was 
subsequently filtered through Celite and slow evaporation to concentrate the solution resulted 
in a yellow crystalline solid. The solid was filtered, washed with anhydrous Et2O (3 × 5 mL) 
and dried in vacuo to afford C2.3 as a yellow crystalline solid. Yield: 22 mg, 0.03 mmol (75 
%). Analytical data for C2.3; 1H NMR (500 MHz, acetone-d6): δ 7.45 (d, J = 1.9 Hz, 1H, 
NCH), 7.30 (s, 1H, NCH), 5.36 (br. s, 1H, CH2), 4.84 (m, 2H, COD-CH), 4.32 (m, 2H, COD-
CH), 4.22 (m, 3H, COD-CH, CH2), 3.81 (br. s, 1H, COD-CH), 3.66 (br. s, 1H, COD-CH), 2.45 
(m, 25H, CH2, COD-CH2, CH3, (CH3)3, carborane cage CH). 13C{1H} NMR (126 MHz, 
acetone-d6): δ 174.2 (d, 1JRh-C = 50.4 Hz, NCN), 122.3 (NCCN), 96.6 (COD-CH), 93.0 (COD-
CH), 81.5 (COD-CH), 75.4 (d, 1JRh-C = 10.1 Hz, COD-CH), 75.0 (d, 1JRh-C = 11.3 Hz, COD-
CH), 59.2 (C(CH3)3), 53.7 (CH2), 47.5 (carborane cage quaternary C), 42.6 (CH2), 36.6 
(NCCH3), 34.3 (COD-CH2), 33.8 (COD-CH2, carborane cage CH), 32.3 ((CH3)3), 32.0-28.9 
(COD-CH2), 3.5 (NCCH3). 11B{1H} NMR (161 MHz, acetone-d6): δ −6.3 (2B), −10.7 (2B), 
−13.0 (2B), −22.1 (3B). HRMS (ESI+): m/z [C27H50B9N2Rh2]+ 706.2982, calcd for [M-
MeCN+H]+ 706.2971. Anal. calcd for C29H52B9N3Rh2: C, 46.70 ; H, 7.03; N, 5.63. Found: C, 
46.40; H, 7.10; N, 5.70. Crystals suitable for X-ray diffraction analysis were grown by slow 
evaporation of a concentrated solution of C2.3 in acetone. Crystals of C2.3’ suitable for X-ray 
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diffraction analysis were grown by re-dissolving crystals of C2.3 in the minimum amount of 
MeCN followed by the addition of anhydrous Et2O and hexane in a ratio of 1:3:3. 
 
Preparation of C2.5  
L2.2 (20 mg, 0.07 mmol), NaH (3.5 mg, 0.15 
mmol) and anhydrous THF (0.5 mL) were 
added to a Young’s Tap NMR tube. The 
suspension was heated at 60 ºC for 14 hours. 
The clear yellow solution was removed via 
syringe from the excess NaH and transferred 
to another Young’s Tap NMR tube containing FeCl2 (5.1 mg, 0.04 mmol). Within a few 
minutes a purple precipitate formed. After 3 hours at room temperature, the reaction mixture 
was exposed to air resulting in the violet precipitate resolublising with the solution becoming 
deep red in colour. The solvent was removed in vacuo and DCM (5 mL) followed by NH4PF6 
(11.4 mg, 0.07 mmol) was added. The reaction was stirred for 10 minutes at room temperature 
then the organic phase was washed with H2O (3 × 5 mL), filtered and dried in vacuo.  The 
product was recrystallised from acetone (5 mL) with H2O (5 mL) to give a red crystalline solid. 
Yield: 7.7 mg, 0.01 mmol (34 %). HRMS (ESI+): m/z 623.5380 [C22H58B18N4Fe]+, Calcd for 
[M-PF6]+ 623.5335. Anal. calcd. for C22H58B18N4FePF6: C, 34.40 ; H, 6.82; N, 7.29. Found: C, 
33.98; H, 6.51; N, 7.33. Crystals suitable for X-ray diffraction analysis were grown from the 
slow evaporation of a mixed solvent system (acetone/water 3:1). 
 
Preparation of C2.6.adduct. 
L2.2 (10 mg, 0.04 mmol), NaH (1.8 mg, 0.08 mmol) and anhydrous THF (0.5 mL) were added 
to a Young’s Tap NMR tube. The suspension was heated at 60 ºC for 14 hours. The clear 
yellow solution was removed via syringe from the excess NaH. The solvent was removed in 
vacuo and anhydrous toluene (0.5 mL) followed by TiCl4 (1eq). Crystals suitable for X-ray 
diffraction analysis were grown from the slow evaporation of a toluene solution. Note: Isolation 










1 T. E. Paxson and M. F. Hawthorne, J. Am. Chem. Soc., 1974, 96, 4674–4676. 
2 E. L. Hoel and M. F. Hawthorne, J. Am. Chem. Soc., 1974, 96, 4676–4677. 
3 J. A. Long, T. B. Marder and M. F. Hawthorne, J. Am. Chem. Soc., 1984, 106,      
3004–3010. 
4 T. B. Marder, J. A. Long and M. F. Hawthorne, J. Chem. Soc. Chem. Commun., 1980, 
677. 
5 J. A. Belmont, J. Soto, R. E. King, A. J. Donaldson, J. D. Hewes and M. F. Hawthorne, 
J. Am. Chem. Soc., 1989, 111, 7475–7486. 
6 F. Teixidor, M. A. Flores, C. Viñas, R. Kivekäs and R. Sillanpää, Angew. Chemie Int. 
Ed., 1996, 35, 2251–2253. 
7 B. Marciniec, Hydrosilylation : a comprehensive review on recent advances, Springer, 
2009. 
8 S. Díez-González and S. P. Nolan, Org. Prep. Proced. Int., 2007, 39, 523–559. 
9 N. Miyaura, Bull. Chem. Soc. Jpn., 2008, 81, 1535–1553. 
10 L. F. R. Gomes, A. F. Trindade, N. R. Candeias, P. M. P. Gois and C. A. M. Afonso, 
Tetrahedron Lett., 2008, 49, 7372–7375. 
11 F. J. Gómez, N. E. Kamber, N. M. Deschamps, A. P. Cole, A. A. Wender and R. M. 
Waymouth, Organometallics, 2007, 26, 4541–4545. 
12 W. Gil, T. Lis, A. M. Trzeciak and J. J. Ziółkowski, Inorganica Chim. Acta, 2006, 359, 
2835–2841. 
13 S. I. Lee, S. Y. Park, J. H. Park, I. G. Jung, A. S. Y. Choi, Y. K. Chung and B. Y. Lee, 
J. Org. Chem., 2006, 71, 91–96. 
14 J. M. Praetorius, C. M. Crudden, V. R. Jensen, C. Esterhuysen, H. G. Raubenheimer, 
V. Paquet, H. Lebel, M. W. Day and R. H. Grubbs, Dalt. Trans., 2008, 129, 4079. 
15 S. Diez-Gonzalez, N. Marion and S. P. Nolan, Chem. Rev., 2009, 109, 3612–3676. 
16 M. Aydemir, A. Baysal, N. Meric, C. Kayan, B. Gümgüm, S. Özkar and E. Şahin, J. 
Organomet. Chem., 2011, 696, 2584–2588. 
17 P. Satyanarayana, G. M. Reddy, H. Maheswaran and M. L. Kantam, Adv. Synth. Catal., 
2013, 355, 1859–1867. 
18 A. McSkimming, B. Chan, M. M. Bhadbhade, G. E. Ball and S. B. Colbran, Chem. - A 
Eur. J., 2015, 21, 2821–2834. 
19 M. Poyatos, W. McNamara, C. Incarvito, E. Clot, E. Peris and R. H. Crabtree, 
Organometallics, 2008, 27, 2128–2136. 
20 M. Poyatos, W. McNamara, C. Incarvito, E. Peris, R. H. Crabtree, W. Ponikwar, H. 
Noth, C. Moinet and W. P. Fehlhammer, Chem. Commun., 2007, 124, 2267. 
21 W. A. Herrmann, L. J. Goossen, C. Köcher and G. R. J. Artus, Angew. Chemie Int. Ed., 
1996, 35, 2805–2807. 
22 D. Enders, H. Gielen and K. Breuer, Tetrahedron: Asymmetry, 1997, 8, 3571–3574. 
23 W.-L. Duan, M. Shi and G.-B. Rong, Chem. Commun., 2003, 2916–2917. 
24 L. H. Gade, V. César and S. Bellemin-Laponnaz, Angew. Chemie Int. Ed., 2004, 43, 
1014–1017. 
25 K. Riener, M. P. Högerl, P. Gigler and F. E. Kühn, ACS Catal., 2012, 2, 613–621. 
  CHAPTER 3 
 
 97 
26 M. F. Hawthorne, D. C. Young and P. A. Wegner, J. Am. Chem. Soc., 1965, 87,    
1818–1819. 
27 R. N. Grimes, Carboranes, Academic Press, 2011. 
28 A A. Danopoulos, N. Tsoureas, A. J. A. Wright and M. E. Light, Organometallics, 
2004, 23, 166–168. 
29 R. A. Andersen, K. Faegri, J. C. Green, A. Haaland, M. F. Lappert, W. P. Leung., 
Inorg. Chem., 1988, 27, 1782–1786. 
30 K. Riener, S. Haslinger, A. Raba, M. P. Högerl, M. Cokoja, W. A. Herrmann and F. E. 
Kühn, Chem. Rev., 2014, 114, 5215–5272. 
31 N. R. C. (US) C. S. Roundtable, Replacing Critical Materials with Abundant 
Materials, National Academies Press (US), 2012. 
32 H. G. Seiler, H. Sigel and A. Sigel, Handbook on toxicity of inorganic compounds, 
1988. 
33 V. V. K. M. Kandepi, J. M. S. Cardoso, E. Peris and B. Royo, Organometallics, 2010, 
29, 2777–2782. 
34 R. Lopes, J. M. S. Cardoso, L. Postigo and B. Royo, Catal. Letters, 2013, 143,     
1061–1066. 
35 D. S. McGuinness, A. Vernon C. Gibson and J. W. Steed, Organometallics, 2004, 23, 
6288–6292. 
36 H. Aihara, T. Matsuo, H. Kawaguchi, H. Ebeling, A. Tuchbreiter, R. Mülhaupt and M. 
E. Lappert, Chem. Commun., 2003, 38, 2204. 
37 D. Zhang, G. Zi, K. A. Scheidt, F. Foubelo, M. Tada, V. Poirier, Y. Sarazin, A. 
Trifonov, M. Nitabaru, T. Nakano, H. Tanaka, N. Kashiwa, T. Fujita and T. Fujita, 
Chem. Soc. Rev., 2015, 44, 1898–1921. 
38 D.-H. Kim, J. H. Won, S.-J. Kim, J. Ko, S. H. Kim, S. Cho and S. O. Kang, 
Organometallics, 2001, 20, 4298–4300. 
39 Y.-J. Lee, J.-D. Lee, H.-J. Jeong, K.-C. Son, J. Ko, A. M. Cheong and S. O. Kang, 
Organometallics, 2005, 24, 3008–3019. 
40 M. F. Hawthorne, D. C. Young, T. D. Andrews, D. V. Howe, R. L. Pilling, A. D. Pitts, 
M. Reintjes, L. F. Warren and P. A. Wegner, J. Am. Chem. Soc., 1968, 90, 879–896. 
41 A. J. Arduengo, R. L. Harlow and M. Kline, J. Am. Chem. Soc., 1991, 113, 361–363. 
42 A. R. Kudinov, D. S. Perekalin, S. S. Rynin, K. A. Lyssenko, G. V. G-Knyazev, P. V. 
Petrovskii, Boron Chemistry at the beginning of the 21st Century, 2003. 
43 M. M. Vinogradov, M. V. Zakharova, S. V. Timofeev, D. A. Loginov, I. B. Sivaev, Y. 
V. Nelyubina, Z. A. Starikova, V. I. Bregadze and A. R. Kudinov, Inorg. Chem. 
Commun., 2015, 51, 80–82. 
44 M. E. Fessler, T. Whelan, J. T. Spencer and R. N. Grimes, J. Am. Chem. Soc., 1987, 
109, 7416–7420. 
45 D. Grafstein and J. Dvorak, Inorg. Chem., 1963, 2, 1128–1133. 
46 S. Papetti and T. L. Heying, J. Am. Chem. Soc., 1964, 86, 2295–2295. 
47 L. F. Warren and M. F. Hawthorne, J. Am. Chem. Soc., 1970, 92, 1157–1173. 
48 M. F. Hawthorne, M. K. Kaloustian and R. J. Wiersemay, J. Am. Chem. Soc., 1971, 93, 
4912–4913. 
49 D. F. Dustin, W. J. Evans, C. J. Jones, R. J. Wiersema, H. Gong, S. Chan and M. F. 
Hawthorne, J. Am. Chem. Soc., 1974, 96, 3085–3090. 
  CHAPTER 3 
 
 98 
50 J. A. Doi, E. A. Mizusawa, C. B. Knobler and M. F. Hawthorne, Inorg. Chem., 1984, 
23, 1482–1484. 
51 K. A. Fallis, D. F. Mullica, E. L. Sappenfield and F. G. A. Stone, Inorg. Chem., 1994, 
33, 4927–4933. 
52 M. M. Vinogradov, Y. V. Nelyubina, A. A. Pavlov, V. V. Novikov, N. V. Shvydkiy 
and A. R. Kudinov, Organometallics, 2017, 36, 791–800. 
53 P. S. Engl, R. Senn, E. Otth and A. Togni, Organometallics, 2015, 34, 1384–1395. 
54 E. Jansen, M. Lutz, B. de Bruin and C. J. Elsevier, Organometallics, 2014, 33,     
2853–2861. 
55 B. J. Truscott, A. M. Z. Slawin and S. P. Nolan, Dalt. Trans, 2013, 42, 270–276. 
56 B. J. Truscott, G. C. Fortman, A. M. Z. Slawin, S. P. Nolan, F. Maseras, S. P. Nolan 
and V. V. Ratovelomanana-Vidal, Org. Biomol. Chem., 2011, 9, 7038. 
57 L. Palacios, A. Di Giuseppe, A. Opalinska, R. Castarlenas, J. J. Pérez-Torrente, F. J. 
Lahoz and L. A. Oro, Organometallics, 2013, 32, 2768–2774. 
58 P. E. Behnken, T. B. Marder, R. T. Baker, C. B. Knobler, M. R. Thompson and M. F. 
Hawthorne, J. Am. Chem. Soc., 1985, 107, 932–940. 
59 H. C. Kang, S. S. Lee, C. B. Knobler and M. F. Hawthorne, Inorg. Chem., 1991, 30, 
2024–2031. 
60 R. N. Grimes, in Comprehensive Organometallic Chemistry, 1982, pp. 459–542. 
61 D. J. Arriola, M. Bokota, J. Richard E. Campbell, J. Klosin, R. E. LaPointe, O. D. 
Redwine, R. B. Shankar, A. Francis J. Timmers and K. A. Abboud, J. Am. Chem. Soc., 
2007, 129, 7065–7076. 
62 D.-H. Kim, J. H. Won, S.-J. Kim, J. Ko, S. H. Kim, A. S. Cho and S. O. Kang, 
Organometallics, 2001, 20, 4298–4300. 
63 J.-D. Lee, Y.-J. Lee, K.-C. Son, M. Cheong,  and J. Ko and S. O. Kang, 
Organometallics, 2007, 26, 3374–3384. 
64 Z. Yinghuai, S. Lo Pei Sia, F. Kooli, K. Carpenter and R. A. Kemp, J. Organomet. 
Chem., 2005, 690, 6284–6291. 
65 Z. Yinghuai, Z. Yulin, K. Carpenter, J. A. Maguire and N. S. Hosmane, J. Organomet. 
Chem., 2005, 690, 2802–2808. 
66 H. Wang, Y. Wang, A. H.-W. Li and Z. Xie, Organometallics, 2001, 20, 5110–5118. 
67 Guofu Zi, A. Hung-Wing Li and Z. Xie, Organometallics, 2002, 21, 3850–3855. 
68 H. Wang, H.-S. Chan, J. Okuda and Z. Xie, Organometallics, 2005, 24, 3118–3124. 
69 F. E. Hahn and M. C. Jahnke, Angew. Chemie Int. Ed., 2008, 47, 3122–3172. 
70 C. E. Willans, C. A. Kilner and M. A. Fox, Chem. - A Eur. J., 2010, 16, 10644–10648. 
71 S. P. Downing and A. A. Danopoulos, Organometallics, 2006, 25, 1337–1340. 
72 M. Gao, Y. Tang, M. Xie, C. Qian and Z. Xie, Organometallics, 2006, 25, 2578–2584. 
73 R. Núñez, O. Tutusaus, F. Teixidor, C. Viñas, A. R. Sillanpää and R. Kivekäs, 
Organometallics, 2004, 23, 2273–2280. 
74 D. M. Speckman, C. B. Knobler and M. F. Hawthorne, Organometallics, 1985, 4,  
426–428. 





  Chapter 4
Synthesis of a chelating N-heterocyclic carbene-carborane RhI complex 
 
The synthesis and full characterisation of RhI-NHC complexes that exhibit closo-carboranyl 
substituents is discussed. These complexes display unprecedented chemistry with a rare 
example of a RhI-metallacycle coordinating through both the NHC and the carbon vertex of the 
carborane. The catalytic activity of these complexes was probed in the hydrosilylation of 
acetophenone. 
 
4.1 Introduction  
In carborane chemistry, “cyclometallation” implies intramolecular metallation forming a 
bicyclic complex in which the metal is bound through a donor atom and either through the 
carbon or a boron vertex of the cage. In the literature, the process of cyclometallation of 
carboranes can be organised into two categories; 1) cyclometallation without a change in the 
formal oxidation state of the metal, and 2) oxidative addition to the metal. The latter mainly 
involves an IrI centre, which spontaneously adds across the B-H bond of the cage to form the 
corresponding MIII hydride complex, and was first reported by Hawthorne and co-workers in 
1975.1 Most recently Lavallo reported carboranyl phosphine ligands bearing either the    
dicarba-closo-dodecaborane (i) or the monocarba-closo-dodecaborate anion (ii), with both 
displaying very different chemistry (Scheme 4.1).2 Carboranyl phosphine ligand i displayed the 
expected oxidative addition across the B-H bond of the B3/B6 vertex to give the IrIII 
metallacycle. Oxidative addition involves the transfer of electrons from the metal to the B-H 
bond and will always take place at the vertices with the least electron density, which in the 
dicarba-closo-dodecaborane are the B3/B6 vertices. Carboranyl phosphine ligand ii resists 
spontaneous B-H cyclometallation, which is the first example reported in the literature.  
Scheme 4.1 IrI(COD) carboranyl phosphine complexes reported by Lavallo and co-workers.2 
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Lavallo suggests that ii has important implications for the design of future carborane catalysts, 
as carboranyl phosphine complexes bearing a dicarba-closo-dodecaborane had previously been 
found to be poor catalysts due to spontaneous B-H cyclometallation impeding on the catalytic 
activity of the complexes.3–6  
Whilst oxidative addition across the B-H bond of the B3/B6 vertices is relatively facile, 
selective B-H activation of specific B-H vertices other than these electrophilic boron atoms is 
very difficult, though remains an active area of research. Metal mediated B-H bond 
functionalisation of carboranes is an important chemical transformation to provide structurally 
diverse carborane derivatives. B-H activation of small boranes has been successful,7–10 but with 
the larger dodecaborane there are only a few examples. Half sandwich IrIII complexes serve as 
effective reagents to induce B-H bond activation to afford metal-boryl complexes.11–13 An 
exquisite example utilises three carborane (o-, m-, p-) dicarboxylates, which act as directing 
groups to allow site specific B-H activation at the B4/7 vertices of m-carborane and B2/10 
vertices of p-carborane, with this being the first example of B-H activation of a p-carborane 
derivative (Figure 4.1, iii). In addition, the directing groups allow switchable reactivity 
between C-H and B-H bonds (Figure 4.1, iv and v).14 
Figure 4.1 Complexes published by Jin and co-workers in which selective B-H (iii and v) and 
C-H (iv) activation is achieved.14 
Typically, C-cyclometallated carboranes are prepared under relatively harsh conditions by 
employing nBuLi to generate C-lithiocarboranes, which are subsequently reacted with a metal 
salt. Some of the earliest examples involved metal σ-carbon bonds to Al and Ga,15 Ni,16 and 
Pt.17 Surprisingly, there are only two examples of carboranes that possess a RhI centre bound 
through a C vertex of the cage, and only one of these is cyclometallated, with nearly four 
decades separating the two publications (Scheme 4.2).18,19 Both RhI complexes are air and 
moisture sensitive, and complex viii was found to be a by-product of the reaction. It was 
proposed that this is formed via nucleophilic addition of the carboranyl anion to complex vii, 





Scheme 4.2 Literature examples of complexes bearing a RhI centre σ-bound to a carboranyl 
carbon.18,19 
In comparison, the literature is rich with examples of C-cyclometallated carborane complexes 
of the higher oxidation states of RhIII and IrIII.12–14,19,21–23 Most recently, an IrIII complex 
coordinated by an o-carboranyl phosphine ligand had been considered for its photophysical 
properties.22 Cyclometallated IrIII complexes have been widely used as colour-tuneable emitters 
in organic light-emitting diodes (OLEDs).24,25 Most examples in the literature look at varying 
the electronic structure of a C^N ligand (typically derivatives of 2-phenylpyridine) to provide 
emitters with the all important sky blue or deep blue phosphorescence.26–28 Alternatively, the 
choice of a strong-field ancillary ligand can provide the same effect,28–30 and it was found that 







Figure 4.2 An IrIII complex supported by an o-carboranyl phosphine reported by x et al. The 
strong field ancillary ligand (o-carborane) leds to a large shift toward blue phosphorescence.22 
Overall, the field of Rh and Ir complexes exhibiting C- or B- coordination through the 
carborane is vast. The majority of these examples have been examined for their coordination 
chemistry, though the catalytic potential of these complexes is rarely examined. The work 
described in this chapter provides interesting insight into the coordination chemistry of      





As discussed in Chapter 3, L2.2 demonstrated interesting coordination chemistry at RhI, with 
isolation of a bimetallic complex (C2.3), which possesses two contrasting RhI environments 
(Scheme 4.3). The complex displayed low temperature isomerisation to yield the 2,1,8 isomer 
as a result of the high steric stress at the metal centre of the [RhI(carborane)(COD)]- anion. The 
work herein looks to extend this work and explore the coordination chemistry of the          
closo-carboranyl imidazolium salts such as L2.1 (Chapter 2) at RhI. The catalytic viability of 
these complexes was evaluated in the hydrosilylation of acetophenone. 
 
4.3 Complex synthesis  
One of the most challenging aspects of the chemistry involving the zwitterionic ligands such as 
L2.2 was achieving full deprotonation, which required a strong base (NaH). In contrast, 
imidazolium halide salts such as L2.1 are known to deprotonate under much milder conditions 
via in situ transmetallation using Ag2O, or by use of other basic metal precursors which 
deprotonate and form the metal carbene bond in situ.31–35 Employing Ag2O in the presence of 
L2.1 and [Rh(COD)Cl]2 in DCM allowed selective deprotonation of the NCHN proton and 
gave the corresponding RhINHC(COD)Cl complex C2.11 in high yield (Scheme 4.3).  






Surprisingly, when the same reaction was repeated in MeCN and an excess of Ag2O was 
employed, the isolated product was identified as an unusual seven-membered metallacycle 
C2.12. In this case, the ligand chelates the RhI centre, coordinating through the carbenic carbon 
of the NHC and through the carbon vertex of the carborane. Deprotonation of the cage CH 
proton under such mild conditions is rare,14,18 with a strong base such as nBuLi usually being 
used prior to addition of the metal precursor (Section 4.1).19,22  
With different products being observed in DCM and MeCN, a range of solvents were screened 
to further understand the role of the solvent in this reaction. In the glove box, C2.11 and Ag2O 
(0.5 eq) were added to a Young’s Tap NMR tube and dissolved in various anhydrous 
deuterated solvents. The reaction mixtures were heated at 45 °C and monitored over time using 
1H NMR spectroscopy. It was found that a coordinating solvent is necessary to promote the 
cyclometallation process, whereas no reaction occurs in non-coordinating solvents, and protic 
solvents led to complex decomposition (Table 4.1). A control reaction was also conducted in 
which C2.11 was heated in MeCN in the absence of Ag, and monitored over the course of 
several days, with no cyclometallation observed. Presumably, Ag2O is acting both as a 
chloride-abstracting agent and a base in this reaction.36 The removal of the chloride must be 
promoted by the presence of a coordinating solvent, which stabilises the cationic RhI centre. 
Following this, the cage CH proton is deprotonated leading to M-C bond formation to yield 
C2.12, with AgOH precipitated as a brown solid from the reaction (Scheme 4.4).  
Table 4.1 Solvent screening reaction in the cyclometallation of C2.11 
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C2.12 
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Decomp
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 0 0 0 0 0  0 17 23 10 0  70 
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Scheme 4.4 Proposed mechanism for the formation of C2.12 from C2.11 using Ag2O. 
Ag2O is not usually known for its chloride abstracting properties, so a range of different silver 
salts were screened to investigate whether C2.12 could be obtained under even milder 
conditions (Table 4.2). Surprisingly, when the superior chloride-abstracting agent AgOTf was 
employed in the reaction, no cyclometallation occurs and around 30 % of C2.11 decomposes. 
This is likely due to the ineffectiveness of AgOTf to act as a base. Jin and co-workers employ 
triethylamine in combination with AgOTf to isolate a C-cyclometallated complex at room 
temperature (Section 4.1).23 However, employing this synthetic method still only led to 
decomposition of C2.11. The results indicated that a dimeric silver salt is required to achieve 





Table 4.2 The effectiveness of different silver salts in the cyclometallation of 
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C2.12 
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4.4 Complex characterisation 
HRMS has been found to be an excellent tool for monitoring the reaction of our                 
NHC-carborane ligands with metal precursors to ensure that the reactions have gone to 
completion. However, both C2.11 and C2.12 give the same molecular ion peak preventing their 
characterisation by HRMS (Figure 4.3).  
 
Figure 4.3 HRMS of C2.11, which is also the molecular ion peak for C2.12. Inset contains the 
observed molecular ion [M− Cl]+ against the calculated mass. 
 
4.4.1 Multinuclear NMR spectroscopic analysis of C2.11 and C2.12 
Upon formation of C2.11 or C2.12, the most downfield resonance at 9.41 ppm observed in the 
1H NMR spectrum of L2.1 disappears, indicative of NHC formation (Figure 4.4). The 13C{1H} 
NMR spectra of C2.11 and C2.12 exhibit doublets at 181.9 ppm and 183.2 ppm respectively, 
which is diagnostic for M-Ccarbene bond formation (Figure 4.5). The 1JRh-C couplings of 50.4 Hz 
and 52.9 Hz is in accordance with similar complexes in the literature.37,38  
The coordination of the NHC to the metal results in the protons of the CH2 tether becoming 
diasterotopic in the 1H NMR spectrum of C2.11, with the H(4) protons splitting into two triplet 
of doublets, resonating at 5.97 and 4.12 ppm. Although the carboranyl unit is 5 bonds from the 
metal centre, there could be restricted rotation about the ethyl linkage due to the steric clash 
between the metal and the carborane. The sterically bulky tBu group could also restrict rotation 
about the M-Ccarbene bond. Upon cyclometallation of C2.11, the absence of the cage CH 
resonance at 4.17 ppm in the 1H NMR spectrum of C2.12 along, with the 13C{1H} NMR 
spectrum exhibiting a doublet at 84.5 ppm, which is attributable to the Rh-coordinated 
carboranyl carbon with 1JRh-C coupling of 52.5 Hz, confirms cyclometallation through the 




Figure 4.4 1H NMR spectrum (500 MHz, DMSO-d6) of L2.1 (A) and 1H NMR spectra (500 
MHz, CDCl3) of C2.11 (B) and C2.12 (C). 








As the ligand in C2.12 is bound through the carbene and carboranyl carbon it is 
conformationally locked, and as a result the COD alkene protons are magnetically inequivalent, 
with each resonating at a unique chemical shift. Assignment of these resonances was made 
possible through use of NOESY NMR spectroscopy (Figure 4.6). The most upfield resonances 
were identified as the alkene protons axial to the carborane, with strong through-space 
interactions between H(19) and the diasterotopic proton (H(4a)) at 6.13 ppm, as well as 
interactions between H(12) and the tBu substituent (H(9)) of the NHC. A strong interaction 
between the resonances attributable to H(12) and H(19) also confirmed that these are vicinal 
protons. Similarly, H(15) and H(16) can be assigned as the downfield resonances at 4.83 and 
4.43 ppm, with a surprisingly strong interaction between H(15) and the tBu group. 
 X-ray diffraction analysis was used in conjunction with the NMR data to rationalise why there 
is such disparity in the chemical shifts of the COD alkene protons (Figure 4.7). The average 
CCOD-Rh distance is 2.107 (Å) trans to the carborane whilst 2.210 (Å) trans to the NHC, 
highlighting the stronger trans influence of the carbene ligand, which is consistent with the 
literature.39 This has a significant effect on the length of the C=C bond distances, with a short 
bond length of 1.385 (Å) for C(15)-C(16) in comparison to 1.405 (Å) for C(12)-C(19). This 
suggests that the alkene trans to the carbene possess more sp2 character hence the protons will 
be more deshielded and appear at a high chemical shift.  
Figure 4.6 NOESY 1H1H NMR spectrum (500 MHz, CDCl3) of C2.12. The cross peaks 
highlighted in pink and blue indicate through space interactions allowing each COD alkenyl 




4.4.2 X-ray diffraction analysis 
Single crystals suitable for X-ray diffraction analysis were grown from the slow evaporation of 
concentrated DCM solutions for both C2.11 and C2.12. The solid state structure of C2.12 
shows a distorted square planar RhI centre, bearing a chelating NHC closo-carborane ligand 
coordinating in a cis fashion through the carbenic carbon and through the carboranyl carbon 
atom. The parameters highlight an elongated C(1)-C(2) bond of the carborane for C2.12. This 
elongation could be to reduce the steric stress at the metal centre, an effect observed in similar 














Figure 4.7 Molecular structures of C2.11 (A) and C2.12 (B and C), C highlights the 
asymmetrical binding of the COD unit. Ellipsoids are shown at 40 % probability and the 







As discussed in Chapter 2 (section 2.2.5), a long-standing problem in X-ray diffraction analysis 
of carboranyl compounds is distinguishing between C and B vertices in cases where one or 
both carbon atoms are not substituted. This is due to C and B having very similar X-ray 
scattering powers as a simple consequence of their period adjacency. It is important to be able 
to correctly identify the coordinating vertex, as the electronic properties of a complex will be 
very different depending on if the ligand is coordinated through a C or B atom, and in some 
literature cases the C and B vertices have been incorrectly assigned.40 There are three methods 
employed for distinguishing between C and B vertices: 1) Set all vertices to be a boron atom 
and inspect the thermal parameter (Ueq) values; those for C should be significantly smaller than 
B; 2) Measure the bond lengths, which is an effective method when the carbon atoms are 
adjacent as this bond should have the shortest connectivity; 3) The VCD method developed by 
Welch and co-workers, an excellent method and the most effective for determining the carbon 
vertices in a carborane.40 This method involves measuring the distances from topologically 
equivalent vertex atoms to the polyhedral centroid, where the shortest connectivities can be 
identified as the C vertices (Figure 4.8). The advantages of using the VCD method became 
apparent on comparing the distances in C2.11, allowing the C1 vertex to be easily identified 
with a VCD distance of 1.491 Å, compared to distances over 1.617 Å for each of the remaining 
vertices (Table 4.4). If we compare this to the thermal parameters, although consistent with the 






Table 4.3 Selected bond distances (Å) for C2.11 and C2.12. 
Distance (Å) 2.11 C2.12  Distance (Å) C2.11 C2.12 
Rh(1)-C(7) 2.036(3) 2.028(3)  Rh(1)-C(19) 2.117(4) 2.146(3) 
Rh(1)-Cl(1) 2.443(8) -  C(12)-C(19) 1.407(6) 1.405(4) 
Rh(1)-C(1) - 2.158(3)  C(15)-C(16) 1.405(4) 1.385(4) 
Rh(1)-C(12) 2.097(4) 2.198(3)  C(1)-C(2) 1.653(5) 1.738(4) 
Rh(1)-C(15) 2.202(3) 2.189(3)  C(12)-C(19) 1.405(4) 1.405(4) 





















In the case of C2.12, the C(1) vertex could not be identified with confidence using any of the 
three methods. The VCD distances were very similar for each vertex. This could be attributed 
to the increase in steric crowding upon cyclometallation, which results in elongation of the 
C(1)-C(2) bond length and an increase in the VCD distance of the C(1) vertex. Similar 
observations have been reported by Lee et al.22 Therefore, from the X-ray diffraction data we 
can confirm that cyclometallation has occurred, with NMR spectroscopy being used to 







Table 4.4 Vertex-to-Centroid Distances (Å) and thermal parameter 
comparisons (Ueq) of C2.11 and C2.12. 
Vertex  C2.11 Ueq  C2.12 Ueq  
C(1)  1.491 0.029  1.663 0.008  
C(2)  1.441 0.023  1.581 0.015  
B(3)  1.636 0.032  1.686 0.021  
B(6)  1.636 0.031  1.685 0.019  
B(7)  1.617 0.034  1.692 0.019  
B(11)  1.622 0.031  1.687 0.018  
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4.5 Selective C-H deprotonation? 
As discussed in the previous section, when ligand L2.1 is reacted with [Rh(COD)Cl2]2 and 
Ag2O in MeCN for 10 hours, a cyclometallated product (C2.12) in which the metal chelates 
through the NHC and the carboranyl carbon is isolated (Scheme 4.3). When the reaction time 
was reduced to 5 hours and the product analysed by 1H NMR spectroscopy, two broad 
resonances were observed at 4.25 and 3.66 ppm that were not present in the 1H NMR spectrum 
of C2.12. It was determined that these signals were attributable to the cage CH proton when the 
metal centre cyclometallates through the B3/B6 vertex of the cage. These vertices are 
equivalent but give rise to diasteromers resulting in the two broad resonances observed.2 In the 
13C{1H} NMR spectrum the double at 84.5 ppm with 1JRh-C coupling of 51.7 Hz indicates that 
the C-cyclometallated complex (C2.12) is also present, suggesting a mix of C and B 
cyclometallation. This coincides with the 1H NMR spectrum integrals of the carboranyl CH 
signals not totalling to 1 when compared to one of the diasterotopic CH2 tether resonances 
(0.35:0.35:1).  
Scheme 4.5. Synthesis of a mixed C- and B-coordinated RhI-metallacycle. 
 
 
Figure 4.9 1H NMR (500 MHz, CD2Cl2) spectrum of isolated product after reacting L2.1 with 




Interestingly, after running an NMR spectrum 12 hours later after keeping the sample at room 
temperature the broad resonances were absent and the NMR data coincides with that of C2.12, 
with 100 % C-cyclometallation observed. The reasoning behind the irreversible conversion of 
B-cyclometallation to C-cyclometallation remains unclear.  
As previously discussed (Section 4.1) examples of a RhI centre bound through the carboranyl 
carbon are very rare.18,19 Further to this, carboranyl phosphine complexes are notorious for 
oxidative addition across the B-H bond.2 The question that arises is why does the RhI centre of 
C2.11 not undergo oxidative addition across the B-H bond? The answer is likely to be due to 
sterics. Unlike phosphines, the steric bulk of an NHC is exerted towards the metal centre, and 
as a result there is inadequate space for oxidative addition across the B-H bond of the 
carborane, especially when the α-substituent of the NHC is a bulky tBu group. To explore the 
possibility of accessing a RhIII complex through oxidative addition, the sterics of the NHC was 
reduced to an N-Me group. Reaction of L2.3 with [Rh(COD)Cl2]2 in the presence of Ag2O (0.5 
eq) gave the corresponding RhINHC(COD)Cl complex C2.13. However, this complex is stable 
and oxidative addition was not observed, which was confirmed by NMR spectroscopy, as well 
as X-ray diffraction analysis (Figure 4.10). This result indicates that even the smallest NHC is 
too sterically bulky for oxidative addition to occur in these types of complexes. 
 









Figure 4.10 Molecular structure of C2.13. Ellipsoids are shown at 50 % probability and the 
hydrogen atoms are omitted for clarity. 
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4.6 Rhodium catalysed hydrosilylation of acetophenone 
To assess the catalytic potential of the RhI complexes C2.11 and C2.12, and the bimetallic 
complex C2.3 (Chapter 3) they were examined in the hydrosilylation of acetophenone with 
diphenylsilane. [Rh(COD)Cl]2 was also screened for useful comparison (Figure 4.12).  
The hydrosilylation of acetophenone can be easily monitored by 1H NMR spectroscopy, with 
only two possible products formed in the reaction (Scheme 4.7). The reactions were carried out 
under strict anhydrous conditions and monitored until the acetophenone was fully consumed. 
The yield of silyl ether A was calculated by comparing the integration of the CH quartet at 4.98 
ppm with that of the benzylic singlet at 6.26 ppm from the internal standard,                       
1,3,5-trimethoxybenzene. The yield of the enol silyl ether B was calculated by comparing the 
integration of one of the vinylic CH doublets at 4.68 ppm with the internal standard. An 
example spectrum is shown in Figure 4.11 and the results of the catalytic screening are 




Scheme 4.7 Hydrosilylation of acetophenone. 
 
Figure 4.11 1H NMR spectrum in C6D6 of the hydrosilylation of acetophenone catalysed by 
complex C2.12 after 12 hours at 50 °C. The labelled resonances belong to the respective 




*No reaction observed below 50 °C 
Figure 4.12 Complexes screened in the hydrosilylation reaction of acetophenone. 
100 % conversion was achieved under very mild conditions using all three catalysts, with the 
bimetallic complex C2.3 being the most active (full conversion in 3 hours at room temperature, 
0.5 mol % catalyst (entry 2)). The RhNHC(COD) centre in C2.3 possesses a labile MeCN, 
rather than a chloride as in C2.11 and C2.12, which could lead to an increase in catalytic 
activity. Although the RhI precursor [Rh(COD)Cl]2 out-performed C2.3, C2.11 and C2.12, the 
fact that the complexes are active is encouraging for further development. In accordance with 
related complexes in the literature,2–6 C2.12 is a relatively poor catalyst and requires heating to 
50 °C to become active (entry 5). This is likely due to the metal centre being co-ordinately 
saturated, and for catalysis to take place the COD moiety must dissociate which requires 
heating. It is noteworthy that when the solvent in the reaction is substituted for THF, a 
considerable increase in reaction time is observed, with 23 hours required to achieve full 
consumption of the acetophenone (entry 4). 
The formation of the silyl enol ether byproduct B in the above hydrosilylation reactions can be 
explained by the extended Hofmann-Gade extended mechanism (Figure 4.13).41–43 The initial 
step involves oxidative addition across the Si-H bond of the disubstituted-silane to yield the 
hydride species I. Next, α-hydride migration leads to formation of the dihydride species II, and 
upon coordination of the ketone to give III there are two possible pathways: 1) proton transfer 
from the metal to the ketone and subsequent reductive elimination of the desired product or 2) 
tautomerism of the ketone and loss of hydrogen forming the silyl enol ether B.  
 
Table 4.5 Examination of complexes in Figure 4.12 in the hydrosilylation of 
acetophenone. 













1 [Rh(COD)Cl]2 0.5 C6H6 0.5 rt 72 29 
2 C2.3 0.5 C6H6 3 rt 62 38 
3 C2.11 1.0 C6H6 8 rt 74 26 
4 C2.11 1.0 THF 23 rt 69 31  
5 C2.12 1.0 C6H6 8 rt 0 0 
6 C2.12 1.0 C6H6 12 50* 64 36 
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Formation of B requires an open coordination site on the rhodium centre, and it has been 
reported that the yield of B can be reduced by increasing the ratio of ligand to [Rh(COD)Cl]2 
used in the reaction as the ligand competes for this coordination site.44 Since we are using a 





























4.7 Conclusions and future work 
The reaction of closo-carborane imidazolium salt L2.1 with Ag2O in non-coordinating solvents 
gives C2.11 in high yields (Scheme 4.8). When a coordinating solvent is employed with an 
excess of Ag2O, an unusual RhI metallacycle exhibiting C-cyclometallation is formed (C2.12). 
Unlike its o-carboranyl phosphine derivatives, this ligand resists oxidative addition; it can be 
proposed that the steric bulk exerted at the metal centre by the NHC moiety prevents oxidative 
addition from occurring. This was explored further by reducing the sterics of the NHC to a Me 
substituent. However, the resulting RhINHC(COD)Cl complex (C2.13) was stable and  
oxidative addition was not observed. The catalytic viability of C2.11 and C2.12, alongside 
bimetallic complex C2.3 reported in Chapter 3, were screened in the catalytic hydrosilylation 
of acetophenone to assess their potential as catalysts. C2.3 proved to be the most effective 
catalyst, although it is not clear if both RhI centres are catalytically active and work 
cooperatively. The RhI(COD)NHC centre in C2.3  possesses a labile MeCN ligand which could 
lead to an increase in activity. The RhI metallacycle C2.12 was found to be a relatively poor 
catalyst when compared to its non-cyclometallated counterpart C2.11. For catalysis to take 
place a ligand must dissociate, which is likely to be the COD. Future reactions should look at 
replacing the COD moiety with a more labile ligand such as CO, which may lead to an increase 
in catalytic activity. Alternatively, oxidation of the metal to RhIII/IrIII could allow investigation 
into more challenging chemical transformations, which the higher oxidation states of RhIII and 
IrIII are renowned for such as transfer hydrogenation.45 This is a focal point of Chapter 5 in 
which higher oxidation state complexes have been prepared.   











4.8.1 General considerations 
All manipulations were carried out under an inert atmosphere by means of standard Schlenk 
line or glovebox techniques unless otherwise stated. Anhydrous solvents were prepared by 
passing over activated alumina to remove water, copper catalyst to remove oxygen and 
molecular sieves to remove any remaining water, via the Dow–Grubbs solvent system, and then 
freeze–pump–thaw degassed prior to use. All chemicals used in this work were bought from 
either Sigma Aldrich or Alfa Aesar and used without further purification. NMR spectra were 
recorded on a Bruker AV500 or a Bruker DPX300 spectrometer. 1H NMR and 13C{1H} NMR 
chemical shifts were referenced against residual solvent peaks. Assignment of 1H and 13C{1H} 
NMR spectra for all complexes was aided by the use of 2D 1H1H COSY, 1H13C HMQC, 1H13C 
HMBC and 13C{1H} DEPT 135 and DOSY experiments. Mass spectra were collected on a 
Bruker Daltonics (micro TOF) instrument operating in the electrospray mode. Elemental 
analyses were performed by Elemental analyses were performed by Mrs Tanya Marinko-Covell 
at The University of Leeds. The preparation of the ligand precursors utilised in this work can be 
found in Chapter 2. The synthesis of [Rh(COD)Cl]2 can be found in Chapter 3. 
 
4.8.2 General catalytic procedure for the hydrosilylation of acetophenone 
In the glove box, to a Young’s tap NMR tube containing C6D6 (0.5 mL) was added Rh complex 
C2.3, C2.11 or C2.12 (1.10 µmol) and 1,3,5-trimethoxybenzene (internal standard, 3.1 mg, 
18.60 µmol), followed by diphenylsilane (21 µL, 0.11 mmol) and acetophenone (12.90 µL,            
11.60 µmol). The reaction was monitored by 1H NMR spectroscopy until acetophenone was 
fully consumed.  
 
4.8.3 Complex synthesis 
Synthesis of C2.11. Imidazolium-closo-carborane bromide salt L2.1 
(100 mg, 0.27 mmol), Ag2O (62 mg, 0.27 mmol), [Rh(COD)Cl]2 (67 
mg, 0.14 mmol), several activated 4 Å molecular sieves and anhydrous 
DCM (5 mL) were added to an ampoule and heated at 45 °C for           
1 hour. The solution was filtered through Celite and the solvent 
removed in vacuo to yield a yellow crystalline solid. The solid was 
washed with hexane (3 × 10 mL) and dried in vacuo to afford the 
product in 74 % yield. (108 mg, 0.20 mmol). 1H NMR (500 MHz, 
CDCl3): δ (ppm) 7.02 (d, J = 2.1 Hz, 1H, H6), 6.84 (d, J = 2.1 Hz, 1H, H5), 5.98 (td, J = 12.6, 
5.0 Hz, 1H, H4), 5.00 (td, J = 8.0, 3.4 Hz, 1H, CODCH), 4.91 (dd, J = 14.2, 7.4 Hz, 1H, COD-
CH), 4.17 (br., 1H, H1), 4.11 (td, J = 12.6, 5.0 Hz, 1H, H4), 3.39 (m, 1H, H3), 3.24 (m, 2H,         
COD-CH), 2.61 (m, 1H, H3), 2.49 (m, 2H, COD-CH2), 2.35 (m, 2H, COD-CH2), 2.02 (m, 2H, 
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CODCH2), 1.94 (s, 9H, C(CH3)3), 1.80 (m, 2H, COD-CH2). 13C{1H} NMR (126 MHz, CDCl3): 
δ (ppm) 181.7 (d, 1JRh-C = 50.4 Hz, C7), 120.6 (C6), 120.0 (C5), 97.3 (d, 1JRh-C = 7.6 Hz, COD-
CH), 95.5 (d, 1 1JRh-C = 7.6 Hz, COD-CH), 73.4 (C2), 71.4 (d, 1JRh-C = 15.1 Hz, COD-CH), 67.4 
(d, 1JRh-C = 15.1 Hz, COD-CH), 63.6 (C1), 58.9 (C8), 51.5 (C4), 38.0 (C3), 34.1 (COD-CH2), 
32.4 (C9), 31.5 (COD-CH2), 29.8 (COD-CH2), 28.2 (COD-CH2). 11B{1H} NMR (161 MHz, 
CDCl3): δ (ppm) −2.5 (1B), −5.4 (1B), −9.2 (2B), −11.0 (2B), −12.9 (4B). HRMS (ESI+): m/z 
[C19H38B10N2Rh]+ 505.3112, calcd for [M − Cl]+ 505.3097. Anal. calcd. for C19H38B10N2ClRh: 
C, 42.18; H, 7.08; N, 5.18. Found: C, 42.40; H, 6.90; N, 5.50. Crystals suitable for X-ray 
diffraction analysis were grown by the slow evaporation of a concentrated solution of the 
product in DCM. 
 
Synthesis of C2.12. Imidazolium-closo-carborane bromide salt 
L2.1 (200 mg, 0.53 mmol), Ag2O (123 mg, 0.53 mmol), 
[Rh(COD)Cl]2 (134 mg, 0.27 mmol), several activated 4 Å 
molecular sieves and anhydrous MeCN (10 mL) were added to an 
ampoule and heated at 45 °C for 10 hours. The solution was 
filtered through Celite and the solvent removed in vacuo to yield 
a yellow crystalline solid. The solid was washed with hexane (3 × 
10 mL) and dried in vacuo to afford the product in 79 % yield. 
(213 mg, 0.42 mmol). 1H NMR (500 MHz, CDCl3): δ (ppm) 7.07 (d, J = 2.0 Hz, 1H, H6), 6.83 
(d, J = 2.0 Hz, 1H, H5), 6.13 (td, J = 13.8, 1.85 Hz, 1H, H4a), 4.83 (t, J = 7.8 Hz, 1H, H15), 4.43 
(dd, J = 15.3, 7.8 Hz, 1H, H16), 3.90 (dt, J = 13.8, 3.45 Hz, 1H, H4b), 3.82 (t, J = 7.2 Hz, 1H, 
H19), 3.21 (m, 1H, H12), 2.75 (m, 1H, H3a), 2.58 (m, 1H, H3b), 2.46 (m, 2H, COD-CH2), 2.16 
(m, 4H, COD-CH2), 1.95 (s, 9H, H9), 1.75 (m, 2H, COD-CH2). 13C{1H} NMR (126 MHz, 
CDCl3): δ (ppm) 183.2 (d, 1JRh-C = 52.9 Hz, C7), 121.9 (C6), 119.2 (C5), 95.7 (d, 1JRh-C = 7.6 Hz, 
COD-CH), 95.0 (d, 1JRh-C = 7.6 Hz, COD-CH), 84.5 (d, 1JRh-C = 51.7 Hz, C1), 81.8 (d, 1JRh-C = 
12.6 Hz, COD-CH), 79.4 (C2), 70.6 (d, 1JRh-C = 8.8 Hz, COD-CH), 58.3 (C8), 49.3 (C4), 41.0 
(C3), 35.0 (COD-CH2), 33.1 (COD-CH2), 32.0 (C9), 28.4 (COD-CH2), 27.3 (COD-CH2). 
11B{1H} NMR (161 MHz, CDCl3): δ (ppm) −4.2 (1B), −5.0 (1B), −6.1 (2B), −6.6 (1B), −8.3 
(1B), −9.0 (1B), −9.84 (2B), −10.8 (1B). HRMS (ESI+): m/z [C19H38B10N2Rh]+ 505.3089, calcd 
for [M + H]+ 505.3097. Anal. Calcd for C19H37B10N2Rh.0.3(H2O): C, 44.44; H, 7.46; N, 5.46. 
Found: C, 44.35; H, 7.47; N, 5.10. Crystals suitable for X-ray diffraction analysis were grown 







Synthesis of C2.13. Prepared as described for C2.11 from L2.3     
(50 mg, 0.15 mmol), Ag2O (70 mg, 0.075 mmol), [Rh(COD)Cl]2   
(37 mg, 0.075  mmol) in anhydrous DCM (5 mL). After purification 
the product was obtained as a yellow crystalline solid in 58 % yield. 
(74 mg, mmol). 1H NMR (500 MHz, CD2Cl2): δ (ppm) 6.84 (m, 1H, 
H6), 6.83 (m, 1H, H5), 5.17 (td, J = 12.6, 3.8 Hz, 1H, H4a), 4.96 (m, 
2H, COD-CH), 4.27 (br. s, 1H, H1), 4.07 (m, 1H, H4b), 4.02 (s, 3H, 
H8), 3.34 (m, 2H, H3a + COD-CH), 3.22 (m, 1H, COD-CH), 2.69 (m, 
1H, H3b), 2.53-2.31 (m, 4H, COD-CH2), 2.07-1.89 (m, 4H, COD-CH2). 13C{1H} NMR (126 
MHz, CD2Cl2): δ (ppm) 184.1 (d, 1JRh-C = 50.4 Hz, C7), 123.1 (C6), 121.2 (C5), 99.7 (d, 1JRh-C = 
6.9 Hz, COD-CH), 99.5 (d, 1 1JRh-C = 6.9 Hz, COD-CH), 73.3 (C2), 69.4 (d, 1JRh-C = 14.4 Hz, 
COD-CH), 69.0 (d, 1JRh-C = 14.7 Hz, COD-CH), 64.2 (C1), 49.9 (C4), 38.5 (C3), 38.1 (C8),                       
33.6 (COD-CH2), 33.4 (COD-CH2), 29.6 (COD-CH2), 29.1 (COD-CH2). 11B{1H} NMR (161 
MHz, CDCl3): δ (ppm) −2.8, −5.6, −9.5, −11.8, −12.9. HRMS (ESI+): m/z [C16H32B10N2Rh]+ 
464.2591, calcd for [M − Cl]+ 464.2587. Crystals suitable for X-ray diffraction analysis were 





















1 E. L. Hoel and M. F. Hawthorne, J. Am. Chem. Soc., 1975, 97, 6388–6395. 
2 J. Estrada, S. E. Lee, S. G. McArthur, A. El-Hellani, F. S. Tham and V. Lavallo, J. 
Organomet. Chem., 2015, 798, 214–217. 
3 K. Tamao, Y. Kiso, K. Sumitani and M. Kumada, J. Am. Chem. Soc., 1972, 94,     
9268–9269. 
4 M. Joost, L. Estévez, S. Mallet-Ladeira, K. Miqueu, A. Amgoune and D. Bourissou, 
Angew. Chemie Int. Ed., 2014, 53, 14512–14516. 
5 M. Joost, A. Zeineddine, L. Estévez, S. Mallet−Ladeira, K. Miqueu, A. Amgoune and 
D. Bourissou, J. Am. Chem. Soc., 2014, 136, 14654–14657. 
6 M. Joost, L. Estévez, K. Miqueu, A. Amgoune and D. Bourissou, Angew. Chemie Int. 
Ed., 2015, 54, 5236–5240. 
7 H. Chen, S. Schlecht, T. C. Semple and J. F. Hartwig, Science., 2000, 287, 1995–1997. 
8 J.-Y. Cho, M. K. Tse, D. Holmes, R. E. Maleczka and M. R. Smith, Science., 2002, 
295, 305–308. 
9 S. Shimada, A. S. Batsanov, J. A. K. Howard and T. B. Marder, Angew. Chemie Int. 
Ed., 2001, 40, 2168–2171. 
10 I. A. I. Mkhalid, J. H. Barnard, T. B. Marder, J. M. Murphy and J. F. Hartwig, Chem. 
Rev., 2010, 110, 890–931. 
11 J.-Y. Bae, Y.-J. Lee, S.-J. Kim, J. Ko, S. Cho and S. O. Kang, Organometallics, 2000, 
19, 1514–1521. 
12 Z.-J. Yao and G.-X. Jin, Organometallics, 2011, 30, 5365–5373. 
13 Z.-J. Yao, G. Su and G.-X. Jin, Chem. - A Eur. J., 2011, 17, 13298–13307. 
14 Z.-J. Yao, W.-B. Yu, Y.-J. Lin, S.-L. Huang, Z.-H. Li and G.-X. Jin, J. Am. Chem. 
Soc., 2014, 136, 2825–2832. 
15 D. A. T. Young, R. J. Wiersema and M. F. Hawthorne, J. Am. Chem. Soc., 1971, 93, 
5687–5694. 
16 A. A. Sayler, H. Beall and J. F. Sieckhaus, J. Am. Chem. Soc., 1973, 95, 5790–5792. 
17 R. Rogowski and K. Cohn, Inorg. Chem., 1972, 11, 1429–1431. 
18 S. Bresadola and B. Longato, Inorg. Chem., 1974, 13, 539–542. 
19 Z.-J. Yao, Y.-J. Lin, B. Xu, G.-X. Jin and M. F. Semmelhack, Dalt. Trans., 2014, 43, 
4938–4940. 
20 M. Basato, A. Biffis, C. Tubaro, C. Graiff, A. Tiripicchio, O. O. Sogbein and K. A. 
Stephenson, Dalt. Trans., 2004, 248, 4092. 
21 H. J. Bae, H. Kim, K. M. Lee, T. Kim, M. Eo, Y. S. Lee, Y. Do, M. H. Lee, M. Grätzel, 
M. K. Nazeeruddin, M. Hoshino and K. Ueno, Dalt. Trans., 2013, 42, 8549. 
22 T. Kim, J. Lee, S. U. Lee and M. H. Lee, Organometallics, 2015, 34, 3455–3458. 
23 B. Xu, Y.-P. Wang, Z.-J. Yao, G.-X. Jin, Y. Hong, T. B. Marder, J. J. Wilczynski, M. 
F. Hawthorne and M. F. Hawthorne, Dalt. Trans., 2015, 44, 1530–1533. 
24 Y. Chi, P.-T. Chou, Y.-H. Hong, W.-H. Liu, T.-H. Li, C.-H. Lai, P.-T. Chou, Y. Chi, 
G.-H. Lee, Y.-T. Tao, C.-H. Chien, J. Leonhardt, M.-Y. Chae and S.-H. Jin, Chem. Soc. 
Rev., 2010, 39, 638–655. 
CHAPTER 4 
 121 
25 H. Yersin, A. F. Rausch, R. Czerwieniec, T. Hofbeck and T. Fischer, Coord. Chem. 
Rev., 2011, 255, 2622–2652. 
26 A. B. Tamayo, B. D. Alleyne, P.I. Djurovich, S. Lamansky, I. Tsyba, Nam N. Ho, A. 
R. Bau and M. E. Thompson, J. Am. Chem. Soc., 2003, 125, 7377–7387. 
27 C. Fan, Y. Li, C. Yang, H. Wu, J. Qin and Y. Cao, Chem. Mater., 2012, 24,          
4581–4587. 
28 E. Baranoff, B. F. E. Curchod, F. Monti, F. Steimer, G. Accorsi, I. Tavernelli, U. 
Rothlisberger, R. Scopelliti, M. Grätzel and M. K. Nazeeruddin, Inorg. Chem., 2012, 
51, 799–811. 
29 V. K. Rai, M. Nishiura, M. Takimoto, Z. Hou, F. S. Ching, L. H. Mei, S. Y. Yu, T. C. 
Pi, S. Wang, S. Okada, M. Hoshino and K. Ueno, Chem. Commun., 2011, 47, 5726. 
30 P. Coppo, E. A. Plummer, L. De Cola, H. Hughes, R. Wang, J. G. Vos, R. Bau, M. E. 
Thompson and M. E. Thompson, Chem. Commun., 2004, 208, 1774–1775. 
31 A. J. Arduengo, H. V. R. Dias, J. C. Calabrese and F. Davidson, Organometallics, 
1993, 12, 3405–3409. 
32 H. M. J. W. And and I. J. B. Lin, Organometallics, 1998, 17, 972–975. 
33 E. Peris, J. Mata, J. A. Loch and R. H. Crabtree, Chem. Commun., 2001, 81, 201–202. 
34 A. A. D. Tulloch, A. A. Danopoulos, S. Kleinhenz, M. E. Light, A. M. B. Hursthouse 
and G. Eastham, Organometallics, 2001, 20, 2027–2031. 
35 A. Raba, M. Cokoja, S. Ewald, K. Riener, E. Herdtweck, A. Pöthig, W. A. Herrmann 
and F. E. Kühn, Organometallics, 2012, 31, 2793–2800. 
36 D. L. Davies, J. Fawcett, R. Krafczyk, D. R. Russell and K. Singh, J. Chem. Soc. Dalt. 
Trans., 1998, 2349. 
37 B. J. Truscott, A. M. Z. Slawin and S. P. Nolan, Dalt. Trans, 2013, 42, 270–276. 
38 M. Tobias Zarka, M. Bortenschlager, K. Wurst, O. Nuyken and R. Weberskirch, 
Organometallics, 2004, 23, 4817–4820. 
39 G. Lázaro, F. J. Fernández-Alvarez, M. Iglesias, C. Horna, E. Vispe, R. Sancho, F. J. 
Lahoz, M. Iglesias, J. J. Pérez-Torrente and L. A. Oro, Catal. Sci. Technol., 2014, 4, 
62–70. 
40 A. McAnaw, G. Scott, L. Elrick, G. M. Rosair and A. J. Welch, Dalton Trans., 2013, 
42, 645–64. 
41 L. H. Gade, V. César and S. Bellemin-Laponnaz, Angew. Chemie Int. Ed., 2004, 43, 
1014–1017. 
42 N. Schneider, M. Finger, C. Haferkemper, S. Bellemin-Laponnaz, P. Hofmann and L. 
H. Gade, Angew. Chemie Int. Ed., 2009, 48, 1609–1613. 
43 P. Gigler, B. Bechlars, W. A. Herrmann and F. E. Kühn, J. Am. Chem. Soc., 2011, 133, 
1589–1596. 
44 C. Reyes, A. Prock and W. P. Giering, Organometallics, 2002, 21, 546–554. 
45 D. Wang and D. Astruc, Chem. Rev., 2015, 115, 6621–6686. 
 




  Chapter 5
Synthesis of IrIII, RhIII and RuII N-heterocyclic carbene-carborane complexes and 
evaluation of their catalytic activity in the transfer hydrogenation of acetophenone 
 
This chapter discusses the application of our NHC-carborane ligands to the higher oxidation 
states of RhIII and IrIII as well as RuII. We have discovered that the nature of the α-substituent of 
the NHC, as well as reaction conditions, can determine the vertex at which cyclometallation 
occurs. A series of IrIII complexes were successfully cyclometallated through the NHC and 
either a carbon atom or the B3/B6 vertex of the cage. Examination of the Ir complexes in the 
transfer hydrogenation of acetophenone revealed that cyclometallation through the carborane 
has a profound effect on the catalytic activity, indicating a bifunctional mechanism and 
involvement of the carborane moiety. 
 
5.1 Introduction 
5.1.1 Asymmetric hydrogenation catalysis  
Transition metal-catalysed enantioselective reduction of ketones is arguably one of the most 
effective techniques for inducing chirality into a molecule, with industrial applications 
spanning agrochemicals, perfumes and pharmaceuticals.1,2 Direct hydrogenation employs 
molecular hydrogen and is essentially 100 % atom efficient, providing an environmentally 
benign synthetic process. The first efficient transition-metal complex used for the asymmetric 
hydrogenation of ketones was reported in 1987 by Noyori and co-workers and was a Ru-based 
BINAP system (Figure 5.1).3 Noyori then went on to publish the second generation catalyst 
[RuCl2(BINAP)diimine] in 1995.4  
In the context of this thesis, particular focus will be on the alternative method utilised for 
hydrogenation known as transfer hydrogenation (TH). Despite suffering from the formation of 
a side product (ketone), which can be easily separated and recycled, this process has advantages 
over direct hydrogenation: i) TH does not require pressurised H2 gas nor an elaborate setup, as 
transformations can be performed at atmospheric pressure, and ii) the chemical hydrogen 
donors used in TH are cheap, display low toxicity and are easy to handle, with 2-propanol most 
commonly being employed.  
 











Figure 5.1 Pioneering work on direct hydrogenation by Noyori.3,4 
TH was first reported in 1925 by the independent research of Meerwein,5 Ponndorf,6 and 
Verley7 on the reduction of ketones and aldehydes to their corresponding alcohols, using 
aluminium alkoxide in the presence of a sacrificial alcohol (Figure 5.2). The drawback to these 
systems is the stoichiometric amounts of aluminium alkoxide required; this has driven the 
development of more efficient systems. Pioneering work by Pfaltz,8 Genêt,9 Lemaire,10 and 
Evans11 in the early 1990s paved the way for future catalyst design (Figure 5.2). However, 
these complexes lacked in activity and/or had insufficient enantioselectivity. Noyori 
revolutionised the field in 1997 with the report of the first transition-metal based system with 
both high activity and high ee (Figure 5.2).12 Following this report, a plethora of metal 
complexes used in TH have been reported including Ru,13–19 Rh,19–24 and Ir.19,25–30 Within these 
systems NHC ligands have featured heavily, ever since Nolan and co-workers reported the first 
example of an Ir-NHC TH catalyst in 2001 (Figure 5.2).30 Efforts towards replacing precious 
metals with inexpensive metals such as Fe,31,32 Co,33 and Ni34 have also been researched. Most 
recently, Morris and co-workers reported an Fe catalyst, which rivals the current Ru catalysts 
used in industry, with 90 % ee and 99 % yield at just 0.02 mmol catalyst loading for the 
reduction of acetophenone to 1-phenylethanol.32 A drawback however is that the Fe catalyst 
requires an elaborate synthetic method.   
It is noteworthy that some of these complexes feature a chelating proton acceptor, which was 
pioneered by the group of Noyori, with the initial report on a Ru complex featuring an amino 
tether.12 These complexes are termed bifunctional or cooperative catalysts, as both the metal 
and chelating group are involved in the catalytic mechanism, which Noyori coined the     
“outer-sphere mechanism”.12 An alternative mechanism was proposed by Hamilton for 
complexes that do not possess a proton accepting group, and was termed the “inner-sphere 
mechanism”.35  




Figure 5.2 Timeline of important advances in the transfer hydrogenation of acetophenone. 
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5.1.2 Mechanistic pathways for asymmetric transfer hydrogenation catalysis  
The inner-sphere TH mechanism proceeds via the alkoxide complex I, which is formed by 
deprotonation of 2-propanol in the presence of a base, which subsequently binds to the metal 
centre (Scheme 5.1). The next step involves β-hydride migration to form the metal hydride 
species II and coordinated acetone, which is released via ligand exchange with the substrate 
III. In the penultimate step the carbonyl is reduced by migratory insertion into the             
metal-hydride bond yielding the metal alkoxide IV. Finally, a second ligand exchange reaction 
yields the secondary alcohol product and the alkoxide species I.    
In the initial step of the outer-sphere mechanism a pericyclic transition state B is formed. The 
metal and amino group accept both hydrogen atoms from 2-propanol forming acetone and the 
hydride complex C. Subsequently, interaction with the substrate leads to formation of another 
pericyclic transition state D and the two protons are donated releasing the product.      
 




Prior to our preliminary catalytic screening reaction in the hydrosilylation of acetophenone 
(Chapter 4, Section 4.6), no catalytic studies had been conducted on NHC complexes bearing 
carboranyl substituents in the literature.36–38 To further investigate the catalytic viability of 
NHC-carboranyl complexes a series of IrIII, RhIII and RuII complexes were prepared and 
screened in the transfer hydrogenation of acetophenone to 1-phenylethanol. Furthermore, as the 
carboranyl unit is thought to be spatially equivalent to a rotating phenyl ring through 360°, 
NHC-phenyl complexes were prepared and examined for useful comparison against the    
NHC-carborane complexes.  
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5.3 Synthesis of an unusual (7,5)-bicyclo-metallated Cp*IrIII-NHC complex 
In the previous chapter, synthetic methods towards complexes of type RhINHC(COD)Cl and a 
RhI-metallacycle were discussed (Scheme 5.2). These synthetic protocols are now applied to 
the higher oxidation of IrIII . The reaction of L2.1 with [IrCp*Cl2]2 and Ag2O in DCM gave a 
cyclometallated IrIII-NHC complex C2.15 in low yield (Scheme 5.2). In addition to NHC 
formation, the 1H NMR spectrum revealed that intramolecular C-H activation of a Me of the 
tBu group had occurred at the IrIII centre. This is shown by the non-equivalent geminal proton 
resonances of the metallated CH2 at 3.39 and 2.30 ppm (2JH-H = 12 Hz), with the diasterotopic 
CH3 groups resonating as two singlets at 1.39 and 1.09 ppm (Figure 5.3). The                      
non-cyclometallated complex C2.14 was not observed, indicating that aliphatic C-H activation 
is facile, as previously reported by Peris et al. for related IrIII-NHCs.39 Attempts were made to 
improve the yield by increasing the reaction time (up to 4 days), as well as carrying out the 
reaction at higher temperatures (70 °C) in DCE. However, no improvement on the yield was 
observed. 
 
Scheme 5.2 Summary of work from Chapter 4 and reaction of L2.1 with an IrIII precursor and 
Ag2O to yield cyclometallated complexes C2.15 and C2.16a/b. 
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The 1H NMR spectrum of C2.15 suggests the presence of two complexes, with small 
resonances neighbouring each of the major peaks, most notably the NHC backbone and Cp*, 
with two Cp* resonances appearing at 1.78 and 1.74 ppm in a 1:4 ratio (Figure 5.3). However, 
micro-analysis and HRMS suggests only one species is present with a molecular ion peak of 
m/z 621.3803 corresponding to the mass of [C2.15 − Cl]+ (Figure 5.4). The X-ray diffraction 
analysis of C2.15, however, revealed the presence of an impurity. Residual electron density 
about the chloride suggests a halide mixed complex, and was modelled as a mixture of Cl and 
Br in a 4:1 ratio. Surprisingly, the micro-analysis coincides with a pure complex containing 
only a chloride atom, though the calculated chemical composition of C, H and N does not alter 
drastically when accounting for the presence of bromide. The molecular structure is presented 
in Figure 5.6 along with selected bond distances in Table 5.1.  
Figure 5.3 1H NMR spectrum (500 MHz, CD2Cl2) of C2.15. 
Figure 5.4 HRMS of C2.15. Inset shows the observed molecular ion peak of [M − Cl]+ against 
the calculated molecular mass. 
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Our previous work with the [RhI(COD)Cl2]2 precursor has shown that solvent-assisted C-H 
deprotonation of the carborane moiety occurs in MeCN (Chapter 4, Section 4.3),40 hence the 
reaction with L2.1 was carried out in MeCN with an excess of Ag2O (Scheme 5.2). Pleasingly, 
cyclometallation through the carborane did occur to give C2.16a/b, though in this case the cage 
coordinates to the metal through a boron vertex whereas in C2.12 the complex cyclometallates 
through the carbon vertex of the cage (Scheme 5.2). Initially it was thought that 
cyclometallation through the cage with an IrIII centre had not occurred, with only the recovery 
of the non-cyclometallated complex C2.15 on workup. It was discovered that C2.16a/b is 
unstable in chlorinated solvents, which are employed during workup to remove the silver      
by-products. To enable C2.16a/b to be isolated without decomposition, the reaction mixture 
was passed through a short silica plug (2 cm) and eluted with MeCN to produce colourless 
crystals of C2.16a/b in 22 % yield. The 1H NMR spectrum confirms the presence of 
diastereomers with two sets of resonances in a 2.3:1 ratio (Figure 5.5). This is a result of the 
stereogenic metal centre and a mixture of B3 and B6 metallation.41,42 HRMS is not able to 
confirm the presence of C2.16a/b as it shares the same molecular ion peak as its non-
cyclometallated counterpart C2.15. Nonetheless, micro-analysis and X-ray diffraction analysis 
were in accordance with the multinuclear NMR data. It is noteworthy that C2.15 forms cleanly 
when C2.16a/b is dissolved in CDCl3 (potential source of DCl), and the absence of the set of 
small resonances that were attributed to halide mixing provides further evidence that halide 
mixing is observed when C2.15 is synthesised via the Ag2O route.  
Figure 5.5 1H NMR spectrum (500 MHz, C6H6) of C2.16a/b (bottom), 1H NMR spectrum (500 
MHz, CDCl3) of C2.15 (top). 
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The molecular structures of C2.15 and C2.16a/b were confirmed by X-ray diffraction analysis 
(Figure 5.6). In both cases, the coordination geometry around the metal centre can be regarded 
as a distorted three-legged piano stool, with a five-membered imidazolylidene-methylene 
metallacycle. In the molecular structure of C2.16a/b, HCl is lost to form a structurally distinct 
(7,5)-bicyclo-metallated system with a C-Ir-B bite angle of 85.65(14)°. The Ir-Ccarbene bond of 
C2.15 at 2.002(5) is in the typical range for Cp*Ir-NHC complexes,43–47 whilst that of C2.16a/b 
is comparatively short at 1.956(3) Å. The Ir-CH2 distances for both complexes, at 2.130(6) and 
2.128(3) Å for C2.15 and C2.16a/b respectively, are longer than expected.39,48 Identifying the 
cyclometallated vertex in C2.16a/b was determined by comparing the thermal parameters (Ueq) 
in conjunction with the VCD method (Table 5.1).49 This allowed the cyclometallated vertex to 
be unambiguously assigned as the B(3/6) vertex, which are equivalent. The B6 VCD of 1.89 Å 
is moderately long, and are typically in the range 1.72-1.78 Å for related B-cyclometallated 
complexes.41,50 It can be proposed that this vertex elongates to relieve steric encumbrance at the 









Figure 5.6 Molecular structures of C2.15 (left) and C2.16a/b (right). Thermal ellipsoids shown 
at 50 % probability and hydrogen atoms are omitted for clarity. The atom labelled as C1(1) in 
C2.15 was found to be a mixture of Cl and Br, and could be modelled in a 4:1 ratio. Note the 
B(3) and B(6) vertices in C2.16a/b are indistinguishable. 
 
































Table 5.1 Vertex-to-Centroid Distances (Å) and thermal parameters 
(Ueq) for C2.16a/b. 
Vertex VCD (Å) Ueq 
C(1) 1.542 0.010 
C(2) 1.579 0.007 
B(3) 1.712 0.021 
B(6) 1.893 0.015 
B(8) 1.723 0.021 
B(11) 1.656 0.017 
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5.4 Cp*M(NHC)Cl2 and (p-cymene)Ru(NHC)Cl2 type complexes bearing a 
closo-carboranyl substituent and their phenyl congeners 
5.4.1 Synthesis of complexes 
Complexes C2.15 and C2.16a/b were isolated in low yields (Section 5.2), and it was proposed 
that the steric bulk of the tBu group was impeding the reaction. To increase the yield and enable 
isolation of a non-cyclometallated Cp*IrIII-(NHC)Cl2 type complex, the steric bulk was reduced 
by replacing the tBu substituent of the NHC with a Me group (L2.3). The reaction of L2.3 with 
[IrCp*Cl2]2 under the same reaction conditions as previously gave the desired complex C2.17 
in excellent yield (Scheme 5.3). The corresponding Cp*Rh(NHC)Cl2 (C2.18) and               
Ru(p-cymene)(NHC)Cl2 (C2.19) complexes were also synthesised using analogous procedures. 
In addition, their phenyl congeners (C6.1-C6.3) were prepared in high yields, which were used 
for comparison in the transfer hydrogenation catalytic study (Section 5.6).  
 
Scheme 5.3 Synthesis of Cp*MIII(NHC)Cl2 and Ru(p-cymene)(NHC)Cl2 type complexes 
bearing a carboranyl substituent (C2.17-C2.19) and their phenyl congeners (C6.1-C6.3). 
 
5.4.2 Characterisation by multinuclear NMR and VT NMR spectroscopic studies 
The 1H NMR spectra of C2.17-C2.19 and C6.1-C6.3 confirmed formation of an NHC, with the 
absence of the characteristic downfield imidazolium resonance. This is further clarified by the 
presence of the diagnostic carbene resonances in the 13C{1H} NMR spectra typically expected 
for IrIII-,45,47,52 RhIII-,52–54 and RuII-NHC complexes (Table 5.2).55,56 The presence of a broad 
singlet in the 1H NMR spectra coupled with peaks in the range −2 to −13 ppm in the 11B{1H} 
NMR spectra confirms the presence of a tethered carboranyl substituent for C2.17-C2.19.  














As observed for C2.15 (Section 5.3), there is the presence of small neighbouring resonances in 
the 1H NMR spectra for each complex for the NHC, N-Me, CH2 linker and Cp* resonances. 
The relative intensities of the two sets of resonances were invariant to the purification processes 
employed (numerous recrystallisations from acetone with pentane and column 
chromatography). The micro-analysis and HRMS for each complex, contradictory to the NMR 
data, suggests the presence of only one species. Moreover, no halide mixing was present in the 
X-ray diffraction data.  
A plausible explanation for the presence of the aforementioned small neighbouring peaks in the 
1H NMR spectra of each complex shown in Scheme 5.3 is rotational isomers (rotamers). 
Rotamers can exist when a complex possesses sterically bulky ligand substituents, which 
hinders rotation about a M-ligand bond, in this case the M-Ccarbene bond. Variable temperature 
(VT) NMR spectroscopy can be an effective technique for determining the presence of 
rotamers,57 hence C2.17 was monitored by 1H NMR spectroscopy over a temperature range 
(223 K-323 K) (Figure 5.7). The 1H NMR spectrum of C2.17 at 223 K reveals the presence of 
three species with three broad singlets for the cage CH proton (H1) at 4.52, 4.44 and 4.39 ppm 
in a 1.2 : 6.2 : 1.0 ratio respectively. This can also be observed for the Cp* group, with two 
resonances at 1.64 ppm and 1.61 ppm, with the broad minor peak at 1.64 ppm clearly splitting 




Table 5.2 Characteristic resonances in the 1H and 13C{1H} NMR spectra 
(500 MHz, CDCl3) for C2.17-C2.19 and C6.1-C6.3. 
Complex 1H cage CH (ppm) 13C{1H} M-Ccarbene  (ppm) 
C2.17 4.45 158.2 
C2.18 4.62 171.9 (d, 1JRh-C = 52.5 Hz) 
C2.19 4.54 175.6 
C6.1 - 157.0 
C6.2 - carbenic resonance not observed 
C6.3 - 174.4 
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Initially it was speculated that a B-cyclometallated species might be present at low temperature, 
which would give rise to diasteromers and could possibly account for the extra resonances. 
However, the phenyl congener C6.1 gives rise to the same neighbouring resonances, suggesting 
the presence of rotamers imposed by the conformational rigidity of the bulky substituents. This 
is further confirmed by the spectra coalescing upon heating to 323 K, with only one set of 
resonances for the NHC backbone protons, cage CH proton and the diasterotopic protons 
observed.  
Figure 5.7 VT 1H NMR spectra 500 MHz (CDCl3, 223-323K) of C2.17.  
The NMR spectra of RuII complex C2.19 is more complex, and is quite broad at room 
temperature (Figure 5.8). Interestingly, heating the sample sharpens the majority of the peaks, 
whilst the diasterotopic CH2 tether protons broaden and are absent at high temperatures. At 
lower temperatures (223 K) the p-cymene aromatic resonance at 5.48 ppm splits into two 
resonances. This can also be observed in the 1H NMR spectrum of its phenyl derivative C6.3 
(Figure 5.9). These observations suggest that upon cooling the p-cymene ring becomes 
conformationally locked and each proton becomes magnetically inequivalent, indicating the 
presence of conformational isomers. 
 

















Figure 5.8 VT 1H NMR spectra (500 MHz, CDCl3, 223-323K) of C2.19. The diasterotopic 












Figure 5.9 1H NMR spectrum (500 MHz, CDCl3) of C6.3 at 323K (A), 273K (B) and 253 K 
(C). 
  CHAPTER 5 
 
 135 
5.4.3 X-ray diffraction analysis 
Crystals suitable for X-ray diffraction analysis were grown from the slow vapour diffusion of 
Et2O into concentrated DCM solutions for each of the RhIII and IrIII complexes, with the 
exception of the RhIII complex C2.18. Despite numerous efforts, a suitable crystal for X-ray 
diffraction analysis of C2.18 was not obtained, and instead they form as hollow tubes 
consisting of multiple crystals, which is rare (Figure 5.10).58 Crystals of the RuII complexes 
were obtained by slow evaporation of concentrated MeCN solutions. 
Figure 5.10 Optical microscopy images of crystals of C2.18. 
The molecular structures of the NHC-carboranyl complexes C2.17 and C2.19 and the phenyl 
analogues C6.1-C6.3 are all closely related and confirm the expected structures assigned by 
multinuclear NMR spectroscopy and HRMS data. The overall coordination geometry of each 
can be can be regarded as distorted three legged piano stools, with the molecular structures 
shown in Figure 5.11, along with selected bond distances provided in Table 5.4. The M-Ccarbene 
bonds are all within the expected ranges for related IrIII,43–47 RhIII,52,53,59 and RuII-NHC 
complexes.55,61,57,58  
Comparing the average M-Cp*(centroid) distance of 1.804 (Å) to that of the average              
Ru-p-cymene (centroid); that for Ru is considerably shorter at 1.684 (Å). This may account for 
the more complex NMR spectra observed for C2.19 and C6.3, as the p-cymene ring will exert 
greater steric encumbrance. This will restrict rotation about the p-cymene and the M-Ccarbene 
bonds leading to the p-cymene protons becoming magnetically inequivalent. The carboranyl 
carbon vertex C(1) was unambiguously determined in each case by measuring the VCD 

















Figure 5.11 Molecular structures of complexes C2.17, C2.19 and C6.1-C6.3. Thermal 
ellipsoids shown at 50 % probability with the exception of C2.17 (30 %), and hydrogen atoms 














































Table 5.3 Selected bond distances (Å) for complexes C2.17, C2.19 and C6.1-C6.3. 
Bond C2.17 C2.19 C6.1 C6.2 C6.3 
M-Ccarbene 1.980(4) 2.064(7) 2.042(5) 2.058(6) 2.105(10) 
M-Ccentroid 1.793 1.682 1.809 1.810 1.686 
M-Cl(1) 2.456(7) 2.415(18) 2.462(12) 2.467(13) 2.480(2) 
M-Cl(2) 2.495(6) 2.435(2) 2.450(12) 2.483(12) 2.455(2) 
VCD (C1) 1.562 1.559 -  - 
VCD (B3) 1.679 1.713 -  - 
VCD (B4) 1.676 1.689 -  - 
VCD (B5) 1.634 1.711 -  - 
VCD (B6) 1.702 1.702 -  - 
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5.5 Synthesis of cyclometallated NHC-carborane complexes of type 
Cp*Ir(NHC)Cl and a cyclometallated benzyl analogue 
5.5.1 Towards site specific cyclometallation 
Employing the same synthetic procedure utilised for L2.1 (Section 5.3), the reaction of L2.3 
with [IrCp*Cl2]2 in MeCN, with an excess of Ag2O, gave a mixture of the B-cyclometallated 
(C2.20a/b) and the C-cyclometallated (C2.21) complexes (Scheme 5.4, A). This is indicative 
in the 1H NMR spectrum of the product, with several overlapping NHC backbone resonances 
(Figure 5.12). When the product is dissolved in a CD2Cl2 the 1H NMR spectrum is far more 
complex than in CD3CN, which could indicate that an equilibrium exists between the           
non-cyclometallated and cyclometallated complexes in chlorinated solvents.60 Micro-analysis of 
the bulk material provides evidence for the presence of only C2.20a/b and/or C2.21 (all of 
which have the same molecular formula), along with the HRMS data revealing just one signal 
at m/z 579.3350, attributable to [complex − Cl]+.  
 
Scheme 5.4 Synthesis of C- and B-cyclometallated NHC carborane complexes (A and B) and 
an NHC cyclometallated benzyl complex (C). 
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Figure 5.12 1H NMR spectrum (300 MHz, CD2Cl2) of mixed B- and C-cyclometallated 
complexes C2.20a/b and C2.21 (A), 1H NMR spectrum (300 MHz, CD3CN) of mixed B- and 
C-cyclometallated complexes C2.20a/b and C2.21 (B) and 1H NMR spectrum (300 MHz, 
CD2Cl2) of C-cyclometallated complex C2.21 (C). 
It is intriguing that when the α-substituent of the NHC is a tBu group, only B-cyclometallation 
is observed (C2.16a/b, section 5.3), whereas with the Me substituted ligand a mixture of B- and 
C-cyclometallation is obtained (Scheme 5.4, A). It can be proposed that selectivity for the      
B-vertex in C2.16a/b is due to steric stress exerted at the metal centre caused by the tBu group. 
The elongation of the B-vertex reduces this steric stress, and with the C-vertices held closer to 
the centroid of the cage they are unable to elongate to the same extent as a B-vertex, resulting 
in selective cyclometallation through the equivalent B3/B6 vertices. Upon replacing tBu with a 
Me substituent this steric crowding is lost and the requirement for elongation of the 
cyclometallated vertex is reduced resulting in a mixture of B- and C-cyclometallation.  
Whether the metal is bound through a C- or B-vertex can influence the electronics of the 
complex, therefore it is beneficial to be able to selectively form one over the other. To negate 
the formation of a mixture of cyclometallated products, an alternative synthetic strategy was 
sought. There is literature precedent for the selective formation of C-cyclometallated 
complexes when nBuLi is employed as a base.51,61 Hence, L5.1 was reacted with nBuLi (2 eq) to 
deprotonate both the imidazolium NCHN and carboranyl CH protons, and subsequently reacted 
with [IrCp*Cl2]2 (Scheme 5.4, A). Analysis of the resulting product revealed selective            
C-cyclometallation, with a much simpler 1H NMR spectrum (Figure 5.12, C).  
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Two sets of resonances are again present in the 1H NMR spectrum of C2.21, which in this case 
is a result of halide exchange to give a mixture of Ir-Cl and Ir-Br, confirmed by X-ray 
diffraction analysis (Section 5.5.2). Deprotonation of L5.1 with nBuLi produces LiBr as a        
by-product, which is present on addition of [IrCp*Cl2]2. It can be suggested that LiBr is 
responsible for the halide exchange. In an attempt to prevent the formation of a mixed halide 
complex, the chloride congener of L5.1 (L3.1) was prepared from 1-chloro-1,2-dicarba-closo-
dodecaborane (P3.2) (Scheme 5.5). Unfortunately, L3.1 could not be isolated in a workable 
yield due to the nucleophilic substitution reaction between P3.2 and I2 being incredibly slow. 
In addition, a considerable amount of the nido ligand (L3.2) was formed making it very 
difficult to isolate L3.1. Due to this it was decided that the mixed halide system would be used 
in catalysis.  
 
Scheme 5.5 Synthesis of a chloride imidazolium salt L3.1. 
To allow a B-cyclometallated complex to be selectively isolated, an imidazolium salt in which 
the carboranyl proton was protected with a Me group (L5.1, Chapter 2, Section 2.4) was 
synthesised. L5.1 was subjected to the same reaction conditions as L2.3, and gave the expected 
Cp*Ir-(NHC)Cl2 type complex (C5.1), which was then reacted with a slight excess of Ag2O in 
MeCN to give the B-cyclometallated complex C5.2a/b in 44 % yield (Scheme 5.4, B). Finally 
an IrIII-NHC cyclometallated benzyl complex (C7.1) was prepared from literature procedure 
(Scheme 5.4, C),62 and was used as a useful comparison against the complexes cyclometallated 
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5.5.2 X-ray diffraction analysis 
Crystals of C2.21 suitable for X-ray diffraction analysis were grown from the slow diffusion of 
hexane into a concentrated DCM solution. The solid-state structure coincides with the NMR 
data, with the electron density of the halide being assigned as 30 % bromide to 70 % chloride. 
Similarly to C2.16a/b, a seven-membered metallacycle with a C-Ir-B bite angle of 90.58(16)° 
is displayed (Figure 5.13). Crystals of C5.1 suitable for X-ray diffraction analysis were 
obtained from the slow diffusion of Et2O into a concentrated DCM solution. Crystals of the 
cyclometallated derivative C5.2a/b could not be obtained. The IrIII-Ccarbene bond lengths at 
2.041(5) Å (C2.21) and 2.002(18) Å (C5.1) are in the typical range for IrIII-NHC complexes. 43–
47 The IrIII-X bond length of C2.21 at 2.549(7) Å is longer than a typical IrIII-Cl bond and 
shorter than a typical Ir-Br bond, 63–65 which is to be expected with the presence of halide 
mixing. The assignment of the carbon vertices in the solid-state structure of C5.1 was facile, as 
both C-atoms are substituted. However, like the RhI metallacycle C2 (Chapter 4, Section 4.3), 
the identity of the C1 vertex in the C-cyclometallated complex C2.21 was ambiguous using the 
VCD method (Table 5.4). The cyclometallated vertex, which was assigned as a carbon atom, 
possessed a very long VCD of 1.696 Å. It also has a considerably long C-C bond length at 
1.741(7) Å, which is consistent with other C-cyclometallated complexes in the literature.50,51,61  
It did, however, have the smallest thermal parameter (Ueq), though of the three methods (VCD, 
C/B-C/B bond lengths, thermal parameters) this is the most unreliable for identifying carbon 
atoms in o-carboranyl cages.66 The elongation of the C-C bond length and VCD of the C1 
vertex is expected to be a result of steric encumbrance at the metal centre. This effect was 
observed in the RhI C-cyclometallated complex (C2.12, Chapter 4, Section 4.3) and in similar 
complexes in the literature.40,51 Therefore, 1H NMR spectroscopy was used to confirm that the 
complex was cyclometallated through the C1 vertex with the absence of the characteristic 
broad singlet for the cage CH proton, which resonates at 4.45 ppm in the non-cyclometallated 




















Figure 5.13 Molecular structures of complexes C2.21 (left) and C5.1 (right). Thermal 




















Table 5.4 Vertex-to-Centroid Distances (Å) and thermal 
parameters (Ueq) of C2.21 and C5.1. 
Vertex C2.21 Ueq C5.1 Ueq 
C(1) 1.696 0.012 1.559 0.050 
C(2) 1.574 0.012 1.587 0.048 
B(3) 1.690 0.024 1.672 0.054 
B(6) 1.688 0.023 1.684 0.051 
B(7) 1.669 0.025 1.691 0.052 
B(11) 1.683 0.025 1.673 0.051 




Transfer hydrogenation offers a mild route to secondary alcohols without the requirement of 
pressurised H2 gas.67 Several different metals have been shown to be effective in this reaction, 
including Ir, Rh and Ru (Section 5.1). To assess the catalytic feasibility of the complexes 
prepared in this work (complexes screened in catalysis are shown in Figure 5.14) they were 
examined in the transfer hydrogenation of acetophenone, alongside the RhIII, IrIII and RuII 
precursors, with the results displayed in Table 5.5. The reactions were carried out under 
anhydrous conditions and conversions were calculated using 1H NMR spectroscopy by 
comparing the integration value of the Me resonance for 1-phenylethanol with that of the 
methoxy singlet of the internal standard, 1,3,5-trimethoxybenzene.  
 
Figure 5.14 Complete series of IrIII, RhIII and RuII complexes synthesised and screened in the 



























Conditions: acetophenone (1 mmol), 2-propanol (2.3 mL, 30 mmol), tBuOK (0.1 mmol, ‡no 
base added), catalyst (Δ1.0 mol % per Ru/Rh/Ir), internal standard = 1,3,5-trimethoxybenzene 
(0.33 mmol), 82 °C, 1 hour. 
Comparing the benchmark reactions using [IrCp*Cl2]2, [RhCp*Cl2]2 and [Ru(p-cymene)Cl2]2, 
Ru is the most active catalyst with quantitative conversion after 1 hour (entry 16), and RhIII is 
the least efficient catalyst with only 12 % conversion after 1 hour (entry 13). Incorporation of 
an NHC ligand saw a slight drop in yield for the Ru complexes (entries 17 and 18), with the 
reverse effect observed for the Rh complexes; incorporation of an NHC ligand bearing a 
dicarba-dodecaborane substituent (C2.18) saw a similar yield at 18 % (entry 14), whilst the 




Table 5.5 Examination of complexes in Figure 5.14 in the transfer hydrogenation 





Entry Catalyst Catalyst Loading (mol %) Conversion (%) 
1 No catalyst 0 8 
2 [IrCp*Cl2]2   1Δ 68 
3 C2.17 1 33 
4 C6.1 1 25 
5 C2.20a/b+C2.21 1 >99 
6 C2.20a/+C2.21 0.5 91 
7 C2.20a/b+C2.21‡ 1 0 
8 C2.21 1 >99 
9 C2.21 0.5 75 
10 C5.2a/b 1 >99 
11 C5.2a/b 0.5 82 
12 C7.1 1 39 
13 [RhCp*Cl2]2   1Δ 12 
14 C2.18 1 18 
15 C6.2 1 35 
16 [Ru(p-cymene)Cl2]2   1Δ >99 
17 C2.19 1 93 
18 C6.3 1 94 
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The most interesting series of results are those involving IrIII complexes. [IrCp*Cl2]2 gave good 
conversion of 68 % after 1 hour (entry 2). Incorporation of an NHC ligand bearing a      
dicarba-dodecaborane substituent (C2.17) deactivated the catalyst, with only 33 % conversion 
after 1 hour (entry 3), which decreased further to 25 % when the phenyl congener (C6.1) was 
employed (entry 4). However, upon cyclometallation of the carborane moiety a significant 
increase in catalytic performance is observed. The mixed C- and B-cyclometallated complex 
(C2.20a/b+C2.21) after 1 hour achieves quantitative conversion (entry 5), and a 91 % 
conversion is achieved in 1 hour upon lowering the catalyst loading to 0.5 mol % (entry 6). 
Intriguingly, the C-cyclometallated complex (C2.21) is less active than the mixed system (75 % 
conversion at 0.5 mol % loading (entry 9)), suggesting that either the B-cyclometallated 
complex is more active or that the mixed halides in C2.21 reduce the activity. However, when 
the B-cyclometallated complex (C5.2a/b) is employed at 0.5 mol % loading only 82 % 
conversion is obtained (entry 11). This suggests then that halide mixing may have an effect on 
catalysis. If we compare these results to the cyclometallated benzyl complex (C7.1), only an 
increase to 39 % conversion is obtained upon cyclometallation (entry 12). This large disparity 
in catalytic activity between the dicarba-dodecaborane and phenyl substituents could suggest 
metal-ligand bifunctional catalysis, in which the carborane moiety becomes involved. A 
proposed mechanism is given in Scheme 5.5, which includes an inner-sphere or an            
outer-sphere intermediate. The catalytically active species is proposed to be an alkoxide, as no 











Scheme 5.6 Proposed inner-sphere or outer-sphere mechanism for the transfer hydrogenation 
of acetophenone by an IrIII complex bearing a cyclometallated NHC-dicarbadodecaborane 
ligand.68 
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5.7 Conclusions and future work 
5.7.1 Conclusions 
A series of RhIII/IrIII and RuII-NHC carboranyl complexes have been prepared by reacting 
imidazolium salts, in the presence of Ag2O, with the corresponding metal precursors (Scheme 
5.6). Formation of an IrIII-NHC complex, when the NHC bears the sterically bulky tBu 
substituent, also results in intermolecular C-H activation of a Me of the tBu group (C2.16a/b). 
This impedes the yield of the reaction, whereas reducing the sterics of the NHC substituent to a 
Me group allows a Cp*IrIIINHC(Cl)2 type complex (C2.17) to be isolated in good yield. In 
addition, using analogous procedures allowed the Rh (C2.18) and Ru (C2.19) analogues to be 
isolated. Solvent-mediated Ag2O cyclometallation is only applicable to the IrIII complexes. The 
nature of the α-substituent of the NHC, as well as reaction conditions, can determine the vertex 
at which cyclometallation occurs. The bulky tBu NHC substituent leads to selective B3/B6 
cyclometallation (C2.16a/b), whilst the Me substituent leads to a mixture of C- and                 
B-cyclometallation (C2.20a/b+C2.21). 
Scheme 5.6 Summary of complexes synthesised in this work. 
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Selective C-cyclometallation can be achieved by initially deprotonating the cage CH proton 
with nBuLi and then subsequently reacting with [IrCp*Cl2]2. To achieve selective                    
B-cyclometallation, the di-substituted carboranyl imidazolium salt L3.1 is employed allowing 
C5.2a/b to be isolated in respectable yield. 
The phenyl congeners of these complexes were prepared and examined for useful comparison, 
as the carboranyl unit is thought to be spatially equivalent to a rotating phenyl ring through 
360°. The complexes were screened in the transfer hydrogenation of acetophenone, and the 
mixed C- and B-cyclometallated system (C2.20a/b+C2.21) was the most active (Figure 5.15). 
Initially the IrIII precursor was used as a benchmark reaction, which gave a respectable 
conversion of 68 % after 1 hour at 1 mol % loading. Incorporation of the NHC ligands (C2.17 
and C6.1) deactivated the catalysts. However, upon cyclometallation of the carboranyl 
substituent, the mixed C- and B-cyclometallated system gave quantitative conversion after 1 
hour with 91 % conversion at 0.5 mol % loading. In comparison the cyclometallated benzyl 
complex (C7.1) only saw a conversion of 39 % .  
 
Figure 5.15 Most interesting catalytic results from the transfer hydrogenation reaction of 
acetophenone.  
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This large disparity in activity between the carboranyl cyclometallated system 
(C2.20a/b+C2.21) and the cyclometallated benzyl complex (C7.1) suggests that the carboranyl 
unit may be involved in the catalytic cycle and go via the outer-sphere mechanism associated 
with bifunctional catalysts. Current work on going in the Willans group involves utilising DFT 
to assess this reaction mechanism. More challenging substrates other than acetophenone are 
also being considered to determine whether C2.20a/b+C2.21 are viable catalysts. 
 
5.7.2 Towards cyclometallation of a RuII-NHC complex 
It is intriguing that the RuII-NHC complex C2.19 resists cyclometallation when Ag2O is 
employed as a base. Since the non-cyclometallated RuII complexes show superior catalytic 
activity (Table 5.5, entries 17 and 18) in comparison to the analogous IrIII non-cyclometallated 
complexes, it would be interesting to investigate whether C2.19 can be cyclometallated under 
certain reaction conditions to potentially yield a superior catalyst. Jin and co-workers reported 
the synthesis of cyclometallated IrIII carboranyl complexes by utilising a chloride-abstracting 
agent (AgOTf) in the presence of a base (TEA) in DCM.50 Employing a similar synthetic 
approach only results in the decomposition of C2.19, with the characteristic resonance for the 
imidazolium salt appearing in the 1H NMR spectrum.  
Alternatively,  a cyclometallated complex can be synthesised by reacting the imidazolium salt 
with a strong base to deprotonate both the imidazolium NCHN and carboranyl CH protons 
(Section 5.5), and subsequently reacted with the metal precursor [Ru(p-cymene)Cl2]2. Using 
nBuLi was unsuccessful, though employing LiHMDS allowed the cyclometallated complex to 
be synthesised (Scheme 5.7), and the major peak in the HRMS was attributable to           
[C2.19’ − Cl]+ (Figure 5.16). Attempts at growing crystals suitable for X-ray diffraction 
analysis were unsuccessful. Future work should look to isolate this complex and fully 
characterise it by multinuclear NMR spectroscopy, X-ray diffraction and micro-analysis, and 






Scheme 5.7 Synthesis of a RuII-NHC carborane cyclometallated complex C2.19’. 
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Figure 5.16 HRMS of  C2.19’. Inset shows the observed molecular ion peak of [M – Cl]+ 
























5.8.1 General considerations 
All manipulations were carried out under an inert atmosphere by means of standard Schlenk 
line or glovebox techniques unless otherwise stated. Anhydrous solvents were prepared by 
passing over activated alumina to remove water, copper catalyst to remove oxygen and 
molecular sieves to remove any remaining water, via the Dow-Grubbs solvent system, and then 
freeze-pump-thaw degassed prior to use. All chemicals used in this work were bought from 
either Sigma Aldrich or Alfa and used without further purification. NMR spectra were recorded 
on a Bruker AV500 or a Bruker DPX300 spectrometer. 1H NMR and 13C{1H} NMR chemical 
shifts were referenced against residual solvent peaks. Assignment of 1H and 13C{1H} NMR 
spectra for all complexes was aided by the use of 2D 1H1H COSY, 1H13C HMQC, 1H13C 
HMBC and 13C{1H} DEPT 135 and DOSY experiments. Mass spectra were collected on a 
Bruker Daltonics (micro TOF) instrument operating in the electrospray mode. Elemental 
analyses were performed by Mr Stephen Boyer at London Metropolitan University.  The 
preparation of the NHC-carborane ligand precursors (L2.1, L2.3 and L5.1) used in this work 
can be found in Chapter 2, Section 2.7.  
 
5.8.2 Metal precursors 
Preparation of [RhCp*Cl2]2.69  
Hydrated RhCl3 (800 mg, 3.04 mmol) was added to an RBF and degassed. Anhydrous MeOH 
(10 mL) and 1,2,3,4,5-pentamethylcyclopentadiene (1.43 mL, 9.13 mmol) was added and 
heated under reflux for 24 hours. The brown precipitate was filtered and washed with cold 
MeOH (10 mL) then Et2O (3 × 10 mL). Yield: 780 mg, 1.26 mmol (83 %). 1H NMR (300 
MHz, CDCl3): δ (ppm) 1.61 (s, 15H, Cp*). Anal. Calcd for C20H30RhCl4: C, 38.87; H, 4.89. 
Found: C, 38.71; H, 4.83.  
 
Preparation of [IrCp*Cl2]2.69  
Hydrated IrCl3 (700 mg, 1.99 mmol) was added to an RBF and degassed. Anhydrous MeOH 
(10 mL) and 1,2,3,4,5-pentamethylcyclopentadiene (0.94 ml, 5.97 mmol) was added and heated 
under reflux for 48 hours. The orange precipitate was filtered and washed with cold MeOH (10 
mL) then Et2O (3 × 10 mL). Yield: 563 mg, 0.71 mmol (71 %). 1H NMR (300 MHz, CDCl3): δ 
(ppm) 1.59 (s, 15H, Cp*). Anal. Calcd for C20H30IrCl4: C, 30.15; H, 3.80. Found: C, 30.07; H, 
3.63. 
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Preparation of [Ru(p-cymene)Cl2]2.70  
Hydrated RuCl3 (2.00 g, 7.65 mmol) in ethanol (100 mL) was heated under reflux with              
α-phellandrene (10 mL, 62.0 mmol) for 4 hours. The brown precipitate was filtered off and 
washed with MeOH. Yield: 2.81 g, 4.59 mmol (60 %). 1H NMR (300 MHz, CDCl3): δ (ppm) 
5.47 (d, J = 6 Hz, 2H, p-cymene benzylic H), 5.33 (d, J = 6 Hz, 2H, p-cymene benzylic H), 
2.92 (septet, J = 6 Hz, 1H, CH), 2.15 (s, 3H, CH3), 1.27 (d, J = 6 Hz, 6H, CH3). Anal. Calcd for 
C20H28RuCl4: C, 39.23; H, 4.61. Found: C, 40.46; H, 5.06 . 
5.8.3 Imidazolium salts 
Preparation of L6.1.  
2-Phenylethylbromide (500 mg, 2.70 mmol), 1-methylimidazole 
(219 mg, 2.67 mmol) and MeCN (5 mL) were added to a Schlenk 
flask and heated at reflux for 18 hours. The reaction was then 
cooled to rt and the solvent removed in vacuo. The residue was 
recrystallized from DCM (5 mL) with Et2O (30 mL) to give a pale yellow oil. This was cooled 
to 4°C to afford L6.1 as an off white solid. Yield 620 mg, 2.32 mmol, (86 %). 1H NMR (300 
MHz, CDCl3): δ (ppm) 10.08 (s, imidazolium NCN), 7.47 (t, J = 3 Hz, 1H, NCH), 7.34 (t, J = 3 
Hz, 1H, NCH), 7.22-7.11 (m, 5H, Benzyl), 4.55 (t, J = 6 Hz, 2H, CH2), 3.94 (s, 3H, CH3), 3.18 
(t, J = 6 Hz, 2H, CH2). 13C{1H} NMR (75 MHz, CDCl3): δ (ppm) 137.1, 135.8, 128.9, 128.8, 
127.4, 123.4, 122.5, 51.0, 36.6, 36.5. HRMS (ESI+): m/z [C12H15N2]+ 187.1235, calcd for       
[M − Br]+ 187.1249. Consistent with data previously reported.71 
 
Preparation of L7.1.72  
1-Methylimidazole (1.65 g, 20.10 mmol) was added to a solution of 
benzyl bromide (3.43 g, 20.10 mmol) dissolved in THF (20 mL). The 
mixture was stirred at ambient temperature overnight and the solvent 
removed furnishing a viscous oil. This oil was washed with Et2O (3 × 
10 mL) and dried in vacuo to give the product as a pale yellow oil. 
Yield: 4.18 g, 16.50 mmol (82 %). 1H NMR (CD3OD, 500 MHz): δ (ppm) 9.09 (s, 1H, 
imidazolium NCN), 7.63 (d, J = 2.0 Hz, 1H, NCH), 7.60 (d, J = 2.0 Hz, 1H, NCH), 7.48-7.39 
(m, 5H, Aryl), 5.46 (s, 2H, CH2), 3.94 (s, 3H, CH3); 13C{1H} NMR (CD3OD, 75 MHz): δ (ppm) 
135.3, 130.3, 130.2, 129.8, 125.1, 123.5, 53.8, 36.9. HRMS (ESI+): m/z [C11H13N2]+ 173.1095, 
calcd. [M − Br]+ 173.1079. Consistent with data previously reported.72 
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5.8.4 NHC-carborane complexes 
 Preparation of Ir complex C2.15.  
To a Schlenk flask was added L2.1 (100 mg, 0.27 mmol), Ag2O 
(34 mg, 0.15 mmol), [Ir(Cp*)Cl2]2 (120 mg, 0.15 mmol) and 
anhydrous DCM (5 mL) along with some 4 Å molecular sieves. 
The reaction was heated at 40 °C for 16 hours, filtered through a   
2 cm silica plug and flushed with DCM (3 × 10 mL). The solvent 
was removed from the filtrate in vacuo and the solid added to Et2O 
(10 mL). This was filtered and removal of the solvent from the 
filtrate in vacuo gave C2.15 as an orange powder. Yield: 63 mg, 0.10 mmol (37 %). 1H NMR 
(300 MHz, CD2Cl2): δ (ppm) 6.87 (d, J = 3.0 Hz, 1H, H6), 6.80 (d, J = 3.0 Hz, 1H, H5), 4.56 
(td, J = 12.0 Hz, 6.0 Hz, 1H, H4a), 4.13 (br. s, 1H, H1), 3.95 (m, 1H, H4b), 3.06 (d, J = 12.0 Hz, 
1H, H9), 2.98 (m, 1H, H3a), 2.63 (m, 1H, H3b), 2.39 (d, J = 12.0 Hz, 1H, H9), 1.78/1.74 (Cp*), 
1.53 (s, 3H, CH3), 1.15 (s, 3H, CH3). 13C{1H} NMR (75 MHz, CD2Cl2): δ (ppm) 164.0 (C7), 
119.7 (C6), 117.3 (C5), 89.7/89.4 (quaternary Cp*), 73.0 (C2), 65.9 (CH3), 62.7 (C1), 49.3 (C4), 
39.7 (C3), 31.4/31.0 (CH3), 28.3 (C9), 10.1/10.0 (Cp*). 11B{1H} NMR (96 MHz, CDCl3): δ 
(ppm) −2.3, −5.4, −9.5, −11.1, −12.6. HRMS (ESI+): m/z [C21H40B10N2Ir]+ 621.3803, calcd for 
[M − Cl]+ 621.3811. Anal. Calcd for C22H42B10ClN2Ir: C, 38.43; H, 6.14; N, 4.27. Found: C, 
38.50; H, 6.21; N, 4.35. 
 
Preparation of Ir complex C2.16a/b.  
To a Schlenk flask was added L2.1 (100 mg, 0.27 mmol), Ag2O 
(94 mg, 0.41 mmol), [Ir(Cp*)Cl2]2 (108 mg, 0.14 mmol) and 
anhydrous MeCN (5 mL) along with some 4 Å molecular sieves. 
The reaction was heated at 70 °C for 24 hours, filtered through a 
2 cm silica plug and flushed with MeCN (3 × 10 mL). The 
solvent volume was reduced to 5 mL in vacuo resulting in 
C2.16a/b as colourless crystals, which were filtered, washed with 
pentane (5 mL) and dried in vacuo. Yield: 41 mg, 0.06 mmol (22 %). 1H NMR (500 MHz, 
C6D6): major isomer (70 %) δ (ppm) 6.11 (d, 1H, J = 2.0 Hz, H6), 5.96 (d, J = 2.0 Hz, 1H, H5), 
4.06 (td, J = 13.1 Hz, 3.0 Hz, 1H, H4a), 3.24 (d, J = 10.0 Hz, 1H, H9), 3.21 (br. s, 1H, H1), 2.64 
(m, 2H, H4b), 2.63 (d, J = 10.0 Hz, 1H, H9), 1.87 (m, 1H, H3a), 1.61 (Cp*), 1.44 (s, 1H, CH3), 
1.06 (s, 1H, CH3). Minor isomer (30 %) δ (ppm) 5.86 (d, 1H, J = 2.0 Hz, H6), 5.74 (d, 1H, J = 
2.0 Hz, H5), 4.35 (td, J = 13.8 Hz, 3.0 Hz, 1H, H4a), 3.07 (d, J = 10.5 Hz, 1H, H9), 3.21 (br. s, 
1H, H1), 2.64 (m, 2H, H4b), 2.63 (d, J = 10.5 Hz, 1H, H9), 2.18 (m, 1H, H3a), 1.98 (m, 1H, H3b), 
1.73 (Cp*), 1.26 (s, 1H, CH3), 0.98 (s, 1H, CH3). 13C{1H} NMR (75 MHz, C6D6): δ (ppm)  
117.6/117.5 (C6), 116.7/116.6 (C5), 93.5/93.0 (quaternary Cp*), 65.8/65.5 (C2), 59.9/58.3 (C1), 
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45.1/44.3 (C4), 41.3 (C3), 31.9/31.2 (CH3), 30.7/30.5 (CH3), 20.6/18.4 (C9), 9.7/9.7 (Cp*). 
11B{1H} NMR (96 MHz, C6D6): δ (ppm) −1.4, −4.0, −7.8, −11.3, −15.3. HRMS (ESI+): m/z 
[C21H39B10N2Ir]+ 620.3766, calcd for [M]+ 620.3733. Anal. Calcd for C21H39B10N2Ir: C, 40.69; 
H, 6.34; N, 4.52. Found: C, 40.80; H, 6.47; N, 4.30. Crystals suitable for X-ray diffraction 
analysis were grown by the slow evaporation of a concentrated solution of C7a/b in MeCN. 
 
Preparation of Ir complex C2.17.  
To a Schlenk flask was added L2.3 (50 mg, 0.15 mmol), Ag2O (17 
mg, 0.075 mmol), [Ir(Cp*)Cl2]2 (60 mg, 0.073 mmol) and anhydrous 
DCM (5 mL), along with some 4 Å molecular sieves. The reaction 
was heated at 40 °C for 16 hours, filtered through Celite and flushed 
with DCM (3 × 5 mL). The solvent was removed from the filtrate in 
vacuo and the residue was recrystallised from acetone (5 
mL)/pentane (30 mL), filtered and dried in vacuo to give C2.17 as a 
yellow solid. Yield: 86 mg, 0.13 mmol (89 %). 1H NMR (300 MHz, CDCl3): δ (ppm) 6.97 (d,  
J = 3.0 Hz, 1H, H6), 6.90 (d, J = 3.0 Hz, 1H, H5), 4.94 (m, 1H, H4a), 4.45 (br. s, 1H, H1), 
3.97/3.95 (s, 3H, H8), 3.71 (m, 1H, H4b), 3.21 (m, 1H, H3a), 2.59 (m, 1H, H3b), 1.64/1.61 (s, 
15H, Cp*). 13C{1H} NMR (75 MHz, CDCl3): δ (ppm) 158.2 (C7), 124.3 (C6), 121.3 (C5), 89.2 
(quaternary Cp*), 71.9 (C2), 60.9 (C1), 49.7 (C4), 39.1 (C3), 38.8 (C8), 9.5/9.3 (Cp*).       
11B{1H} NMR (96 MHz, CDCl3): δ (ppm) −2.2, −5.0, −9.6, −13.0. HRMS (ESI+): m/z 
[C18H35B10N2IrCl]+ 615.3121, calcd for [M − Cl]+ 615.3106. Anal. Calcd for C18H35B10N2IrCl2: 
C, 33.22; H, 5.42; N, 4.31. Found: C, 33.12; H, 5.34; N, 4.37. Crystals suitable for X-ray 
diffraction analysis were grown by the slow diffusion of hexane into a concentrated solution of 
C2.17 in DCM. 
 
Preparation of Rh complex C2.18.  
To a Schlenk flask was added L2.3  (50 mg, 0.15 mmol), Ag2O (17 
mg, 0.075 mmol), [Rh(Cp*)Cl2]2 (46 mg, 0.074 mmol) and 
anhydrous DCM (5 mL), along with some 4 Å molecular sieves. The 
reaction was heated at 40 °C for 16 hours, filtered through Celite and 
flushed with DCM (3 × 5 mL). The solvent was removed from the 
filtrate in vacuo and the residue was recrystallised from acetone (5 
mL)/pentane (30 mL), filtered and dried in vacuo to give C2.18 as a 
yellow solid. Yield: 79 mg, 0.14 mmol (95 %). 1H NMR (300 MHz, CDCl3): δ (ppm) 7.04 (d,   
J = 3.0 Hz, 1H, H6), 6.99 (d, J = 3.0 Hz, 1H, H5), 5.02 (m, 1H, H4a), 4.62 (br. s, 1H, H1), 4.00 
(s, 3H, H8), 3.76 (m, 1H, H4b), 3.20 (m, 1H, H3a), 2.50 (m, 1H, H3b), 1.60 (s, 15H, Cp*). 
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13C{1H} NMR (75 MHz, CDCl3): δ (ppm) 171.9 (d, 1JRh-C = 52.5 Hz, C7), 125.3 (C6), 122.2 
(C5), 96.6 (d, 1JRh-C = 7.5 Hz, quaternary Cp*), 71.9 (C2), 61.0 (C1), 50.0 (C4), 39.3 (C3), 38.8 
(C8), 9.6 (Cp*). 11B{1H} NMR (96 MHz, CDCl3): δ (ppm) −2.2, −5.1, −9.7, −12.8. HRMS 
(ESI+): m/z 526.2550 [C18H35B10N2RhCl]+, calcd for [M − Cl]+ 526.2525. Anal. Calcd for 
C18H35B10Cl2N2Rh: C, 38.51; H, 6.28; N, 4.99. Found: C, 38.63; H, 6.32; N, 5.13. 
 
Preparation of Ru complex C2.19.  
To a Schlenk flask was added L2.3 (50 mg, 0.15 mmol), Ag2O 
(17 mg, 0.075 mmol), [Ru(p-cymene)Cl2]2 (46 mg, 0.075 mmol) 
and anhydrous DCM (5 mL), along with some 4 Å molecular 
sieves. The reaction was heated at 40 °C for 3 hours, filtered 
through Celite and flushed with DCM (3 × 5 mL). The solvent 
was removed from the filtrate in vacuo and the residue subjected 
to column chromatography on silica using a gradient elution with 
CH2Cl2/MeOH (2 %). Recrystallisation from MeCN gave C2.19 
as a microcrystalline orange solid. Yield: 58 mg, 0.10 mmol (67 %). 1H NMR (500 MHz, 
DCM): major δ (ppm) 7.08 (d, J = 2.0 Hz, 1H, H6), 7.03 (d, J = 2.0 Hz, 1H, H5), 5.40 (d, J = 
5.0 Hz, 2H, p-cymene Ar-H), 5.06 (d, J = 5.0 Hz, 2H, p-cymene Ar-H), 4.93 (br. s, 1H, H4a), 
4.54 (br. s, 1H, carboranyl H1), 3.94 (s, 3H, H8), 3.82 (br. s, 1H, H4b), 2.93 (br. s, 1H, H3a), 2.90 
(septet, J = 10 Hz, 1H, H14), 2.64 (br. s, 1H, H3b), 1.93 (s, 3H, H9), 1.26 (d, J = 10 Hz, 6H, H15). 
13C{1H} NMR (126 MHz, CD2Cl2): δ (ppm) 175.6 (C7), 125.3 (C6), 122.0 (C5), 110.4             
(p-cymene quaternary C), 99.4 (p-cymene quaternary C), 86.4 (p-cymene Ar), 82.4 (p-cymene 
Ar), 72.6 (C2), 61.5 (C1), 50.5 (C4), 39.9 (C8), 39.0 (C3), 31.2 (C14), 23.0 (C9), 21.9/18.8 (C15). 
11B{1H} NMR (161 MHz, CD2Cl2): δ (ppm) −2.4, −5.4, −9.8, −12.9. HRMS (ESI+): m/z 
[C18H34B10N2RuCl]+ 523.2460, calcd for [M − Cl]+ 523.2455. Anal. Calcd for 
C18H34B10N2RuCl2: C, 38.71; H, 6.14; N, 5.02. Found: C, 38.63; H, 6.02; N, 5.12. Crystals 
suitable for X-ray diffraction analysis were grown by the slow evaporation of a concentrated 
solution of C2.19 in MeCN. 
 
Preparation of Ir complex C2.20a/b and C2.21 mixture.  
To a Schlenk flask was added C2.17 (100 mg, 0.15 mmol), Ag2O (52 mg, 0.22 mmol) and 
anhydrous MeCN (5 mL) along with some 4 Å molecular sieves. The reaction was heated at 70 
°C for 16 hours, filtered through a 2 cm silica plug and flushed with MeCN (2 × 10 mL). The 
solvent was reduced to 5 mL and the desired product was precipitated with Et2O (30 mL), 
filtered and the solvent removed in vacuo to give a mixture of C2.20a/b and C2.21. Yield: 52 
mg, 0.08 mmol (53 %). HRMS (ESI+): m/z [C18H34B10N2Ir]+ 579.3350, calcd for [M − Cl]+ 
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579.3340. Anal. Calcd for C18H34B10N2IrCl: C, 35.20; H, 5.58; N, 4.56. Found: C, 35.34; H, 
5.57; N, 4.63. 
Preparation of Ir complex C2.21.  
To a Schlenk flask was added L2.3 (50 mg, 0.15 mmol) and 
anhydrous THF (5 mL). The solution was cooled to -78 °C and a 
1.6 M solution of nBuLi in hexane (133 µL, 0.32 mmol) was added 
dropwise. This was stirred at -78 °C for 30 minutes, then the 
temperature was then raised to 0 °C and stirred for a further 1 
hour. A solution of [IrCp*Cl2]2 (60 mg, 0.073 mmol) in THF        
(3 mL) was added at 0 °C and the reaction was stirred at room 
temperature for 12 hours. The solvent was removed in vacuo, 
DCM (5 mL) added and filtered through a 2 cm silica plug which was flushed with DCM (2 × 
10 mL). The solvent volume was reduced to 5 mL and the product precipitated with pentane 
(30 mL), filtered and dried in vacuo to give C2.21 as a yellow solid. Yield: 68 mg, 0.11 mmol 
(73 %). 1H NMR (300 MHz, CD2Cl2): δ (ppm) 6.97 (m, 1H, H6), 6.90 (s, 1H, H5), 4.54 (m, 1H, 
H4a), 3.98/3.94 (s, 3H, H8), 3.72 (m, 1H, H4b), 2.82 (m, 1H, H3a), 2.66 (m, 1H, H3b), 1.53/1.48 
(Cp*). 13C{1H} NMR (75 MHz, CD2Cl2): δ (ppm) carbenic C not observed, 126.0/125.9 (C6), 
121.2 (C5), 93.8/93.5 (quaternary Cp*), 46.2 (C4), 42.3, 41.0, 39.2 (C8), 9.6/9.3 (Cp*). HRMS 
(ESI+): m/z [C22H29B10N2Ir]+ 549.1650, Calcd for [M-X]+ 549.1635. Crystals suitable for X-ray 
diffraction analysis were grown by the slow diffusion of hexane into of a concentrated solution 
of C2.21 in DCM. 
 
Preparation of Ir complex C5.1.  
Prepared as described for C2.17, starting from L5.1 (50 mg, 0.14 
mmol), Ag2O (16 mg, 0.07 mmol), [Ir(Cp*)Cl2]2 (56 mg, 0.07 
mmol) and anhydrous DCM (5 mL). After purification the product 
was obtained as a yellow solid. Yield: 80 mg, 0.12 mmol (86 %). 
1H NMR (300 MHz, CDCl3): δ (ppm) 6.99 (d, J = 2.1 Hz, H6), 
6.92 (d, J = 2.1 Hz, H5), 5.04 (m, 1H, H4a), 3.99/3.97 (s, 3H, H8), 
3.84 (td, J = 12.0 Hz, 3 Hz, 1H, H4b), 3.41 (m, 1H, H3a), 2.48 (m, 
1H, H3b), 2.15 (s, 3H, H9), 1.67/1.63 (Cp*). 13C{1H} NMR (75 
MHz, CDCl3): δ (ppm) 158.6 (C7), 121.3 (C6), 89.4/89.1 (quaternary Cp*), 74.9 (carboranyl 
quaternary C) (only one carboranyl quaternary C observed), 49.9 (C4), 38.9 (C8), 36.6 (C3), 
23.9 (C9), 9.5/9.3 (Cp*). 11B{1H} NMR (96 MHz, CDCl3): δ (ppm) −3.7, −6.1, −10.0. HRMS 
(ESI+): m/z [C19H37B10N2IrCl]+ 629.3283, calcd for [M-Cl]+ 629.3263. Crystals suitable for    
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X-ray diffraction analysis were grown by the slow diffusion of hexane into a concentrated 
solution of C5.1 in DCM. 
 
Preparation of Ir complex C5.2a/b.  
This complex was prepared as described for C2.20a/b and C2.21, 
starting from C5.1 (60 mg, 0.09 mmol), Ag2O (16 mg, 0.07 mmol) 
and anhydrous MeCN (5 mL). After purification the product was 
obtained as a yellow solid. Yield: 25 mg, 0.04 mmol (44 %). 1H 
NMR (500 MHz, CD3CN): δ (ppm) 7.23 (d, J = 2.0 Hz, 1H, NCH), 
7.19 (d, J = 2.0 Hz, 1H, NCH), 7.14 (d, J = 2.0 Hz, 1H, NCH), 
7.11 (d, J = 2.0 Hz, 1H, NCH), 5.01 (td, J = 12.5 Hz, 6.0 Hz, 1H, 
CH2), 4.25 (m, 1H, CH2), 4.02–3.95 (m, 1H, CH2), 3.71/3.61 (s, 3H, CH3), 3.17 (m, 1H, CH2), 
2.72 (m, 1H, CH2), 2.30 (m, 1H, CH2), 2.17 (s, 1H, CH3), 1.72/1.68/1.63 (Cp*). 13C{1H} NMR 
(126 MHz, CD3CN): δ (ppm) 124.4 (NCH), 122.8 (NCH), 95.5/89.6 (quaternary Cp*), 50.5 
(C4), 37.9, (C3), 36.9 (C8), 23.9 (C9), 9.3, 9.2, 9.0, 8.8 (Cp* region). 11B{1H} NMR (161 MHz, 
CD3CN): δ (ppm) −4.2, −6.3, −8.5, −9.8, −10.6. HRMS (ESI+): m/z [C19H36B10N2Ir]+ 593.3513, 
calcd for [M − Cl]+ 593.3497. Anal. Calcd for C19H36B10ClN2Ir: C, 36.32; H, 5.78; N, 4.46. 
Found: C, 36.45; H, 5.77; N; 4.60. 
 
5.8.5 NHC-Benzyl complexes 
 Preparation of C6.1.  
To a Schlenk flask was added L6.1 (50 mg, 0.19 mmol), Ag2O (22 
mg, 0.095 mmol), [Ir(Cp*)Cl2]2 (76 mg, 0.095 mmol) and 
anhydrous DCM (5 mL) along with some 4 Å molecular sieves. 
The reaction was heated at 40 °C for 16 hours and filtered over 
Celite, which was flushed with DCM (3 × 5 mL). The solvent was 
removed from the filtrate in vacuo and the residue was 
recrystallised from acetone (5 mL) with pentane (30 mL), filtered 
and dried in vacuo to give C7.1 as a yellow solid. Yield: 97 mg, 
0.17 mmol (89 %). 1H NMR (300 MHz, CDCl3): δ (ppm) 7.47–7.20 (m, 5H, Ar), 6.95–6.89 (m, 
2H, H5/6), 5.08 (dt, J = 12.0, 6.0 Hz, 1H, H4a), 4.00/3.98 (s, 3H, H8) 3.89 (dt, J = 12.0, 6.0 Hz, 
1H, H4b), 3.50 (dt, J = 12.0, 6.0 Hz, 1H, H3a) 2.99 (dt, J = 12.0, 6.0 Hz, 1H, H3b), 1.62/1.59 (s, 
15H, Cp*). 13C{1H} NMR (75 MHz, CDCl3): δ (ppm) 157.0 (C7) 138.7 (Ar), 129.4 (Ar), 128.7 
(Ar), 126.7 (Ar), 123.5 (C6), 121.5 (C5), 88.8 (quaternary Cp*), 52.2 (C4), 38.7 (C8), 38.4 (C3), 
9.5/9.3 (Cp*). HRMS (ESI+): m/z [C22H29N2IrCl]+ 549.1650, Calcd for [M − Cl]+ 549.1635. 
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Anal. Calcd for C22H29N2IrCl2: C, 45.20; H, 5.00; N, 4.79. Found: C, 45.06; H, 4.93; N, 4.85. 
Crystals suitable for X-ray diffraction analysis were grown by the slow diffusion of hexane into 
a concentrated solution of C6.1 in DCM. 
 
 Preparation of Rh complex C6.2.  
Prepared as described for C2.18 from L6.1 (50 mg, 0.19 mmol), 
Ag2O (22 mg, 0.095 eq), [Rh(Cp*)Cl2]2 (59 mg, 0.095 mmol) and 
anhydrous DCM (5 mL) After purification the product was 
obtained as an orange solid. Yield: 86 mg, 0.17 mmol, (92 %). 1H 
NMR (300 MHz, CDCl3): δ (ppm) 7.50-7.15 (m, 5H, benzyl), 
7.02-6.97 (m, 2H, H5/6), 5.20 (m, 1H, H4a), 4.06/4.04 (s, 3H, H8) 
3.92 (m, 1H, H4b), 3.51 (m, 1H, H3a) 2.96 (m, 1H, H3b), 1.62/1.58 
(s, 15H, Cp*). 13C{1H} NMR (75 MHz, CDCl3): δ (ppm) 138.7 (benzyl), 129.4 (benzyl), 128.7 
(benzyl), 126.7 (benzyl), 124.5 (C6), 122.5 (C5), 96.3 (d, 1JRh-C = Hz, quaternary Cp*), 52.5 
(C4), 39.3 (C8), 38.2 (C4), 9.8/9.6 (Cp*). HRMS (ESI+): m/z [C22H29N2RhCl]+ 459.1074, calcd 
for [M − Cl]+ 459.1069. Anal. Calcd for C22H29N2RhCl2: C, 53.35; H, 5.90; N, 5.66. Found: C, 
53.18; H, 5.95; N, 5.73. (Note: the resonance for the carbenic carbon is not observable in the 
13C NMR spectrum.) Crystals suitable for X-ray diffraction analysis were grown by the slow 
diffusion of hexane into a concentrated solution of C6.2 in DCM. 
 
 Preparation of Ru complex C6.3.  
To a Schlenk flask was added L6.1 (50 mg, 0.19 mmol), Ag2O 
(22 mg, 0.095 mmol), [Ru(p-cymene)Cl2]2 (58 mg, 0.095 
mmol), anhydrous DCM (5 mL) and anhydrous MeOH (0.1 mL) 
along with a small number of 4 Å molecular sieves. The reaction 
was heated at 40 °C for 3 hour. The reaction was then cooled to 
rt, filtered over Celite and further washed with DCM (3 × 5 
mL). The solvent was removed in vacuo and the residue 
subjected to column chromatography on silica using a gradient 
elution with DCM/MeOH (2 %) to afford an orange solid. Recrystallized from acetone (5 mL) 
with pentane (30 mL), afforded C6.3 as an orange powder. Yield: 69 mg, 0.14 mmol (74 %). 
1H NMR (500 MHz, 273 K, CDCl3): Major isomer; δ (ppm) 7.38-7.22 (m, 5H, benzyl), 7.08 (d, 
J = 2 Hz, 1H, H6), 7.02 (d, J = 2 Hz, 1H, H5),  5.29 (m, 2H, p-cymene Ar-H), 5.05 (d, J = 5 Hz, 
1H, p-cymene Ar-H), 4.92 (m, 1H, H4a), 4.84 (d, J = 5 Hz, 1H, p-cymene Ar-H), 4.08 (m, 1H, 
H4b), 3.97 (s, 3H, H8), 3.34 (m, 1H, H3a), 2.97 (m, 1H, H3b), 2.88 (septet, J = 10 Hz, H14), 1.95 
(s, 3H, H9), 1.20 (d, J = 5 Hz, 6H, H15). 13C{1H} NMR (126 MHz, CDCl3): δ (ppm) 174.0 (C7), 
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138.6 (benzyl), 129.3 (H6), 128.8 (H5), 126.8 29 (benzyl), 124.1 (benzyl), 121.8 (benzyl), 109.0 
(p-cymene quaternary C), 99.2 (p-cymene quaternary C), 85.1/84.8 (p-cymene Ar), 82.7/82.4 
(p-cymene Ar), 53.1 (C4), 39.7 (C8), 37.9 (C3), 30.7 (C14), 22.7/22.5 (C15), 18.7 (C9). HRMS 
(ESI+): m/z [C22H28N2RuCl]+ 457.0995, calcd for [M − Cl]+ 457.0982. Crystals suitable for X-
ray diffraction analysis were grown by the slow diffusion of hexane into a concentrated 
solution of C6.3 in DCM. (Note: complex exists as two isomers in solution with only the major 
isomer quoted and the resonances for the diasterotopic CH2 protons are only visible at 
temperatures below room temperature). 
 
Preparation of Ir complex C7.1.62  
To a Schlenk flask was added L7.1 (50 mg, 0.20 mmol), Ag2O           
(23 mg, 0.10 mmol), [Ir(Cp*)Cl2]2 (79 mg, 0.10 mmol) and anhydrous 
DCM (5 mL) along with some 4 Å molecular sieves. The reaction was 
heated at 40 °C for 18 hours and filtered over Celite, which was 
flushed with DCM (3 × 5 mL). The solvent was removed from the 
filtrate in vacuo and the residue was recrystallised from DCM (5 mL) 
with hexane (30 mL), filtered and dried in vacuo to give C7.1 as a yellow solid. Yield: 65 mg, 
0.17 mmol (62 %). 1H NMR (CD3OD, 500 MHz): δ (ppm) 7.44−7.33 (m, 5H, Aryl) 7.27 (d, J = 
2.0 Hz, 1H, NCH), 6.91 (d, J = 2.0 Hz, 1H, NCH), 6.09 (d, J = 14.4 Hz, 1H, CH2) 5.22 (d, J = 
14.9 Hz, 1H, CH2), 4.02 (s, 3H, CH3), 1.66 (s, 15H, Cp*). 13C{1H} NMR (75 MHz, CDCl3): δ 
(ppm) 128.8, 128.6, 128.1, 123.4, 122.0, 89.0, 54.7, 38.9, 9.4 (needs stronger carbon). HRMS 
(ESI+): m/z [C21H26N2Ir]+ 499.1716, calcd for [M − Cl]+ 499.1725. Consistent with data 
previously reported.62 
 
Catalytic transfer hydrogenation general procedure. Catalyst (0.01 or 0.005 mmol) and 
1,3,5-trimethoxybenzene (55.50 mg, 0.33 mmol) were added to an ampoule and degassed. In a 
Glovebox, tBuOK (14 mg, 0.10 mmol) and acetophenone (117 µL, 1.00 mmol) were added to 
the ampoule. Under an atmosphere of N2, anhydrous iPrOH (2.30 mL, 30.00 mmol) was added 
and the reaction was heated at 82 °C for 1 hour. The reaction mixture was quenched by cooling 
in an ice bath and an aliquot (0.10 mL) was added to an NMR tube with CDCl3 (0.40 mL). 
Conversion was calculated using 1H NMR spectroscopy by comparing the integration of the Me 
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  Chapter 6
Synthesis, structure and biomedical evaluation of silver complexes bearing     
NHC-carborane ligands 
 
This chapter discusses the diverse coordination modes of NHC-carborane ligands at AgI. The 
steric nature of the ligand precursor plays a crucial role in the overall stability and the type of 
silver complex formed, with the first structurally elucidated example of AgI directly bound 
through the carborane reported. In addition, a series of carboranyl complexes derived from the 
natural product theobromine were synthesised. The antiproliferative properties of these 
complexes against the HCT116 (colon) cancer cell line were evaluated. 
 
6.1 Introduction 
6.1.1 History of silver 
Silver has been used extensively throughout history as a potent antimicrobial agent, specifically 
in the form of silver nitrate, with reports of its utility as early as the 17th century for the 
treatment of chronic ulcers and open wounds.1 By the 19th century it had become common 
practice for dilute solutions of silver nitrate to be dropped into the eyes of new-born babies to 
prevent transmission of bacterial infections during birth.2 The discovery of penicillin in the late 
20th century, often termed the ‘miracle drug’, marked the decline of silver antimicrobials. 
However, with the discovery of antibiotics came the emergence of antibiotic resistant bacteria 
resulting in a resurgence in silver, with silver sulfadiazine becoming one of the most widely 
used topical burn treatments (Figure 6.1).3 It’s effectiveness as an antimicrobial agent is owed 
to its steady release of Ag+ ions over a prolonged period of time, providing maximum 
protection against infection as the wound heals.4 Other silver salts such as silver nitrate, which 
deposit large amounts of silver in one instance, would require frequent reapplication deeming 
them much less effective and impractical. More recently, Collins et al. reported that antibiotics 
when dosed with ionic silver can kill between 10 and 1,000 times more bacteria, and also shed 
some light on the mode of action of silver as an antimicrobial, as the precise mechanism is still 
under debate.5 They report that ionic silver attacks bacterial cells in two main ways: i) by 
increasing the permeability of the cell membrane, allowing large-molecule antibiotics to bypass 
the protective coating of gram-negative bacteria, and ii) by disruption of the cell’s metabolism 
leading to high levels of toxic oxygenated compounds being produced.  
  CHAPTER 6 
 
 163 
However, before silver can be added to our antibiotics, a major complication to overcome is 
that a high concentration of silver in the body can lead to the skin turning blue-grey in colour, a 




Figure 6.1. Structure of silver sulfadiazine. 
  
6.1.2 AgI-NHCs as antimicrobials  
As previously mentioned, silver sulfadiazine is a highly effective antimicrobial agent due to its 
steady release of Ag+ ions over a prolonged period of time.4 A slow release rate of silver is 
affiliated with its ancillary ligands, the more stable the complex, the slower the silver is 
released. Currently, AgI-NHC complexes are the most widely studied type of metal-NHC in 
antimicrobials. Professor Wiley J. Youngs is well established in this area of chemistry, with his 
earliest work reporting water soluble pyridine-linked pincer AgI-NHC complexes, which were 
found to be much more active than silver nitrate against E. coli, S. aureus and P. aeruginosa 
(Figure 6.2, 1).7 This was attributed to the slower release of Ag+ ions from AgI-NHCs into the 
culture medium. Encapsulation of a AgI-NHC complex (Figure 6.2, 2) further enhances the 
antimicrobial activity, demonstrating faster kill rate and increased bioavailability of Ag+ ions 
when compared to silver sulfadiazine and silver nitrate.8 This was attributed to the polymer 
providing a very slow release of Ag+ ions, which are trapped within the polymer matrix as the 
silver complex decomposes. Unfortunately, the imidazolium salt formed upon decomposition 
of the AgI-NHC complex was found to be toxic and highlighted the importance of utilising 
non-toxic ancillary ligands, which was the natural progression of Youngs’ research, with the 
synthesis of NHC complexes derived from caffeine (Figure 6.2, 3).9,10  
Figure 6.2 Complexes reported by Youngs et al.7–10 
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6.1.3 AgI-NHCs in the treatment of cancer  
Cancer is one of the leading causes of death in the Western world, and it is expected that one in 
two people will develop cancer according to the most accurate prognosis from Cancer Research 
UK.11 If we are to triumph in our interminable battle with cancer we must continue to develop 
more effective treatments. The development of cisplatin was a milestone in oncology and is 
still used in modern medicine for the treatment of cancer. However, cisplatin can have severe 
side effects, as well as tumours capable of building resistance to the platinum-based drug. This 
has driven research into finding replacement metallodrugs with complexes of titanium, iron and 
ruthenium going through clinical trials.12–14 Silver is renowned for its antimicrobial properties 
but had been over looked with regards to its cytotoxic properties. One of the first silver 
compounds reported to exhibit cytotoxic properties was a silver fluorobenzoate dimer.15 Five 
years later the first AgI-NHC complexes (4-6) were reported by Youngs (Figure 6.3), and were 
screened against OVCAR-3 (ovarian), MB157 (breast) and HeLa (cervical) cancer cell lines, 

















Table 6.1 SilverI-NHC acetate complexes and their respective IC50 values 
against ovarian, breast and cervical cancer call lines.16 
 IC50 (µM) OVCAR-3 IC50 (µM) MB157 IC50 (µM) HeLa 
Cisplatin 12 25 25 
4 35 8 >200 
5 30 20 >200 
6 20 10 >200 
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The effectiveness of a compound to induce proliferation of cancer cells can be quantified by a 
number of different techniques, the most effective method involves measuring the 
incorporation of methyl-[3H]-thymidine (radioactive derivative of the DNA precursor 
thymidine) into the DNA of dividing cancer cells.17 The concentration of                         
methyl-[3H]-thymidine is measured allowing an IC50 value to be derived. IC50 is defined as the 
concentration of the complex required to achieve incorporation of methyl-[3H]-thymidine into 
half of the cancer cells in the assay, a parameter indicative of cell death.  
Complexes 4-6 exhibited highest cytotoxicity towards the MB157 cell line and had little effect 
on the HeLa cell line, highlighting the selectivity towards specific cancers for this type of 
complexes (Table 6.1). The effectiveness of complexes 4-6 as potential anticancer drugs was 
further highlighted when substantial tumour death was observed in in vivo studies in mice, with 
high selectivity towards the cancerous cells. More recently, Willans et al. reported a family of 
xanthine-derived imidazolium salts, prepared from caffeine, theophylline and theobromine.18 
SilverI-NHC complexes were prepared and evaluated against eight cancer cell lines and 
hydrophobicity values sought as a means to assess the ability of each complex to cross the cell 
membrane (Figure 6.4). Although cisplatin was most active, the study highlighted that 
introducing a hydrophilic substituent (R = (CH)2OH) increased the antiproliferative properties. 
It was proposed this increase in potency was due to the ability of the complex to cross the cell 
membrane more easily, which was determined from the hydrophobicity studies. From the 
remaining alkyl substituted complexes (R = Me, nBu and Ph); the complex bearing the most 
sterically bulky subsistent (R = Ph) was found to the most cytotoxic. It was proposed that the 
sterically bulky N-substituents on the ligand may result in a slower release rate of silver, 
resulting in an increase in cytotoxicity. From these conclusions it was proposed that a Ag 
complex that possesses hydrophilic qualities, as well as steric bulk would lead to a more 









Figure 6.4 Silver(I)-NHC complexes derived from the natural xanthine products caffeine, 
theophylline and theobromine.18 
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This led on to further research, and in unpublished work the Willans group report a series of 
AgI-NHC complexes possessing a N-hydroxyethyl substituent whilst varying the steric bulk of 
the other N-substituent (7-11) (Graph 6.1). These complexes were tested against the pancreatic 
caner cell line (Panc 10.05), and the IC50 values supported their proposed theory from the 
previous study; that fine tuning of the hydrophilic properties of the complex to allow easier 
passage across the cell membrane, coupled with using sterically bulk substituents to allow for a 














Graph 6.1 Silver(I)-NHC complexes and their respective IC50 values against the Panc 10.05 
cancer cell line. 
With the successful preparation of a AgI-NHC complex (10) with cytotoxicity comparable to 
that of cisplatin, the focus turned towards the development of a drug delivery system. 
Encapsulation of the AgI-NHC complexes into micelles formed from a polyethylene glycol 
based polymer (mPEG5000P(Phe)). Interestingly, the anticancer activity of the micelles 
displayed higher potency than the non-encapsulated AgI-NHC complex against the Panc 10.05 
cancer cell line. It was proposed that either the polymer may exhibit cytotoxic properties, or 
that the micelles stabilise the complex resulting in a slow release of Ag+ ions. Future work aims 
towards testing the micelles in vivo to evaluate their efficiency at delivering the complex to the 
tumour cells. 
 




In Chapters 4 and 5 RhI and IrIII complexes bearing L1 were prepared via in situ 
transmetallation using Ag2O, with examples shown in Scheme 6.1. In this section of work the 
focus was isolation of the AgI-NHC complex, which was previously prepared in situ in 
previous reactions, by employing the same reaction conditions with the exception of adding the 
metal precursor (Scheme 6.1). In addition, a series of carboranyl complexes derived from the 
natural product theobromine were synthesised and, similarly to the catalytic study in Chapter 5, 
phenyl congeners of each of the carboranyl complexes were also prepared for useful 
comparison when evaluating their antiproliferative properties. 
 
6.3 Synthesis of a silver σ-bound carboranyl Ag2(NHC)2 complex  
Reaction of  L2.1 with Ag2O (0.55 eq) under anhydrous conditions in CD2Cl2 was monitored 
by 1H NMR spectroscopy (Scheme 6.1). A visible indication that a reaction is occurring is the 
consumption of the sparingly soluble Ag2O and the precipitation of a grey solid, presumably 
AgBr, which is easily removed by filtering the solution through Celite. Full conversion of L2.1 
was not achieved until the amount of Ag2O added to the reaction was increased to 1 equivalent. 
Analysis of the 1H NMR spectrum after 9 hours revealed complete disappearance of the 
resonance for the imidazolium proton (H7), which is strongly characteristic of the formation of 
a metal-NHC bond (Figure 6.5). The characteristic carboranyl proton (H1) is a broad singlet 
hidden under the CH2 resonance at 4.31 ppm. The 2D 1H13C HMQC experiment confirms this, 
with strong coupling observed between this resonance and the carboranyl cage carbon at 63.3 
ppm (Figure 6.5).  
 
Scheme 6.1 Example reactions in which silver was used as a transmetallating agent from 
Chapters 4 and 5, and the Synthesis of AgI-NHC complexes C2.24 and C2.25. 
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Figure 6.5 1H NMR and 1H13C HMQC spectra (300 MHz, CD2Cl2) of C2.24. Inset highlights 
the coupling between the masked H(1) resonance and the carboranyl carbon C(1). 
 C2.24 appears unstable, and within a few hours of forming the complex signs of 
decomposition are observed in anhydrous solvent, with the characteristic imidazolium H(7) 
proton reappearing in the 1H NMR spectrum and formation of a black precipitate, presumably 
Ag0. However, single crystals of C2.24 suitable for XRD analysis can be grown within           
12 hours by slow diffusion of diethyl ether into the NMR sample. The asymmetric unit of 
C2.24 consists of a molecule of AgBr(NHC), which possess a centre of inversion to give the 








Figure 6.6 Molecular structure of C2.24 (left) and packed structure (right) highlighting the 
inter-molecular hydrogen bonding between the carboranyl proton and the bromides (red dotted 
lines). Thermal ellipsoids shown at 50 % probability and hydrogen atoms are omitted for 
clarity. Bromides are disordered over two positions with 50 % occupancy. 
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The geometry about the silver centre is distorted trigonal planar, and in relation to the two 
NHCs can be considered bent with an Ag(2)-Ag(1)-C(7) bond angle of 157.4°, which is typical 
of similar Ag2(NHC)2 halide complexes in the literature.19 With the bromides disordered over 
two positions, with 50 % occupancy, a centroid between each was generated to give an average 
distance for each of the Ag-Br bonds. The Ag-Br(1) bond at 2.628 (Å) is considerably longer 
than the Ag-Br(2) bond length of 2.282 (Å). Within the extended structure of C2.24, hydrogen 
bonding between H(1) and the bridging bromide atoms is observed (Figure 6.6). 
Obtaining reproducible results from this reaction was problematic due to the instability of the 
complex. Crystals of a second complex were also found in the product mixture, and were 
characterised as an unusual macrocycle C2.25, in which the silver is bound to the NHC of one 
molecule of ligand and the carboranyl carbon of another, with the geometry about the silver 
being almost linear with bond angles of 176.3° for C(7)-Ag(2)-C(12) and 177.1° for           
C(1)-Ag(2)-C(18) (Figure 6.7). The formation of C2.25 is intriguing as the 1H and 13C{1H} 
NMR spectra of C2.24 clearly indicate the carboranyl cage proton (H1) is present. This 
suggests that C2.25 could be a decomposition product of C2.24. It is noteworthy that the 
crystallisation mother liquor does change colour from colourless to dark orange, which may 
indicate the formation of HBr and/or Br2 upon formation of the C2.25. The crystals were 
picked by hand, and in an attempt to obtain spectroscopic data were redissolved in CD2Cl2, but 
unfortunately the complex was too unstable in solution. Although C2.25 is unstable, this is the 
first structurally elucidated example of silver directly bound to o-carborane. The selected bond 
distances for C2.24 and C2.25 are provided in Table 6.2, and the Ag-Ccarbene bond lengths are 








Figure 6.7 Molecular structure of C2.25. Thermal ellipsoids shown at 50 % probability and 
hydrogen atoms are omitted for clarity. 
 
 

































Table 6.2 Selected bond distances (Å) for C2.24 and C2.25. 
C2.24 C2.25 
Bond Distance (Å) Bond Distance (Å) 
Ag(1)-C(7) 2.034(4) Ag(1)-C(7) 2.096(3) 
Ag(1)-Br(1)centroid 2.628 Ag(2)-C(18) 2.115(3) 
Ag(1)-Br(2) centroid 2.282 Ag(1)-C(12) 2.120(3) 
  Ag(2)-C(1) 2.131(3) 
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6.4 Towards the synthesis of stable silver NHC carborane complexes  
Complexes of type Ag2Br2(NHC)2 such as C2.24 are uncommon, and it can be rationalised that 
the sterically bulky tBu group of C2.24 prevents the formation of the more traditional 
Ag(NHC)2Br type complex (Section 6.2.1). It is important to retain some steric protection of 
the metal centre, as research within the Willans group has demonstrated that these out perform 
ligand systems containing little steric protection in anticancer studies.22 With this in mind, a 
ligand precursor containing a mesityl substituent (L2.4) was prepared (Scheme 6.2). Its phenyl 
congener L8.1 was also prepared for useful comparison when evaluating the complexes as 
potential anticancer agents. 
Scheme 6.2 Synthesis of Ag(NHC)2Br complexes C2.26 and C8.1. 
Adopting the same synthetic procedure used for the synthesis of C2.24 allowed the 
corresponding Ag(NHC)2Br  type complexes C2.26 and C8.1 to be isolated in good yields. 
These were fully characterised by multinuclear NMR spectroscopy, HRMS, and elemental 
analysis. Single crystals of each were grown from either the slow evaporation of a concentrated 
MeCN solution (C2.26), or the slow diffusion of Et2O into a concentrated DCM solution 
(C8.1), with the molecular structures shown in Figure 6.8 and selected bond distances given in 
Table 6.3. The molecular structures unveiled that for carboranyl complex C2.26, the bromide 
is bound to the silver centre, which exhibits a distorted T-shaped geometry to accommodate for 
the sterically bulky ligands. The Ag-Br bond length is rather long but is typical for these type of 
complexes.19 In comparison,  phenyl complex C8.1 forms the more traditional cationic complex 














Figure 6.8 Molecular structure of C2.26 (left) and C8.1 (right). Thermal ellipsoids shown at  
40 % probability and hydrogen atoms are omitted for clarity. 
 
Although the solid state structures revealed an abundance of structural information, in solution 
complexes can behave very differently. 13C{1H} NMR spectroscopy provides more definitive 
information of the nature of the silverI-NHC bonding in solution.  Silver has two naturally 
occurring isotopes, 107Ag and 109Ag, with a percentage abundance of 51.8 % and 48.2 % 
respectively. Both are NMR active with a nuclear spin of ½. Given this information, one would 
expect the carbenic carbon to have a splitting pattern of two doublets. This can be observed in 
the 13C{1H} NMR spectrum of C8.1 at 182.0 ppm, with coupling constants of 209.3 and 182.0 
Hz, which is in the typical range for these types of complexes.23 It is also common for long-
range coupling to be observed to the backbone carbons of the NHC ring for complexes that 
exhibit carbene coupling to silver, which can be observed in the 13C{1H} NMR spectrum of 
C8.1 at around 122.5 ppm (Figure 6.9, top). The carbenic resonance for C2.26, however is not 
observed (Figure 6.9, bottom). The appearance of the carbenic resonance for some silver 
complexes can be concentration dependent.24 It is also common for the resonance to appear as a 
singlet with all coupling information lost. Lin et al. proposed these characteristics are indicative 
of a complex that is fluxional in solution,25 which may be expected to be the case for C2.26; 
with a rather long Ag-Br bond one would expect dissolution into separate ions in solution.  
Table 6.3 Selected bond distances (Å) for C2.26 and C8.1. 
Bond C2.26 C8.1 Angle C2.26 C8.1 
C(7)-Ag(1) 2.100(7) 2.069(4) C(20)-Ag(1)-C(7) 159.6(8) 176.1(14) 
C(20)-Ag(1) 2.106(7) 2.077(4)    
Br(1)-Ag(1) 2.906(9) -    
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Figure 6.9 13C{1H} NMR spectra (126 MHz, CD2Cl2) for C2.26 (bottom) and C8.1 (top), 
which were fully assigned through the aid of  2D 1H1H COSY, 1H13C HMQC, 1H13C HMBC 
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6.5 Theobromine derived silver-NHC complexes 
6.5.1 Synthesis of imidazolium salts  
Theobromine (1) is a naturally occurring xanthine derivative and is the main alkaloid found in 
chocolate. Youngs et al. were the first to functionalise theobromine, through reaction with 
iodoethanol in refluxing DMF with a base (K2CO3), allowing isolation of a product substituted 
only at the backbone (2) (Scheme 6.3). This is due to the amine being a much stronger 
nucleophile when deprotonated than the imidazole nitrogen. Although the poor nucleophilicity 
of the imidazole nitrogen allows for excellent site selectivity, methylation of this nitrogen 
requires a high excess of MeI (20 eq) to form the imidazolium salt (3), and any attempts at 
introducing alternative groups other than Me have failed, limiting synthetic functionality to the 
first step of this synthesis.22 
 
Scheme 6.3 Synthesis of a theobromine-derived imidazolium salt. 
Willans et al. have reported various derivatives of theophylline, which were subsequently 
coordinated to AgI, and screened against a range of cancer cell lines (Section 6.1.3).18 
Derivatives of theobromine other than that reported by Youngs are yet to be explored. This 
work looked to compliment the previous study by preparing carboranyl derivatives of 
theophylline, and to evaluate the antiproliferative properties of the corresponding AgI 
complexes. Initial efforts to incorporate a carboranyl unit employed a similar synthetic strategy 
reported by Youngs; reaction of theobromine with bromomethyl-o-carborane (P1.1, Chapter 2, 
Section 2.1) in the presence of a base (Cs2CO3) with heating at 82 °C for 24 hours in MeCN 
(Scheme 6.4, A). However, analysis of the crude product indicated that no reaction had taken 
place. Literature findings report that SN2 type substitution reactions on P1.1 are very 
challenging,26 and is termed a “dead” synthon due to the strong σ-accepting effect of the cage. 
However, Litvinov et al. reported the first successful nucleophilic substitution reaction at P1.1 
by replacing the inorganic base with Et3N.27 It was proposed that utilising Et3N as a base 
“frees-up” the negative charge of the nucleophile, making substitution much easier. When the 
more traditional inorganic bases were used in these reactions no reaction occurs, and it was 
proposed that the inorganic salts form a strong ionic pair with the deprotonated substrate 
resulting, in no reaction taking place. This chemistry was therefore explored, and when Cs2CO3 
was substituted for Et3N the desired product (L1.3) was obtained (Scheme 6.4, B). However, 
the reaction is incredibly slow and L1.3 could not be isolated in a workable yield. In addition, 
the product is contaminated with the nido species (L1.4), which is presumably formed by NEt3 
deboronating L1.3.  
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Scheme 6.4 Attempted synthesis of a theobromine-derived carboranyl compound L1.3. 
Multi nuclear NMR spectroscopy provided evidence for formation of L1.4, with a broad singlet 
at −3.0 ppm in the 1H NMR spectrum being indicative of the bridging proton at the open 
pentagonal face of the cage. This can also be observed in the 11B{1H} NMR spectrum. Removal 
of a BH vertex results in an uneven distribution of electron density within the cage resulting in 
some boron atoms becoming highly shielded and resonating at −35.2 and −37.5 ppm. Details of 
this phenomenon are explained in Chapter 2, Section 2.2.2.  
As an alternative synthetic approach, P9.1-P11.1 were prepared in acceptable to high yields by 
reaction of theobromine with the corresponding alkynyl halides (Scheme 6.5). The significant 
drop in yield when employing 4-bromo-1-butyne to synthesise P11.1, in comparison to when 
using the shorter alkyne (propargyl bromide) to prepare P9.1, can be rationalised by the fact 
that the SN2 transition of 4-bromo-1-butyne is not as stable as that of propargyl bromide, which 
is stabilised by the π-system of the alkynyl unit. Attempts were made to prepare P11.1 in higher 
yield by employing longer reaction times, and carrying the reaction out at higher temperatures 
(120 °C, DMF) but all were unsuccessful.  
Scheme 6.5 Synthesis of theobromine-derived imidazolium salts. 
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Reaction of alkynyl compounds with B10H12(MeCN)2 can be an effective route to a variety of 
carboranyl compounds but is often low yielding (Chapter 1, Section 1.5.1). Hence, the reaction 
of P9.1-P11.1 with B10H12(MeCN)2 under anhydrous conditions gave carboranyl precursors 
(P9.2-P11.2) in only 38-52 % yield.  
Finally, each precursor (P9.2-P11.2 and P12.1) was subsequently methylated by heating at 
reflux in MeCN with MeI, which required prolonged reaction times of 3 days to achieve yields 
between 42-85 % (Scheme 6.5). Shorter reaction times are possible when using DMF, which is 
the solvent employed in the literature, but an increase in yield is not observed. There are only 
two by products in this reaction; excess MeI, which can be removed in vacuo, and any 
unreacted imidazole, which unlike the product is soluble in Et2O. This allows any unreacted 
imidazole to be reclaimed, which is much more difficult if DMF is employed. 
Figure 6.10 provides fully assigned 1H NMR spectra of each step of the synthesis of L9.1. 
Evidence for alkylation of theobromine with a 1-bromo-2-butyne substituent is provided by the 
loss of the amine proton at 11.09 ppm, the presence of a quartet at 4.55 ppm for the methylene 
linker, and a triplet at 1.73 ppm for the Me group (Figure 6.10, B). The splitting patterns 
observed for these resonances are a result of long range 4J coupling (2.2 Hz) between the 
alkynyl proton and the methylene linker. Upon formation of the carborane in the next step, the 
11B{1H} NMR spectrum exhibits the characteristic resonances of a closo-carborane with peaks 
ranging from -3 to -12  ppm. The 1H NMR spectrum provides further clarity, with a downfield 
shift of the methyl group that was once an internal alkyne and is now part of a electron 
withdrawing icosahedral cage (Figure 6.10, C). Interestingly, the methylene bridge protons 
become diasterotopic and resonate as two doublets at 4.81 ppm and 4.70 ppm (2JH-H = 15.2 Hz). 
This is observed in each of the carboranyl compounds and can be rationalised through 
observing P9.2 in the space-filling model (Figure 6.11). The bulky o-carborane substituent 
conformationally locks the methylene bridge due to the steric hindrance of the surrounding 
carbonyl groups, resulting in protons being magnetically inequivalent. In comparison, alkynyl 
precursors P9.1-P11.1 can freely rotate about the methylene bridge carbon, hence the protons 
are magnetically equivalent and appear as one resonance. 
The 1H NMR spectrum of L10.1 provides clear evidence for methylation of the imidazole 
nitrogen, with a large downfield shift of the NCHN (H8) proton at 9.34 ppm (Figure 6.10, D). 
All attempts at obtaining crystals suitable for XRD analysis of imidazolium salts (L9.1-L12.1) 
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Figure 6.10 1H NMR spectra (500 MHz, 298 K, DMSO-d6) for theobromine (A), alkylated 
theobromine compound P10.1 (B), carboranyl substituted theobromine P10.2 (C) and 
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6.5.2 Synthesis of AgI-OAc complexes 
Initial efforts looked towards synthesising complexes using Ag2O (Scheme 6.6, A). However, 
due to the low acidity of the imidazolium NCHN proton, no reaction occurred between L10.1 
and Ag2O. This has previously been found by the Willans group, with more success found 
employing AgOAc.18 Hence, reaction of L10.1 with AgOAc at room temperature for 48 hours 
allowed the corresponding AgI-OAc complex C10.1 to be isolated in a respectable yield of 55 
% (Scheme 6.6, B). Interestingly when L9.1 or L11.1 are employed, the corresponding 
complexes C9.1 and C11.1 could not be isolated, with the formation of a black precipitate as 
the reaction proceeds, presumably Ag0. The benzyl derivative C12.1 however, could be isolated 
in high yields (Scheme 6.6, C).  
The 1H NMR spectrum of C9.1 provides evidence for NHC formation, with the absence of the 
imidazolium resonance and presence of a singlet at 1.95 ppm characteristic of the methyl 
resonance of the acetate unit (Figure 6.12).18,28 The 13C{1H} NMR spectrum provides further 
clarity, exhibiting a carbene resonance at 188.4 ppm (Figure 6.13). The 11B{1H} NMR 
spectrum of C10.1 shows the expected peaks for a closo-carboranyl compound (Figure 6.12, 
inset). C10.1 could not be characterised by HRMS due to scrambling, with the major molecular 
ion peaks corresponding to the ligand and an Ag(NHC)2 complex (Figure 6.14). Micro analysis 
confirmed that C10.1 had formed, and not the dimeric Ag(NHC)2 type complex that the HRMS 
suggests. 
Scheme 6.6 Initial efforts towards synthesising a AgI complex (A), synthesis of NHC-
carboranyl AgI-OAc complex C10.1 and attempted synthesis of C9.1 and C11.1 (B) and 
synthesis of an NHC-benzyl AgI-OAc complex (C). 
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Figure 6.12 1H NMR spectrum (500 MHz, CD2Cl2) and 11B{1H} NMR spectrum (196 MHz, 
CD2Cl2) of C10.1 (inset). 
Figure 6.13 13C{1H} NMR spectrum (126 MHz, CD2Cl2) of C10.1. 
 
Figure 6.14 HRMS of C10.1. Inset shows the observed molecular ion peak of [Ag(NHC)2]+ for 
C10.1 against the calculated mass. 
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The molecular structure of complexes C10.1 and C11.1 were elucidated by X-ray diffraction 
analysis (Figure 6.15). Crystals suitable for XRD analysis for both complexes were obtained 
from the slow diffusion of Et2O into concentrated DCM solutions. The Ag-Ccarbene bond lengths 
of 2.108(3) Å (C10.1) and 2.134(7) Å (C11.1) are within the expected range of similar 
(NHC)AgOAc type complexes in the literature (Table 6.4),18 and the geometry about the silver 
atoms deviate slightly from linearity, with C(8)-Ag(1)-O(3) bond angles of 171.8° and 175.9° 
for C10.1 and C11.1 respectively.  
 
Figure 6.15 Molecular structures for C10.1 (left) and C11.1 (right). Thermal ellipsoids shown 
at 50 % probability and hydrogen atoms are omitted for clarity. 
 
6.5.3 Decomposition studies of the AgI-OAc complexes 
It is interesting that of the carboranyl complexes C9.1-C11.1, only C10.1 can be isolated in 
good yield. Both C9.1 and C11.1 possess an acidic cage CH proton, and it can be suggested 
that this could interact with the silver leading to decomposition of the complexes. It is 
noteworthy however, that over the course of several weeks C10.1 shows signs of 
decomposition in the solid state even when stored in a dark environment. In comparison, 
phenyl complex C11.1 remains stable and even when dissolved in hydrous DMSO-d6 no 
decomposition is observed, even after several weeks. When C10.1 is dissolved in hydrous 
DMSO-d6 signs of decomposition are apparent within a couple of hours. This can be observed 
visually with the formation of a black precipitate presumably Ag0, and by 1H NMR 
spectroscopy, with the presence of a small downfield resonance characteristic of the 
imidazolium proton in the 1H NMR spectrum. After leaving the sample of C10.1 for a further 9 
days and observing the 1H NMR spectrum, it was surprising to see that deboronation of the 
cage had occurred, with a characteristic resonance at −3.0 ppm for the bridging proton of the 
open face of the cage. This suggests that the theobromine unit is electron withdrawing and 
increases the susceptibility of the cage towards deboronation. It is unusual for deboronation to 
occur under such mild conditions but there are examples in the literature.29–31  
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Kahl et al. reported the serendipitous degradation reaction of a closo-carboranyl porphyrin (A) 
to the nido-species in hydrous DMSO (Figure 6.16).29 This led to further investigation into the 
factors which effect the decomposition of the closo cage to the nido species, by exploring the 
nature of the α-substituent of the cage and solvent used in the reaction (Figure 6.16, B-F). It 
was reported that DMSO out performed various polar solvents containing 5 % water (DMF,   
N-methylpyrrolidinone, MeCN, THF and acetone) and that when anhydrous solvents were 
employed no degradation of the cage was observed. Rapid deboronation was observed with 
strongly electron withdrawing groups (B and C) but introducing a methylene linker between 
the cage and the electron withdrawing substituent (D) made the cage resilient to deboronation. 










Figure 6.16 A closo-carboranyl porphyrin (A) reported by Kahl et al. and a series of 
functionalised carboranes (B-F) screened for their degradation in DMSO.29 
It was concluded that the degradation reaction was dependent on the ability of the solvent to 
stabilise the nucleophilic attack by water, and that electron withdrawing α-substituents facilitate 
deboronation. In light of this research a series of decomposition studies were carried out to 
determine whether the theobromine moiety promotes deboronation. Each of the theobromine 
derived carboranyl compounds (P9.2, P10.2, P11.2, L9.1, L10.1, L11.1 and C10.1) were 
placed in an NMR tube and dissolved in DMSO-d6 (<0.02% H2O) and monitored by 1H and 
11B{1H} NMR spectroscopy. In accordance with Kahl’s findings, no deboronation occurs in the 
absence of water. To each sample was then added 5 % D2O, and it was found that P9.2 and 
L9.1 are deboronated by D2O, with L9.1 deboronating the fastest (Table 6.4). It can be 
proposed that L9.1 is more prone to deboronation due to formation of a stable zwitterionic 
compound (L9.2). In comparison, the deboronated product of P9.2 is presumably stabilised by 
a hydronium cation (P9.3). The disubstituted carboranyl compounds P10.1 and L10.1 are 
resilient towards deboronation. The electron density induced onto the cage by the methyl group 
reduces the electropositive nature of the boron atoms, hence providing stability towards 
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degradation of the cage. Similarly, the compounds possessing a longer tether between the 
theobromine unit and the cage (P11.1 and L11.1) also resist deboronation.  
      * refer to NMR spectra on the next page for an example of how % yield is measured. 
Table 6.4 Deboronation screening reactions involving the reaction of each of the 
theobromine derived carboranyl compounds P9.2, P10.2, P11.2, L9.1, L10.1, 
L11.1 and C10.1 with D2O (5%) in DMSO-d6. Inset schemes highlight the 







Compound Deboronated product formed       
(% yield)* 
P9.2 P9.3 (5) 
L9.1 L9.2 (14) 
P10.2 - 
L10.1 - 
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To illustrate how the decomposition products are identified, the 1H and 11B{1H} NMR spectra 
of L9.1 dissolved in DMSO-d6 (5 % D2O) (Figure 6.17, bottom), and the 1H and 11B{1H} 
NMR of the same sample recorded 9 days later (Figure 6.17, top) are provided. The 
decomposition product (L9.2) is indicated by the red dots. The appearance of an imidazolium 
peak further upfield at 9.21 ppm is likely due to the loss of hydrogen bonding interaction 
between the iodide counterion and the imidazolium proton, as L9.2 is zwitterionic. The 
carboranyl proton, a broad singlet at 5.11 ppm for L9.1, becomes shielded with a shift to 2.15 
ppm upon deboronation due to the increase in charge density of the cage upon loss of the B 
vertex. This is also the case for the methylene bridge protons, which appear further upfield at 
4.31 ppm. The 11B{1H} NMR spectrum further clarifies this with the diagnostic resonances of a 










Figure 6.17 1H NMR spectrum (300 MHz, DMSO-d6) (bottom) and 11B{1H} NMR (96 MHz, 
DMSO-d6) spectrum (inset) for L9.1 with 5 % D2O, and 1H NMR spectrum (300 MHz, DMSO-
d6) (top) and 11B{1H} NMR spectrum (96 MHz, DMSO-d6) (inset) of the same sample recorded 
9 days later (top). 
The question that arises is why does C10.1 fully deboronate to L10.2, when its precursors 
P10.2 and L10.1 are completely stable? It can be suggested that the silver withdraws electron 
density from the theobromine unit increasing the electrophilicity of the boron atoms, hence the 
susceptibility of the cage towards deboronation is increased. Alternatively, the weakly basic 
acetate unit may be involved in deboronation. It can be proposed from these observations that 
the stability of the AgI-OAc complexes (C9.1-C11.1) is not only linked to the susceptibility of 
the cage towards deboronation, but also whether the carboranyl unit possess an acidic CH 
proton. Future ligand design should look to further increase the stability of the cage whilst 
ensuring the cage CH proton is substituted if a more stable AgI-OAc complex is to be isolated. 
A route to a potentially more stable AgI-OAc carboranyl complex C13.1 that could be looked at 
in the future is provided in Section 6.7.  
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6.6 Anticancer testing 
Preliminary studies revealed that the Ag(NHC)2Br type complexes C2.26 and C8.1 (Section 
6.3), and AgOAc xanthine-derived complexes C10.1 and C12.1 (Section 6.4.2) exhibit 
antiproliferative activity against the HCT116+/+ and HCT116−/− (colon) cancer cell lines 










Figure 6.18 Ag-NHC complexes screened against the HCT116+/+ and HCT116−/− cancer cell 
lines. 
The in vitro cytotoxicity of the complexes were determined using MTT-based assays involving 
a 96 hour complex-exposure period. The MTT based assay is a colorimetric assay for cellular 
growth and was the first homogeneous cell viability assay developed for a 96-well format that 
is highly effective for high-throughput screening.32 Viable cells reduce MTT (yellow) to 
formazan (purple), which has an absorbance maximum near 570 nm (Figure 6.19). The 
quantity of formazan is measured by recording changes in absorbance in this region. Upon 
apoptosis (cell death), the ability to reduce MTT to formazan is lost, therefore colour is an 
effective marker to measure cytotoxicity (loss of viable cells) and is quantified as an IC50 value. 
IC50 is defined as the concentration of the complex required to achieve cell death in 50 % of the 
cells. 
 
Figure 6.19 Reduction of MTT to formazan and representation of a 96-well MTT assay 
whereby increasing numbers of viable cells resulted in increased purple colouring. 
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Each of the complexes tested were screened a total of three times to give an average IC50 value, 
and in most cases results showed good reproducibility (Table 6.5). Interestingly C2.26 was 
found to be most potent (entry 1), being more effective than the phenyl complex C8.1 (entry 2). 
In comparison the xanthine-derived complexes are not as effective and a reverse of potency 
was observed with phenyl complex C12.1 outperforming carboranyl derivative C10.1 (entries 3 
and 4). The greater antiproliferative activity of C12.1 can be rationalised by its superior 
stability (Section 6.5.2), allowing for a slower release of Ag over the 96 hour period providing 
a superior cytotoxicity profile.  
Another interesting observation is that the IC50 values for each complex are the same 
irrespective to the cell line they are screened against (HCT116+/+ or HCT116−/−). The 
difference between the two cell lines is that HCT116−/− does not possess the p53 gene, also 
known as the tumour suppressor protein, i.e. it prevents the formation of tumours. The p53 
gene is the most commonly mutated gene in people who have cancer, hence, is involved in the 
complex mechanism leading to tumour formation.  
By screening the complexes against the HCT116+/+ and HCT116−/− cell lines it could be 
determined whether cell apoptosis was dependant on the p53 gene. With the IC50 values  
unaffected across both cell lines it can be hypothesised that the AgI complexes induce apoptosis 









Table 6.5 IC50 (µM) for Ag-NHC complexes screened against the HCT116+/+ and     
HCT116−/− cell lines. 
   HCT116+/+ HCT116−/− 
Entry Complex Run 1 Run 2 Run 3 
Average 
(SD) 
Run 1 Run 2 Run 3 
Average 
(SD) 
1 C2.26 1.5 1.0 1.3   1.3 ± 0.2 
) 
1.6 1.0 1.8 1.5 ± 0.4 
2 C8.1 16.0 7.7 7.7 10.5 ± 4.8 14.0 7.6 7.7 9.8 ± 3.7 
3 C10.1 17.7 15.4 19.7 17.6 ± 2.1 18.6 16.3 25.8 20.2 ± 5.0 
4 C12.1 17.0 9.0 8.9 11.6 ± 4.6 16.7 8.5 8.7 11.3 ± 4.6 
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6.7 Conclusions and future work 
A series of AgI NHC-carborane complexes have been prepared by reacting imidazolium salts in 
with Ag2O (Scheme 6.7, A). It was found that when the α-substituent of the NHC was a 
sterically bulky tBu group, an uncommon Ag(NHC)2Br2 type complex C2.24 is formed which 
is unstable. A second complex (C2.25) was also present upon crystallisation of the product 
material, which is suspected to be a decomposition product of C2.24. Reducing the sterics of 
the NHC allowed a stable AgI-NHC carborane complex C2.26 to be isolated (Scheme 6.7, B). 
A phenyl derivative C8.1 was prepared by analogous procedure.  
Scheme 6.7 Summary of ligands and complexes synthesised in this chapter. 
  CHAPTER 6 
 
 187 
In addition, a series of carboranyl xanthine derivatives L9.1-L11.1 and a phenyl derivative 
L12.1 were prepared (Scheme 6.7, C and D). When these ligand precursors were reacted with 
AgOAc it was determined that if the carborane possesses an acidic CH proton the complex was 
unstable and could not be isolated (C9.1 and C11.1). Substituting this proton for a Me group 
(L10.1), or employing the phenyl ligand precursor L12.1, allowed the corresponding AgI 
complexes to be isolated in good yield (Scheme 6.7 C and D). Phenyl complexes C8.1 and 
C12.1 were prepared for useful comparison when evaluating the cytotoxic properties of the 
complexes against the HCT116 (colon) cancer cell line. C2.24 was found to be the more potent 
than C8.1, with an IC50 value of 1.3 ± 0.2 (µM) compared to 10.5 ± 4.8 (µM) for C8.1. The 
xanthine-derived complexes showed a reverse of potency with the phenyl complex C12.1 
outperforming the carboranyl derivative C10.1 (Table 6.6).  
It is intriguing that C2.24 outperforms C8.1. Why this is the case remains unclear and future 
efforts should look towards screening both complexes against other cancer cell lines, as 
research has shown AgI-NHC complexes can have selectivity towards specific cancers.16 The 
complexes should also be screened against non cancerous cell lines to determine whether the 
complexes show selectivity for the cancer cells over healthy cells. With regards to C10.1, it is 
suspected that its relatively poor antiproliferative activity is a result of its poor stability. A more 
stable complex such as C13.1 could be prepared by increasing the tether length between the 
electron withdrawing theobromine unit and the cage to reduce the susceptibility of the cage 
towards deboronation. A proposed synthesis is outlined in Scheme 6.8. 









All manipulations were carried out under an inert atmosphere by means of standard Schlenk 
line or glovebox techniques unless otherwise stated. Anhydrous solvents were prepared by 
passing over activated alumina to remove water, copper catalyst to remove oxygen and 
molecular sieves to remove any remaining water, via the Dow-Grubbs solvent system, and then 
freeze-pump-thaw degassed prior to use. All chemicals used in this work were bought from 
either Sigma Aldrich or Alfa and used without further purification. NMR spectra were recorded 
on a Bruker AV500, Bruker AV400 or a Bruker DPX300 spectrometer. 1H NMR and 13C{1H} 
NMR chemical shifts were referenced against residual solvent peaks. Assignment of 1H and 
13C{1H} NMR spectra for all compounds was aided by the use of 2D 1H1H COSY, 1H13C 
HMQC, 1H13C HMBC and 13C{1H} DEPT 135 and DOSY experiments. Mass spectra were 
collected on a Bruker Daltonics (micro TOF) instrument operating in the electrospray mode. 
Elemental analyses were performed by Mr Stephen Boyer at London Metropolitan University. 
The preparation of NHC-carborane ligand precursors L2.1 and L2.4 can be found in Chapter 2. 
 
6.8.1 Ligand Precursors 
Preparation of P9.1.   
To an RBF was added MeCN (30 mL), theobromine (3.00 g, 
16.70 mmol), CsCO3 (10.80 g, 33.30 mmol) and propargyl 
bromide (2.27 mL, 25.00 mmol, 80 % wt toluene) and then 
heated at 80 °C for 18 hours. The reaction was then cooled to 
room temperature and the solvent removed in vacuo. DCM (50 
mL) was added, filtered and H2O (30 mL) added, and the 
organic phase was collected. This was further washed with H2O (2 × 30 mL), dried over 
MgSO4, filtered and the solvent removed in vacuo. The off white residue was recrystallised 
from DCM (20 mL) with pentane (50 mL) to give a white powder. Yield: 2.99 g, 13.70 mmol, 
(82 %). 1H NMR (500 MHz, CDCl3): δ (ppm) 7.52 (m, 1H, H8), 4.79 (d, J = 2.5 Hz, 2H, H3), 
3.99 (m, 3H, H13), 3.59 (s, 3H, H14), 2.17 (t, J = 2.5 Hz, 1H, H1). 13C NMR (126 MHz, CDCl3): 
δ (ppm) 154.5 (C5), 151.0 (C12), 149.3 (C10), 141.9 (C8), 107.7 (C6), 78.8 (C2), 70.6 (C1), 33.8 
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Preparation of P10.1.  
Prepared as described for P9.1 from theobromine (3.00 g, 
16.70 mmol), CsCO3 (10.80 g, 33.30 mmol) and 1-bromo-2-
butyne (1.60 mL, 18.40 mmol) in MeCN (30 mL). After 
work up the product was obtained as a white powder.           
Yield: 2.95 g, 12.70 mmol, 76 %. 1H NMR (500 MHz, 
CDCl3): δ (ppm) 7.50 (m, 1H, H8), 4.72 (q, J = 2 Hz, 2.5 
Hz, 2H, H3), 3.98 (m, 3H, H13), 3.58 (m, 3H, H14), 1,76 (t, J = 2Hz, 3H, H15). 13C NMR (126 
MHz, CDCl3): δ (ppm) 154.7 (C5), 151.1 (C12), 149.1 (C10), 141.7 (C8), 107.7 (C6), 78.3 (C2), 
73.9 (C1), 33.7 (C13), 31.1 (C3), 29.9 (C14), 3.8 (C15). HRMS (ESI+): m/z [C11H12N4O2Na]+ 
255.0857, calcd for [M + Na]+ 255.0852.  
 
Preparation of P11.1.  
Prepared as described for P9.1 from theobromine (3.00 g,         
16.70 mmol), CsCO3 (10.80 g, 33.30 mmol)  and 4-bromo-1-
butyne (1.88 mL, 20.00 mmol) in MeCN (30 mL). After work 
up the product was obtained as a white powder. Yield: 1.55 g,        
6.68 mmol (40 %). 1H NMR (300 MHz, CDCl3): δ (ppm) 7.50 
(s, 1H, H8), 4.27–4.14 (m, 2H, H2), 3.98 (s, 3H, H13), 3.56 (s, 
3H, H14), 2.58 (td, J = 7.3, 2.7 Hz, 2H, H3), 1.96 (t, J = 2.7 Hz, 1H, H15). 13C NMR (75 MHz, 
CDCl3): δ (ppm) 155.1 (C5), 151.4 (C12), 149.0 (C10), 141.7 (C8), 107.7 (C6), 81.0 (C1), 69.9 
(C2), 39.7 (C3), 33.7 (C13), 29.8 (C14), 17.8 (C15). HRMS (ESI+): m/z 255.0860 
[C11H12N4O2Na]+, calcd for [M + Na]+ 255.0858.  
 
 
Preparation of P12.1.  
Prepared as described for P9.1 from theobromine (3.00 g,     
16.70 mmol), CsCO3 (10.80 g, 33.30 mmol) and benzyl 
bromide (1.99 mL, 16.70 mmol) in MeCN (30 mL). After 
work up the product was obtained as a white powder. Yield: 
3.62 g, 13.40 mmol (80 %). 1H NMR (500 MHz, CDCl3): δ 
(ppm) 7.49 (m, 3H, H1, H8), 7.30 (m, 2H, H15), 7.24 (m, 1H, 
H16), 5.19 (s, 2H, H3), 3.98 (m, 3H, H13), 3.57 (s, 3H, H14). 13C NMR (126 MHz, CDCl3): δ 
(ppm) 155.4 (C5), 151.8 C12), 149.0 (C10), 141.7 (C8), 137.5 (C2), 129.0 (C1), 128.5 (C15), 127.7 
(C16), 107.8 (C6), 44.6 (C3), 33.7 (C13), 29.9 (C14). HRMS (ESI+): m/z [C14H14N4O2Na]+ 
293.1025, calcd for [M + Na]+  293.1009.  
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Preparation of P9.2.  
To a Schlenk flask was added P9.1 (1.00 g, 4.58 mmol) and 
B10H12(MeCN)2 (927 mg, 4.58 mmol) and degassed. Anhydrous 
toluene (10 mL) and anhydrous MeCN (3 mL) was added and 
slowly heated to 100 °C and kept at this temperature for 18 
hours. The reaction was cooled to room temperature and the 
solvent was removed in vacuo. The product was extracted with 
Et2O  (2 × 15 mL) and filtered. This was washed with 1 M NaOH solution (2 × 10 mL) then 
H2O (2 × 10 mL), dried over MgSO4, filtered and solvent removed in vacuo. The residue was 
recrystallised from Et2O (10 mL) with hexane (30 mL), filtered and solvent removed in vacuo 
to give a white powder. Yield: 807 mg, 2.40 mmol (52 %). 1H NMR (500 MHz, CDCl3): δ 
(ppm) 7.56 (s, 1H, H8), 4.88 (d, J = 14.9 Hz, 1H, H3), 4.60 (d, J = 14.9 Hz, 1H, H3), 4.20 (br. s, 
1H, H1), 3.98 (s, 3H, H13), 3.58 (s, 3H, H14). 13C NMR (126 MHz, CDCl3): δ (ppm) 154.5 (C5), 
151.6 (C12), 149.4 (C10), 142.6 (C8), 107.3 (C6), 74.0 (C2), 61.3 (C1), 45.3 (C3), 33.9 (C13), 30.2 
(C14). 11B{1H} NMR (161 MHz, CDCl3): δ (ppm) −1.4 (1B), −4.8 (1B), −10.0 (2B), −10.8 
(2B), −12.9 (4B). HRMS (ESI+): m/z [C10H21B10N4O2]+ 337.2670, calcd for [M + H]+ 337.2667.  
 
Preparation of P10.2. 
To a Schlenk flask was added P10.1 (1.00 g, 4.31 mmol), 
B10H12(MeCN)2 (871 mg, 4.31 mmol), anhydrous toluene         
(10 mL) and anhydrous MeCN (3 mL) and slowly heated to 
100 °C and kept at this temperature for 18 hours. The reaction 
was cooled to room temperature and the solvent was removed 
in vacuo. The residue was dissolved in a minimum amount of 
DCM and purified by silica chromatography, which was eluted with ethyl acetate/hexane 1:2. 
The product fractions were combined and the solvent is removed in vacuo. The residue was 
dissolved in Et2O (5 mL) and the product was precipitated as a white powder with hexane (30 
mL), this was filtered and dried in vacuo. Yield: 573 mg, 1.63 mmol (38 %). 1H NMR (500 
MHz, CDCl3): δ (ppm) 7.56 (d, J = 0.6 Hz, 1H, H8), 4.86 (d, J = 14.8 Hz, 1H, H3), 4.64 (d, J = 
14.8 Hz, 1H, H3), 3.99 (d, J = 0.6 Hz, 3H, H13), 3.59 (s, 3H, H14), 2.34 (s, 3H, H15). 13C NMR 
(126 MHz, CDCl3): δ (ppm) 154.7 (C5), 151.5 (C12), 149.5 (C10), 142.4 (C8), 107.4 (C6), 77.4 
(C2), 75.9 (C1), 42.5 (C3), 33.9 (C13), 30.2 (C14), 23.5 (C15). 11B{1H} NMR (161 MHz, CDCl3): 
δ (ppm) −3.2 (1B), −6.0 (1B), −9.9 (8B). HRMS (ESI+): m/z [C11H23B10N4O2]+ 351.2824, calcd 
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Preparation of P11.2.  
To a Schlenk flask was added P11.1 (1.00 g, 4.31 mmol), 
B10H12(MeCN)2 (871 mg, 4.31 mmol), anhydrous toluene 
(10 mL) and anhydrous MeCN (3 mL) and slowly heated 
to 100 °C and kept at this temperature for 18 hours. The 
reaction was cooled to room temperature and the solvent 
was removed in vacuo. The residue was dissolved in a 
minimum amount of DCM and purified by silica 
chromatography, which was eluted with ethyl acetate/hexane 1:2 and then the product is eluted 
with DCM/MeOH (10 %). The product fractions are combined and the solvent was removed in 
vacuo. The residue was dissolved in Et2O (5 mL) and the product was precipitated as a white 
powder with hexane (30 mL), this as filtered and dried in vacuo. Yield: 680 mg, 1.93 mmol   
(45 %). 1H NMR (300 MHz, CDCl3): δ (ppm) 7.52 (s, 1H, H8), 4.12 (m, 2H, H2), 3.96 (s, 1H, 
H13), 3.73 (br. s, 1H, H15), 2.52 (s, 3H, H14). 13C NMR (75 MHz, CDCl3): δ (ppm) 154.8 (C5), 
151.2 (C12), 149.2 (C10), 142.0 (C8), 107.6 (C6), 72.4 (C15), 61.6 (C1), 40.0 (C3), 35.12 (C2), 
33.8 (C13), 29.89 (C14). 11B{1H} NMR (96 MHz, dmso-d6): δ (ppm) −2.1 (1B), −5.3 (1B),     
−9.1 (2B), −11.6 (6B). HRMS (ESI+): m/z [C13H23B10N5O2Na]+ 413.2600, calcd for                
[M + MeCN + Na − H2]+ 413.2716.  
 
Preparation of L9.1.  
An ampoule was charged with MeCN (5 mL), P9.2 (1.17 g,   
3.48 mmol) and MeI (6.49 mL, 104.3 mmol) and heated at 80 °C 
for 7 days. The reaction was then cooled to room temperature 
and solvent removed in vacuo. To the residue was added Et2O 
(30 mL) and then sonicated, filtered, washed with Et2O (20 mL) 
and dried in vacuo to give a white powder. Yield:  631 mg, 1.46 
mmol (42 %). 1H NMR (500 MHz, DMSO-d6): δ (ppm) 9.35 (s, 1H, H8), 5.11 (br. s, 1H, H1), 
4.81 (d, J = 15.1 Hz, 1H, H3), 4.58 (d, J = 15.1 Hz, 1H, H3), 4.16 (s, 3H, H14), 4.06 (s, 3H, H13), 
3.76 (s, 3H, H15). 13C NMR (126 MHz, DMSO-d6): δ (ppm) 152.7 (C5), 150.1 (C12), 140.5 (C8), 
139.9 (C10), 107.5 (C6), 73.2 (C2), 62.4 (C1), 45.1 (C3), 37.0 (C14), 35.8 (C13), 31.8 (C15). 
11B{1H} NMR (161 MHz, DMSO-d6): δ (ppm) −2.9 (1B), −5.2 (1B), −10.0 (2B), −11.6 (3B),       
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Preparation of L10.1.  
Prepared as described for L9.1 from P10.2 (500 mg,       
1.43 mmol) and MeI (2.67 mL, 42.6 mmol) in MeCN (5 
mL). After purification the product was obtained as a white 
powder. Yield: 287 mg, 0.64 mmol (45 %). 1H NMR (500 
MHz, DMSO-d6): δ (ppm) 9.34 (s, 1H, H8), 4.86 (d,             
J = 15.4 Hz, 1H, H3), 4.64 (d, J = 15.4 Hz, 1H, H3), 4.16 (s, 
3H, H14), 4.07 (s, 3H, H13), 3.77 (s, 3H, H15), 2.35 (s, 3H, H16). 13C NMR (126 MHz, DMSO-
d6): δ (ppm) 152.9 (C5), 150.1 (C12), 140.5 (C8), 140.0 (C10), 107.4 (C6), 77.9 (C2), 75.7 (C1), 
43.0 (C3), 37.0 (C14), 35.8 (C13), 31.8 (C15), 22.6 (C16). 11B{1H} NMR (161 MHz, DMSO-d6): δ 
(ppm) −2.9 (1B), −5.2 (1B), −10.0 (2B), −11.6 (3B), −12.9 (3B). HRMS (ESI+): m/z 
[C11H23B10N4O2]+ 366.2963, calcd for [M − I]+ 366.2944.  
 
Preparation of L11.1.  
Prepared as described for L9.1 from P11.2 (450 mg, 
1.28 mmol) and MeI (2.40 mL, 38.5 mmol) in MeCN 
(5 mL). After purification the product was obtained as 
a yellow powder. Yield: 189 mg, 0.86 mmol            
(67 %).1H NMR (500 MHz, dmso-d6): δ (ppm) 9.29 
(s, 1H, H8), 5.38 (br. s, 1H, H16), 4.14 (s, 1H, H14), 
4.04 (s, 3H, H13), 3.98 (m, 2H, H3), 3.72 (s, 3H, H15). 
13C NMR (75 MHz, dmso-d6): δ (ppm) 152.8 (C5), 149.7 (C12), 139.1 (C8), 139.5 (C10), 107.8 
(C6), 73.0 (C1), 63.6 (C16), 36.9 (C14), 35.6 (C13), 33.0 (C3), 31.4 (C15). 11B NMR (96 MHz, 
CD3CN): δ (ppm) −2.83, −5.58, −9.47, −11.78, −12.93. HRMS (ESI+): m/z [C11H23B10N4O2]+ 
366.2960, calcd for [M − I]+ 366.2944. (Note: only one of the CH2 resonance is observed). 
 
Preparation of L12.1.  
An ampoule was charged with MeCN (5 mL), P12.1 (1.00 g, 
3.70 mmol) and MeI (6.91 mL, 111 mmol) and heated at    
80 °C for 100 hours. The reaction was then cooled to room 
temperature and solvent removed in vacuo. To the residue 
was added DCM (5 mL) and the product recrystallised with 
hexane (30 mL) this was then filtered yielding a sticky 
orange solid. This was dissolved in DCM (5 mL) and hexane (5 mL) is added, the solvent is 
removed in vacuo to give a fluffy golden solid, which is highly hygroscopic. Yield: 1.30 g,   
3.15 mmol (85 %). 1H NMR (500 MHz, DMSO-d6): δ (ppm) 9.32 (s, 1H, H8), 7.33 (m, 4H, 
H1,16), 7.28 (m, 1H, H17), 5.09 (s, 2H, H3), 4.15 (s, 3H, H14), 4.07 (s, 3H, H13), 3.74 (s, 3H, H15). 
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13C NMR (126 MHz, DMSO-d6): δ (ppm) 153.2 (C5), 150.0 (C12), 139.8 (C8), 139.6 (C10), 
136.2 (C2), 128.3 (C1), 127.7 (C16), 127.4 (C17), 107.8 (C6), 44.5 (C3), 36.9 (C14), 35.7 (C13), 
31.5 (C15). HRMS (ESI+): m/z [C15H17N4O2]+ 285.1343, calcd for [M − I]+ 285.1346.  
 
Preparation of L8.1.  
To an ampoule was added MeCN (2 mL), mesityl imidazole 
(576 mg, 3.09 mmol) and 2-bromoethyl-benzene (0.42 mL, 
3.09 mmol) and heated at reflux for 18 hours. The reaction 
was cooled to room temperature and the product was 
precipitated with Et2O (30 mL), filtered and dried in vacuo to 
give a white microcrystalline solid. Yield: 886 mg, 2.39 mmol 
(77 %). 1H NMR (500 MHz, DMSO-d6): δ (ppm) 9.35 (t, J = 1.5 Hz, 1H, H7), 8.12 (t, J = 1.7 
Hz, 1H, H5), 7.87 (t, J = 1.8 Hz, 1H, H6), 7.28 (m, 2H, H15), 7.24 (s, 2H, H1), 7.22 (m, 1H, H14), 
7.10 (s, 2H, H10), 4.62 (t, J = 6.8 Hz, 2H, H4), 3.26 (t, J = 6.8 Hz, 2H, H3), 2.30 (s, 3H, H13), 
1.86 (s, 6H, H12). 13C NMR (126 MHz, DMSO-d6): δ (ppm) 140.2 (C11), 137.2 (C7), 136.6 (C2), 
134.1 (C9), 130.9 (C8), 129.1 (C10), 128.7 (C1/15), 128.5 (C1/15), 126.8 (C14), 123.8 (C6), 123.1 
(C5), 50.2 (C4), 34.9 (C3), 20.5 (C13), 16.7 (C12). HRMS (ESI+): m/z [C20H23N2]+ 291.1870, 
calcd for [M − Br]+ 291.1856.  
 
6.8.2 Complexes 
Preparation of C2.26.  
An ampoule was charged with L8.1 (200 mg, 0.46 mmol) 
and Ag2O (53 mg, 0.23 mmol) and degassed. Anhydrous 
DCM (5 mL) was added and the mixture is stirred at room 
temperature for 24 hours. The solution was filtered through 
Celite and the solvent was removed in vacuo. The residue 
was dissolved in Et2O (5 mL) and the product was 
precipitated with hexane (15 mL), filtered and dried in 
vacuo to give a beige powder. Yield: 141 mg, 0.16 mmol 
(68 %). 1H NMR (500 MHz, CD2Cl2): δ (ppm) 7.07 (d, J = 1.8 Hz, 1H, H5), 6.97 (s, 2H, H10), 
6.87 (d, J = 1.8 Hz, 1H, H6), 5.33 (br. s, 1H, H1), 4.07 (m, 2H, H4), 3.05 (m, 2H, H3), 2.37 (s, 
3H, H13), 1.89 (s, 6H, H12). 13C NMR (126 MHz, DMSO-d6): δ (ppm) 139.6 (C11), 136.7 (C8), 
135.7 (C9), 129.7 (C10), 122.7 (C6), 121.2 (C5), 73.1 (C2), 64.4 (C1), 50.7 (C4), 37.8 (C3), 21.4 
(C13), 18.2 (C12). 11B{1H} NMR (161 MHz, DMSO-d6): δ (ppm) −3.2, −5.5, −10.0 (2B), −9.5,       
−13.0. HRMS (ESI+): m/z [C32H56B20AgN4]+ 819.5598, calcd for [M − Br]+ 819.5562. Anal. 
Calcd for C32H56B20AgBrN4: C, 42.67; H, 6.27; N, 6.22. Found: C, 42.49; H6.16; N, 6.17. 
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Preparation of C8.1.  
An ampoule was charged with L8.1 (200 mg, 0.54 mmol) 
and Ag2O (69 mg, 0.30 mmol) and degassed. Anhydrous 
DCM (5 mL) was added and the mixture is stirred at room 
temperature for 24 hours. The solution was filtered through 
Celite and the solvent removed in vacuo and methanol         
(5 mL) was added. The insoluble particulate was filtered and 
the product was precipitated with Et2O (30 mL), filtered and 
dried in vacuo to give a white powder. Yield: 145 mg,      
0.19 mmol (70 %). 1H NMR (500 MHz, CD2Cl2): δ (ppm) 7.20 (s, 1H, H5), 7.18 (m, 3H, 
H14,15), 6.90 (m, 4H, H1,10), 6.84 (s, 1H, H6), 4.26 (t, J = 6.5 Hz, 2H, H4), 3.00 (t, J = 6.5 Hz, 
2H, H3), 2.31 (s, 3H, H13), 1.74 (s, 6H, H12). 13C NMR (126 MHz, DMSO-d6): δ (ppm) 182.9 
(C7), 139.9 (C11), 137.7 (C2), 136.1 (C8), 135.4 (C9), 129.6 (C10), 129.4 (C1), 129.1 (C15), 127.4 
(C14), 123.0 (C6), 122.4 (C5), 53.4 (C4), 38.0 (C3), 21.4 (C13), 17.9 (C12). HRMS (ESI+): m/z 
[C40H44AgN4]+ 689.2621, calcd for [M − Br]+ 689.2615. Anal. Calcd for C, 62.51; H, 5.77; N, 
7.29. Found: C, 62.38; H, 5.89; N, 7.17. 
 
Preparation of C10.1.  
An ampoule was charged with L10.1 (150 mg,     
0.31 mmol), AgOAc (102 mg, 0.61 mmol) and 
anhydrous DCM (5 mL) and stirred at room 
temperature for 48 hours. The reaction mixture 
was filtered through Celite washed with DCM     
(5 mL) and the solvent volume reduced to 5 mL in 
vacuo. The product was precipitate with diethyl ether (30 mL), filtered and dried in vacuo to 
give a white powder. Yield: 90 mg, 0.17 mmol (55 %). 1H NMR (500 MHz, CD2Cl2): δ (ppm)  
4.88 (d, J = 14.9 Hz, 1H, H3), 4.61 (d, J = 14.9 Hz, 1H, H3), 4.21 (s, 3H, H14), 4.11 (s, 3H, H13), 
3.81 (s, 3H, H15), 2.32 (s, 3H, H16), 1.95 (s, 3H, H18). 13C NMR (126 MHz, DMSO-d6): δ (ppm) 
188.4 (C8), 178.8 (C17), 153.3 (C5), 151.2 (C12), 141.2 (C10), 110.1 (C6), 78.2 (C1), 75.8 (C2), 
43.6 (C3), 40.5 (C14), 39.2 (C13), 32.9 (C15), 23.7 (C16), 22.9 (C18). 11B{1H} NMR (161 MHz, 
CD2Cl2): δ (ppm) −3.3 (1B), −6.0 (1B), −9.9 (8B). Anal. Calcd for C14H27AgB10N4O4: C, 31.65; 
H, 5.12; N, 10.54. Found: C, 31.58; H, 4.97; N, 10.37.  Complex could not be characterised by 
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Preparation of C12.1.  
Prepared as described for C10.1 from  L12.1 
(300 mg, 0.73 mmol) and AgOAc (255 mg, 
1.53 mmol) in anhydrous DCM (5 mL). and 
stirred at room temperature for 48 hours. After 
purification the product was obtained as a white 
powder. Yield: 191 mg, 0.42 mmol (58 %). 1H 
NMR (500 MHz, CD2Cl2): δ (ppm) 7.42-7.39 (m, 2H, H1), 7.33-7.24 (m, 3H, H16/17), 5.15 (s, 
2H, H3), 4.16 (s, 3H, H14), 4.11 (s, 3H, H13), 3.76 (s, 3H, H15), 1.94 (s, 3H, H19). 13C NMR (126 
MHz, CD2Cl2): δ (ppm) 187.2 (C8), 178.7 (C18), 153.9 (C5), 151.2 (C12), 140.8 (C10), 137.2 
(C2), 129.1 (C1), 128.9 (C16), 128.3 (C17), 110.4 (C6), 45.6 (C3), 40.3 (C14), 39.1 (C13), 32.4 
(C15), 22.9 (C19). Anal. Calcd for C17H20AgN4O4: C, 45.15; H, 4.46; N, 12.39. Found: C, 45.17; 
H, 34.10; N, 12.48. Complex could not be characterised by HRMS due to scrambling. The 
major peak molecular ion peak observed corresponded to m/z [C30H32AgN8O4]+ 675.1602, 




In vitro cell tests were performed at the Cancer Pharmacology Institute at the University of  
Huddersfield by Mr. Suliman Atallah who works under the supervision of Prof. Roger Phillips. 
Cells were incubated in 96-well plates, at 2 × 103 cells per well in 200 µL of growth media 
(RPMI 1640 supplemented with 10 % foetal calf serum, sodium pyruvate (1 mM) and             
L-glutamine (2 mM)). Cells were incubated for 24 hours at 37 °C in an atmosphere of 5 % CO2 
prior to drug exposure. Silver compounds were dissolved in DMSO at a concentration of 25 
mM and diluted with medium to obtain drug solutions ranging from 25 µM to 0.049 µM. The 
final DMSO concentration was 0.1 % (v/v) which is non-toxic to cells. Drug solutions were 
applied to cells and incubated for 96 hours at 37 °C in an atmosphere of 5 % CO2. The 
solutions were removed from the wells and fresh medium added to each well along with 20 µL 
MTT (5 mg mL-1), and incubated for 4 hours at 37 °C in an atmosphere of 5 % CO2. The 
solutions were removed and DMSO (150 µL) was added to each well to dissolve the purple 
formazan crystals. A plate reader was used to measure the absorbance at 540 nm. Lanes 
containing medium only, and cells in medium only (no drug), were used as blanks for the 
spectrophotometer and 100 % cell survival respectively. Cell survival was determined as the 
true absorbance of treated cells divided by the true absorbance of controls and expressed as a 
percentage. The concentration required to kill 50 % of cells (IC50) was determined from plots of 
% survival against drug concentration.  
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